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ABSTRACT 
Deoxynivalenol (DON), produced by Fusarium graminearum and Fusarium culmorum, 
is commonly found in wheat, corn, oats and barley. We hypothesize DON exposure could 
change leukocyte subset number and their migration potential in peripheral blood with 
interaction of age and sex, which could be sensitive biomarkers to predict DON exposure for 
human epidemiological screening.  
The first mouse study was done in 6-7 week old BALB/c mice. Peripheral blood (PB) and 
splenic leukocytes were stained and detected by flow cytometry. The results showed the 
percentage of B cells (CD19
+
) in PB was reduced in both sexes at 1.0 and 2.0 ppm at 14 d, 
with no reduction of B cells after 28 d. Monocytes (CD11b
+
) in PB and macrophage cells 
(CD11b
+
) in spleen were decreased in female BALB/c mice at 1.0 and 2.0 ppm after 28 d, 
which suggested sex hormones interacted with DON immunotoxicity. No toxicity was 
observed at doses 0.5 ppm or less. 
The second mouse study was done in 2-3 month old and 16 month old BALB/c mice. 
Granulocytes in both ages and sexes were increased at 1.0 and 2.0 ppm DON at 14 d, but 
normalized after 28 d. Percentage of T helper cells in PB was decreased in young female 
mice fed 2.0 ppm DON after 14 d, not after 28 d. Percentage of CXCR5
+
 B cells was 
decreased in old female mice fed 2.0 ppm DON after 14 d, but not after 28 d. CD29
+
CD11a
+
 
neutrophils were increased at 1.0 and 2.0 ppm DON in old male mice after 14 d, but no 
difference was observed after 28 d. CCR9
+
 T cytotoxic cells were increased in old male mice 
fed 2.0 ppm DON after 28 d. Taken together, these results suggested DON inhibited T helper 
cells in young female mice and interrupted B cell, neutrophil and T cytotoxic cell migration 
potentials in old mice. Most DON toxicity was transient, and interacted with age and sex. 
In conclusion, the surface markers of leukocytes in PB were changed in BALB/c mice 
fed 1.0 ppm and 2.0 ppm DON. Age and sex interacted with DON exposure. Most of the 
effects of DON were temporary, which suggested BALB/c mice adapted to DON exposure.
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CHAPTER 1 GENERAL INTRODUCTION 
Research questions 
Immune system and intestine are the two main targets after DON exposure.  Few studies 
reported the effects of subchronic low doses of DON, which simulated real human exposures 
in comparison with advisory guidelines for DON ranging from 0.5-2 ppm across the EU, 
Canada, China and US (Landgren 2005). In our lab, a previous study found 1.0 ppm DON 
plus 0.9 ppm 3-Ac DON and 2.0 ppm DON plus 1.8 ppm 3-Ac DON inhibited peripheral 
blood lymphocytes in male BALB/c mice after 28 d (Landgren 2005), which suggested 
peripheral blood leukocytes could be sensitive biomarker to predict low dose of DON 
exposure in human epidemiological study. 
The current mouse studies were to find sensitive biomarkers in peripheral blood to 
predict low dose of immunotoxicity of DON. General markers used in order to determine if 
DON inhibits T helper, T cytotoxic, B, monocytes and neutrophils were CD4, CD8, CD19, 
CD11b, and CD11b
+
 (granulocytes), respectively. CD11b is also a marker for neutrophils 
which can be separated from monocytes due to different intercellular granularity. In order to 
investigate the possibility that DON altered cell migration potential, special markers were 
selected: CXCR5 for B cells, CD62L, CCR7, CCR9 and CCR10 for T cells, CD29 and 
CD11a for monocytes and neutrophils. CXCR5 is the chemokine receptor expressed in B 
cells in order to direct B cell access to follicles (Boehmer et al. 2005).  Chemokines mediate 
control of T cell traffic in lymphoid and peripheral tissues. Naive T cell homing to lymph 
nodes undergoes multistep interactions with endothelial cells. After initial tethering and 
rolling via L-selectin (CD62L), further arrest of rolling cells is activated by CCR7 (Ebert et 
al. 2005). CCR9 selectively directs T cell access to small intestine by interaction with CCL25. 
CCR10 is a frequent marker in inflammatory T cells, preferentially on effecter T cells in 
peripheral blood in order to direct T cells to large intestine and skin (Ebert et al. 2005; 
Williams 2004). Lymphocyte function-associated antigen-1 (LFA1, known as CD11a-CD18), 
and very late antigen 4 (VLA4, CD29) are important adhesion markers to regulate mature 
neutrophil and non-differentiated monocyte migration to tissues (Ley et al. 2007; Imhof and 
Aurrand-Lions 2004).  
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Spleen is the biggest secondary lymphoid organ. In the animal model, splenic leukocytes 
were collected and stained by basic markers: CD4, CD8, CD19 and CD11b in order to 
investigate if cell migration happens between peripheral blood and spleen. 
Age, sex, dose, exposure time of DON all could change the final measurement of DON‟s 
influence on peripheral blood and splenic leukocyte surface markers. Therefore, 2-3 month 
old vs. 16 month old BALB/c (both sexes) were fed DON after 14 d and 28 d in order to 
investigate if age could enhance DON toxicity to the immune system, if different sensitivity 
occurs between female and male, and if longer exposure time could induce toxicity 
cumulatively. 
Dissertation organization 
This document contains a general literature review and two manuscripts. The general 
literature review includes all relevant information on DON, approaches to the study of 
immunotoxicity and age and sex influence on the immune system. Two manuscripts for 
publication are included as separate chapters. General Conclusions with discussion of results 
and suggestions for future studies included. References appear at the end of each chapter. 
Bibliography 
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CHAPTER 2 LITERATURE REVIEW 
General information 
Deoxynivalenol (DON, vomitoxin) is a type B trichothecene. The occurrence of DON is 
associated primarily with Fusarium graminearum (Gibberella zeae) and F. culmorum, both 
of which are important plant pathogens which cause Fusarium head blight in wheat and 
Gibberella ear rot in maize. F. graminearum grows optimally at a temperature of 25 °C and 
at a water activity above 0.88. F. culmorum grows optimally at 21 °C and at a water activity 
above 0.87. The formation of DON in growing crops is dependent on climate and will thus 
vary between geographical regions. Moreover, DON can also be produced during storage 
where moisture content of stored grains is less rigorously controlled (Christian Larsen et al. 
2004; review by WHO 1991; Isebaert et al. 2004; Lori et al. 2003). DON is one of the more 
polar trichothecenes with molecular weight, 296.3 g mol
-1
 and the molecular formula 
C15H20O6. It has a 12, 13 epoxy group, OH group, and an α, β- unsaturated keto group, with 
the chemical name is 12, 13-epoxy-3α, 7α, 15-trihydroxy-trichothec-9-en-8-one (Fig 2.1). 
 
Trichothecene R1 R2 R3 R4 R5 
DON OH H OH OH =O 
3-Ac DON OAC H OH OH =O 
 15-Ac DON OH H OAC OH =O 
Nivalenol (NIV) OH OH OH OH =O 
 4-Ac NIV OH OAC OH OH =O 
Diacetoxyscirpenol OH OAC OAC H H 
Fig 2.1 Trichothecene skeleton and selected mytotoxins shown in this chapter  
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Once produced in the field or during storage, it is very difficult to get rid of DON from 
final human product of consumption. Therefore, knowledge of adverse effects and how to 
reduce the toxicity of DON are important questions. In the following, DON metabolism and 
DON main toxicities, especially immunotoxicity are discussed. And guidelines of 
immunotoxicology used for biomaterials, and how do age and sex influence the immune 
system were introduced. Finally, DON exposure and the approaches used for detoxification 
of DON are discussed. 
Approaches and concepts in immunotoxicology 
The immune system involves complex multicellular interactions that are required for a 
balance of host defense and self-tolerance (homeostasis). The immune system responds not 
only to its own signals but also to signals from non-lymphoid systems (neuropeptide and 
steroid hormones), which contribute to the complexity of immunotoxicology. The 
development of immunotoxicology has benefited from recent advancements of immunology. 
As we observed, dysfunction of immune system are associated with a variety of 
immunotoxicants, such as heavy metals (Dietert et al. 2004; Hostýnek et al. 2002), PCBs 
(Larsen 2006), and mycotoxins (Sharma 1993).  The regulatory guideline for 
immuntoxicology was set up just 10 year ago.  
The Office of Prevention, Pesticide and Toxic Substances of EPA (1996) developed a 
guidelines intended to meet testing requirements of the Federal Insecticide, Fungicide and 
Rodenticide Act (OPPTS 880.3550). The immunotoxicity was defined as “the ability of a test 
substance to induce dysfunction or inappropriate suppressive or stimulatory responses in 
components of the immune system”. The routes of exposure for the immunotoxicity studies 
will be analogous to the route of exposure for subchronic study, usually after dosing by the 
oral route.  Young animals (6~8 weeks, n=10) will be used. The tests include observation of 
animals (food intake/ body weight), clinical examination (hematology, clinical biochemistry), 
gross necropsy and tissue preparation (spleen, thymus and bone marrow), and 
immunotoxicity tests. The immunotoxicity tests include humoral immunity (antibody plaque-
forming cell assay and immunoglobulin quantification), specific cell-mediated immunity 
(lymphocyte blastogenesis, delayed-type hypersensitivity reaction, and cytotoxic T-
lymphocyte assay), and non-specific cell-mediate immunity (natural killer cell activity, and 
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macrophage number and phagocytosis). If any dysfunction or impairment of the components 
of the immune system is indicated in any of above (Tier I) tests, then Tier II (OPPTS 
880.3800, 40 CFR 158.165) immunotoxicity studies are required. Altered host resistance 
after challenge with infectious agents or with tumor cells may be required. Other 
immunotoxicological studies include immune histochemistry for lymphoid organs and tissues, 
as well as measurements of serum complement, antibody response to T-independent antigens, 
and enumeration of subpopulations of T and B lymphocytes. 
Six different agencies within the U.S. Department of Health and Human Services, Food 
and Drug Administration, Center for Devices and Radiological Health, Molecular Biology 
Branch, Division of Life Science, and Office of Science and Technology (1999, 
http://www.fda.gov/cdrh/ost/ostggp/immunotox.html) developed immunotoxicity guidance to 
provide FDA reviewers and manufacturers with a systematic approach for evaluating 
potential adverse immunological effects of medical devices and constituent materials. In this 
guideline, the definition of immunotoxicity refers to “any adverse effect on the structure or 
function of the immune system, or on other systems as a result of immune system 
dysfunction”. The adverse or immunotoxic effect could be immunosuppression if humoral or 
cellular immunity of host is impaired against infectious or neoplastic diseases, or 
immunostimulation (autoimmunity, hypersensitivity, or chronic inflammation) resulting in 
tissue damage. FDA provides examples of the specific types of tests that might be used to 
study the responses listed in Table 2.1. These tests separated into three groups: functional 
assays, soluble mediators and phenotyping. Table 2.2 provides examples of the specific types 
of tests that might be used to study the responses listed in Table 2.1. 
Table 2.1: classification of immune responses associated with potential immune effects 
Immunotoxic 
effects 
Histopa- 
thology 
Humoral 
response 
Tcells NK 
cells 
macrophages Granulocytes Host 
resistant 
hypersensitivity NC C C NA NA C NA 
inflammation C NC C NA C C NA 
immunosuppression NC C C C C C C 
immunostimulation NC C C NA NC NA NC 
autoimmunity C C C NA NA NC NA 
C    = Critical, NC = Non-Critical, NA = Not Applicable or Not Needed, 
Cited from http://www.fda.gov/cdrh/ost/ostggp/immunotox.html#T2 
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Table 2.2: Examples of tests for the evaluation of immune responses 
Immune 
responses 
Functional assays Soluble mediators Phenotyping 
Humoral 
response 
Immunoassays (e.g. ELISA) for 
antibody response to antigen plus 
adjuvant* Plaque-forming cells  
Lymphocyte proliferation  
Antibody-dependent cell-mediated 
cytotoxicity  
Passive cutaneous anaphylaxis 
Direct anaphylaxis 
Complement (including C3a 
and C5a anaphylatoxins)*, 
Immune complexes 
 
Cell surface markers 
T cells 
Guinea pig maximization test* 
Mouse local lymph node assay* 
Mouse ear swelling test 
Lymphocyte proliferation 
Mixed lymphocyte reactio 
Cytokine patterns indicative 
of T cell subsets (e.g. Th1 
and Th2) 
Cell surface markers 
(helper and cytotoxic 
T-cells) 
NK cells Tumor cytotoxicity / Cell surface markers 
Macrophages 
Phagocytosis* 
Antigen presentation 
Cytokines (IL-1, TNF-alpha, 
IL-6, TGF-beta) 
MHC markers 
Granulocytes 
Degranulation  
Phagocytosis 
Chemokines, Bioactive 
amines, Inflammatory 
cytokines, Enzymes 
/ 
Host 
resistance 
Resistance to bacteria, viruses and 
tumors 
/ / 
Cited from website of FDA http://www.fda.gov/cdrh/ost/ostggp/immunotox.html#T2 *Most commonly 
used tests. 
Many approaches to assess xenobiotic of immunotoxicity were based on traditional 
laboratory animals, most rats and mice. Evaluation of immunotoxicity potential using 
wildlife may help environmental risk assessment. Marine bivalve mollusk is used as model 
for marine immunotoxicity related to domestic and industrial wastes, especially for stable 
compounds such as organochlorines. Fish are sensitive models for evaluation of aquatic 
pollutants such as metals, polycyclic aromatic hydrocarbons, and halogenated aromatic 
hydrocarbons. Amphibian models such as tadpole, frogs, and salamanders are used for 
immunotoxic evaluation due to the problem of global amphibian declines after agricultural 
pesticide exposure. Earthworm is used for a model of chemical-induced immunotoxic 
potential of xenobiotics in terrestrial ecosystems. In risk assessment of immunotoxicity, it is 
important to find the sensitive models and advanced method to decide the potential toxicity 
of test compounds to overall environmental health (Tryphonas et al. 2005). 
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 In order to predict the risk of immunotoxic exposure in human populations, accurate and 
quantitative experimental or clinical immune tests of human health effects should be 
established. Rodent species and non-human primates are common models substituting for 
human epidemiological study. Testing schemes proposed by the World Health Organization 
(WHO, 1996) for human immunotoxicology includes blood count and clinical chemistry, 
inflammation and nonspecific immunity (C-reactive protein, NK cell, phagocytosis assay), 
cellular immunity (delayed-type hypersensitivity, surface analysis for CD4, CD8, CD3, and 
CD20), and humoral immunity (serum Ig, antibody to ubiquitous antigen, response to protein 
antigen, auto-antibody tiers, proliferation to recall antigen, Ig E to allergen). Additionally, 
developmental immunotoxicology and gut mucosal immunotoxicology have used rodent 
species as models due to inexpensive, convenient, and practical characteristics. Guinea pig, 
mouse, and rat models are used often for safety assessment of protein allergenicity 
(Tryphonas et al. 2005). 
Most assessment of chemical toxicity has relied on laboratory animals.  There is still a 
gap when transferring animal data to human populations. The chemical form of test 
compound, tissue collected, age, sex, cell type, and in vitro/in vivo assay all influence the 
final measurement (Tryphonas et al. 2005). Therefore, differences in sensitivity associated 
with factors should be carefully reviewed when setting up a guideline for testing compounds. 
Age related difference in immune system 
The effects of aging on the immune system are widespread and extend from 
hematopoietic stem cells (HSCs) and progenitors in the bone marrow and thymus to mature 
lymphocytes in secondary lymphoid organs. Studies of age-related effects on innate 
immunity are limited compared to studies on adaptive immunity. 
Aging and hematopoietic stem cells 
Adult bone marrow cells (BMCs) include two populations: mesenchymal stem cells 
(MSCs), which can differentiate into bone, cartilage, and fat; and hematopoietic stem cells 
(HSCs), which can proliferate and generate new HSCs and differentiate into myeloid and 
lymphoid cells. Aging hematopoietic stem cells decline in function and exhibit dysregulation 
in gene expression (Chambers et al. 2007). 
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The ability of HSCs to proliferate and differentiate was decreased with aging. Through 
cross-transplantation model, the effects of aging on the number of Lin (-)c-kit
+
 HSCs, on 
their ability to differentiate towards a lymphocyte phenotype, and on the role of the 
microenviroment in hematopoietic differentiation were evaluated (Donnini et al 2007). The 
results showed the absolute number of purified Lin(-)c-kit+ cells from bone marrow was 
significantly lower in aged than in young mice and HSCs from aged mice showed a reduced 
differentiation capacity in T cells and NK cells. The role of microenviroment in HSC 
differentiation was evaluated by injecting young HSCs into young or aged recipients. The 
results showed the differentiation of HSCs from young mice in T and NK cells are less 
efficient in aged than in young recipients. If injection of HSCs from aged in young recipients, 
the results showed HSCs from aged mice can differentiate in CD4+T cells with IL-4 
production in young recipients. Therefore, aging is associated with numerical and functional 
alterations of HSCs and microenvironment required for differentiation. 
 Linton and Dorshkind (2004) explained that bone marrow from old mice does not 
efficiently generate lymphoid progeny in that fewer lymphoid progenitors are produced by 
old mice or those lymphoid progenitors produced had reduced proliferation and/or survival. 
The loss of lymphoid-biased HSC may contribute to the impaired immune response to 
infectious diseases and cancers in the aged.  
In Cho et al. (2008) study, three classes of HSCs can be distinguished based on their 
differentiation programs: lymphoid-biased (generate fewer myeloid), balanced (generate 
equal number of lymphoid and myeloid), and myeloid-biased (produce reduced number of 
lymphoid). It was reported that aging causes a marked shift in the representation of these 
HSC subsets. A clonal analysis of repopulating HSCs demonstrates that lymphoid-biased 
HSCs are lost and long-lived myeloid-biased HSCs accumulate in the aged. Myeloid-biased 
HSCs from young and aged sources behave similarly in all aspects tested. Genetic factors 
contribute to the age-related changes of the HSC subsets. In comparison to B6 mice, aged D2 
mice show a more pronounced shift towards myeloid-biased HSCs with a corresponding 
reduction in the number of both T and B cell precursors. Age related changes in favor HSC to 
myeloid lineage were also observed in Liang et al. (2005). In this study, young or old 
C57BL/6 bone marrow (BM) cells were injected into old or young Ly5 congenic mice. The 
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result showed the increased ages of HSC donors and HSC transplant recipients caused 
marked skewing of the pattern of engraftment toward the myeloid lineage, indicating that 
HSC-intrinsic and HSC-extrinsic (microenvironmental) age-related changes favor 
myelopoiesis. At the same time, it was observed the overall size of individual stem-cell 
clones generated in recipients receiving a single CRU was not affected by donor age. These 
studies suggest that low levels of lymphocytes in the blood could be a marker associated with 
HSC aging. 
The relationship between age and stem cells in human was examined. Moresi  et al. (2005) 
studied the number of circulating CD34
+
 stem cells and their capacity to generate  
granulocyte-macrophagic (CFU-GM), erythroid (BFU-E), and mixed (CFU-GEMM) in 130 
healthy subjects (80 females and 50 males) ranging in age from 16 to 100 years. The result 
showed that the absolute number of circulating CD34 
+
 cells progressively and significantly 
decreased with advancing age, with a 2-fold reduction in subjects aged more than 80 years. 
The number of CFU-GM, BFU-E, and CFU-GEMM colonies which developed from the 
number of CD34
+
 purified cells per ml significantly decreased with advancing age. The 
reduction of CD34
+
 cell number and clonogenic capacity during aging was statistically 
significant in males but not in females. When evaluated on a per cell basis, a significant age-
related decrease in the number of CFU-GM colonies was observed in female but not in male 
subjects. This study demonstrates the influence of gender on age-related alterations of the 
number and clonogenic capacity of CD34
+
 cells in the peripheral blood (Moresi  et al. 2005). 
This study also suggested developing method to detect surface markers of stem cell in 
circulation could be a substitute way for direct bone marrow measurement. 
Aging is associated with loss of bone, and increase in the volume of adipose tissue, 
especially some diseases could develop more adipocytes in bone marrow, which are result in 
decreased lymphocytes production. To study the effect of aging, gender, and age-related 
disorders on lineage differentiation, Jiang et al. (2008) did a study in a human population 
including 80 healthy subjects and patients with two age-related disorders: osteoarthritis (OA) 
and rheumatoid arthritis (RA).  RANKL (bone reabsorption) and PPAR-γ (adipogenic 
specific transcription factor) levels exhibited a clear positive correlation with age in female 
patients, but not in males. Compared with age-matched controls, RA and OA patients 
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exhibited increased RANKL, and PPAR- γ mRNA levels in bone marrow (p < 0.05). These 
results indicate aging and age-related disorders affect gene expression and increased 
adipogenesis and osteoclastogenesis (related to bone loss). 
Age-dependent accumulation of mitochondrial DNA (mtDNA) mutations in murine 
hematopoietic stem cells is related to genetic background. Hematopoietic stem cells (HSCs) 
and progenitors were isolated by flow cytometry sorting on Lin (-) Kit (+) CD34 (-) 
parameters from young and old C57BL/6 (B6) and BALB/c mice. An increased level of 
mtDNA mutations in single HSCs was observed in old B6 when compared with young B6 
mice (P=0.003); in contrast, no significant age-dependent accumulation of mutations was 
observed in BALB/c mice (old versus young, P=0.202) and the level of mutations in both 
young and old BALB mice was close to that of old B6 mice (P>0.280). Cellular reactive 
oxygen species (ROS) in mouse HSCs could not be correlated with the level of mtDNA 
mutations in these cells, although B6 mice had a higher proportion of ROS (-) cells when 
compared with the BALB mice. Propagation assays of single HSCs showed B6 cells form 
larger colonies compared with cells from BALB mice, irrespective of age and mtDNA 
mutation load. These results suggested age-related mtDNA somatic mutation accumulation in 
mouse HSCs is influenced by the nuclear genetic background and that these mutations may 
not obviously correlate to either cellular ROS content or HSC senescence (Yao et al. 2007). 
 Overall, proliferative and differentiation potential of HSCs were decreased with aging. 
The microenvironment of the HSCs influences the differentiation of HSCs to different cell 
populations (Donnini et al 2007). HSC-intrinsic and HSC-extrinsic (microenvironmental) 
age-related changes favor myelopoiesis, although single stem cell capacity was similar with 
aging (Linton and Dorshkind 2004; Cho et al. 2008; Liang et al. 2005). Loss of bone and 
increased fatty tissue with aging is also related to decreased lymphocytes in old populations, 
especially in patients with age-related diseases (Jiang et al. 2008). Additionally, translating 
animal data to humans should consider that different animal strains could influence 
measurement in stem cells study (Yao et al. 2007). Finally, investigation of circulating stem 
cell numbers and differentiation potentials could be a useful approach to immunotoxicity 
study in human populations, as an alternative to bone marrow stem cell studies that are not 
used very often in human (Moresi  et al. 2005). 
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Aging and T cell development 
The thymus itself does not contain stems cells that produce T cells, and the bone marrow 
–derived precursors have to migrate into the thymus. Mature T helper and T cytotoxic cells 
were generated by in thymus by several steps from double negative, to double positive and 
finally to single positive T cells. After their production in thymus, newly produced T cells 
migrate into secondary lymphoid organs by circulation and lymphatic. Influence of aging on 
T cell development happens from bone marrow T-lineage cell differentiation in the early 
stage, to stage of development in thymus, to functions in secondary lymphoid organs. 
Aging influence to differentiation of T-lineage HSC in bone marrow 
How aging impacts the T-lineage potential of hematopoietic progenitors has been studied 
by Zediak et al. (2007).  The result showed aged BM progenitors are less efficient at giving 
rise to T-lineage cells by using experimental conditions that do not involve irradiation. Aged 
unfractionated BM, purified multipotent progenitors (MPPs), and purified HSCs produce 
fewer T-lineage cells than their young counterparts when assessed in vitro and in vivo in 
young host animals. Limit-dilution analysis of purified HSCs in vitro revealed that a lower 
fraction of aged HSCs possessed T potential. Additionally, single-cell analysis showed that 
aged T-competent HSCs gave rise to fewer T-lineage cells. In contrast, aged MPPs did not 
have a lower T-precursor frequency even though they produced fewer T-lineage cells in bulk 
assays. These data suggest that T-compromised HSCs do not transition to the downstream 
MPP pool and that the smaller burst size of T-competent HSCs is also reflected in their MPP 
progeny. This work therefore demonstrates that multiple age-related defects in T cell 
potential occur within the bone marrow population. 
 Aging influence on primary T cell development in thymus    
Thymic involution is the mark of hematopoietic aging. Aging defects can occur at 
multiple points along the developmental pathway, both in the T progenitors themselves and 
in the thymic stromal cells that support their development. The evidence for age-related 
thymopoiesis defects at key steps in the production of naïve mature T cells, and interaction 
between stromal aging and progenitor aging (Zediak and Bhandoo 2005). 
Reduction in the developmental potential of intrathymic T cell progenitors with age was 
observed in C57BL/6J mice (2 vs 17 months). The result showed aging reduced the number 
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of immature T cell subpopulations (CD3
–
CD4
–
CD8
–
CD44
+
CD25
–
) and early T lineage 
progenitor (Lin
–
CD44
+
CD25
–
CD117
high
CD127
low/neg
, earliest intrathymic precursor, ETP) in 
the thymus. The frequency of ETP declines with age and their potential to reconstitute the 
thymus is diminished. The results also showed ETP from aged mice proliferate less was 
related to a higher rate of apoptosis in old mice than their counterparts from young animals 
(Min et al. 2004). 
It was reported that age-related change in thymic T-cell development is associated with 
genetic loci on mouse chromosomes 1, 3, and 11 (Hsu et al. 2002). Age-related decline in 
thymic T-cell development was observed in 22-month-old C57BL/6J X DBA/2J (BXD) 
recombinant inbred strains of mice. There was a positive correlation of the concanavalin A 
(Con A)-induced thymocyte proliferative response with the capability of thymocytes to 
mature to the CD4
+
 CD8
+
 stage. The accumulation of CD4
-
CD8
- 
stage of thymocytes in 22-
month-old BXD mice was further identified to be associated with a developmental block 
between the CD25
-
CD44
+
 and the CD25
+
CD44
+
 stages (very early T cell development stage 
in thymus). The quantitative trait loci regulating the Con A-induced thymocyte proliferative 
response were mapped to mouse chromosome 1, 3, and 11. These results suggest that several 
genetic loci regulate the intra-thymic T-cell maturation process and play an important role in 
determining age-related decline in thymic T-cell development. 
Aging influence on secondary T cell function and development 
The peripheral T cell pool is formed during early life by thymic emigrants but the 
majority of T cells in the pool in adults are actually produced within the tissue. Despite the 
maintenance of normal T cell numbers with age, there is a reduction in CD4
+
 and CD8
+
 
regulated response. An immune system deteriorating with age, especially, the changes in T 
cell function in older mice and man, could be related to higher morbidity and mortality from 
infectious diseases, increased prevalence of specific cancers and autoimmune diseases in old 
people (Aspinall 2003). 
Tamir and Miller (1999) reported aging impairs induction of cyclin-dependent kinases 
and down-regulation of p27 in mouse CD4
+
 cells. Cyclin-dependent kinases belong to a 
group of protein kinases to regulate cell cycle (eg. CDK2, CDK4, and CDK6 regulating G1 
phase).  One family of inhibitors includes P21, P27, and P57 molecules that influence a wide 
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range of cyclin-CDK complexes. In this study, it was reported aging led to significant 
declines in the ability of mouse CD4
+
 T cells to respond to CD3 and CD28 stimuli by 
induction of the cyclin-dependent kinases CDK2, CDK4, and CDK6. Altered CDK activation 
is likely to mediate the age-related decline in T cell proliferation to polyclonal stimulation. 
Aging retards the decline of P27 in stimulated CD4
+
 cells, with no change in induction of 
P21. These results indicate T helper cell from old mice has impaired proliferation response 
linked to early activation defects. 
 Tamir et al. (2000) reported age-dependent alterations in the assembly of signal 
transduction complexes at the site of T cell and antigen present cell (APC) interaction. 
Activation of T lymphocytes as a result of interaction with APCs involves a series of cellular 
and biochemical events. In this study, the effect of aging on the activation-induced 
redistribution of plasma membrane proteins LAT, PKC- , Vav, actin, and the DNA-binding 
factor NF-ATcf was studied in aging nontransgenic mice and hybridoma cell line 145-2C11 
as APC. These results showed that defects in the ability of T helper cells from aged donors to 
move kinase substrates and coupling factors, including LAT and Vav, into the T cell/APC 
contact region may contribute to the decline with age in NF-ATc-dependent gene expression, 
and thus to defects in T cell clonal expansion. 
Kirk et al. (1999) reported declined c-Jun N-terminal kinase (JNK) response with age 
may be related to reduced T helper cells proliferation function. In vitro kinase assays on JNK 
in CD4+ T-cells, from young and old mice, was activated by antibodies to CD3, CD4, and 
CD28. JNK is activated when T-lymphocytes are stimulated jointly through the T-cell 
receptor (TCR) and CD28, and it contributes to T-cell activation and IL-2 production through 
phosphorylation of transcription factors, including c-Jun. The result showed decline in JNK 
activity and c-Jun phosphorylation in stimulated CD4
+
 T cells from old mice. Aging dose not 
alter the level of Ras activation. These results suggested a decline with age in JNK responses 
may contribute to the decline in proliferation and IL-2 production in T helper cells from old 
mice. 
Aging changes the naive T cell compartment and then inverses the ratio naive: memory T 
cell. Lazuardi  et al. (2005) found age-related loss of naive T cells and dysfunction of T /B 
cells in human lymph node. Lymph node tissue was taken from healthy young and elderly 
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people.  The result showed relative number of CD8
+
 T cells decreases with age but that the 
relative number of CD4
+
 T cells does not. And it was observed that very pronounced age-
dependent loss of CD45RA 
+
 naive T cells. The number and size of follicles and the relative 
number of CD20 
+
 B cells are similar in young and elderly donors. If clonal T –cell 
expansions was found in young donors, it was correlated with higher number of CD20
+
 B 
cells, higher relative size of germinal centers, and higher number of immunoglobulinM-
expressing cells than young donors without clonal T cells expansions. Corresponding 
changes were not found in old donors with clonal T-cell expansions. These results suggested 
depletion of naive T cells and the apparent dysregulation of T-cell/B-cell interactions in old 
age. 
Wu and Meydani (2004) reported aging is associated with a shift toward T h (2) type 
immune system, which attributed a change in phenotypic profile of T cells, increased ratio of 
memory to naive T cells with aging since IL-4 and IL-10 preferentially secreted by memory 
cells while IL-2 is preferentially secreted by naive cells. PGE2 inhibits T cells proliferation, 
inhibited T h1 cytokine, upregulate Th2 cytokine. Increased PGE2 with aging is due to over-
expression of COX-2, whereas ceramide mediates age-associated increase in macrophage 
COX-2 expression by elevated NF-Κb acitivity. 
However, in some cases, increased memory T cytotoxic cells with aging are not always 
related to bad conditions. Vesosky et al. (2006) investigated early resistance to 
Mycobacterium tuberculosis with aging by female C57BL/6 or BALB/c mice at 1, 2, 3, 6, 9, 
12, 18, and 21 months of age. The results showed proportion of memory CD8
+
 T cells 
increases in the lung and spleen with age in that the proportion of CD8
+
CD44
hi
CD
45
RBlo 
cells gradually increased with age, with 12- to 21-month-old mice having a significantly 
higher proportion of memory CD8
+
 T cells in the lungs and spleen as compared to mice 
between 1 and 9 months of age. At the same time, non-specific IFN-γ production by CD8+ T 
cells and proportion of CD8
+
 T cells expressing Th1 cytokine receptors increased with age, 
which all contributed to increased early resistance of mice to M. tuberculosis with age. 
Therefore, increased population of memory CD8 T cells could contribute to innate immune 
response to M.tuberculosis. 
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CD8
+
 T cells represent an important immunological component of protection against 
viral infections. The most dramatic change at the population level is the appearance and 
persistence of CD8
+
 T cell clonal expansions (TCE), whose frequency increases steadily with 
age with reduced activity. Messaoudi et al. (2006) investigated trafficking and phenotypic 
characteristics of CD8 TCE, as well as their responsiveness to homeostatic regulation. Wild 
type C57BL/6, Congenic B6.Ly-5.2/cr, and Rag-1-knockout (KO) B6.129S7Tm1-mom (4–6 
mo and 20–24 mo of age) were used for research.  It was reported that TCE have access to 
secondary lymphoid tissues and to tertiary sites in aged animals. Age-related TCE are a 
specialized subset of T central memory (TCM) CD8 cells. TCE can be distinguished from 
other TCM by increased IL-7R  and IL-2/15Rβ levels. TCE proliferate at the same steady 
pace regardless of the environmental cues. Messaoudi et al. (2004) reported age-related CD8 
T cell clonal expansions constrict CD8 T cell repertoire and have the potential to impair 
immune defense. Female C57/BL6 (B6, 21 months vs 2-4 months) was immunized HSV-1 
virus. In HSV-1 infection of B6 mice, >90% of the responding CD8+ T cells use Vβ10 or 
Vβ8 and are directed against a single glycoprotein B (gB498-505) epitope, gB-8p. It was 
observed that old animals bearing CD8
+
 TCE within Vβ10 or Vβ8 families failed to mount 
an effective immune response against HSV-1, as judged by reduced numbers of peptide-
major histocompatibility complex tetramer+ CD8 T cells and an absence of antiviral lytic 
function.  These results showed TCE impaired the ability of aging mice to mount a 
productive immune response against new antigenic challenge, which could contribute to the 
immunodeficiency with aging. 
Regulatory T cells (Treg), CD4
+
CD25
+
 T cells which constitute
 
5–10% of CD4+ T cells 
in normal naive mice are a key cell type for regulating cellular immunity and maintaining 
self-tolerance. CD4
+
CD25
+
 cell population has the highest regulatory function within the T 
cell compartment and can prevent autoimmune disease. The transcription factor, Foxp3 
required for the development of Treg, is expressed in most CD4
+
CD25
+
 T cells and is low in 
CD4
+
CD25
- 
T cells. Male C57BL/6 mice at 2, 12 and 24 months ages were used. In vitro 
analyses revealed CD4
+
CD25
–
 T
 
cells from aged mice showed diminished proliferative 
responses, although CD4
+
CD25
+
 function did not change with aging.
 
Aged CD4
+
CD25
– 
T 
cells included a Foxp3
+
 suppressive CD4 T cell population. The results suggested age-related 
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decline
 
in T cell-mediated immune responses is ascribable to changes
 
in the CD4
+
CD25
–
 T 
cell population and not to a functional
 
augmentation of suppressive CD4
+
CD25
+
 T cells 
(Nishioka et al. 2006). Alzheimer (AD) and Parkinson disease (PD) are related to protein-
misfolding and are accompanied by neuroinflammation. The analysis of T reg from AD and 
PD patients as well as non-affected individuals revealed that the frequency of Treg (CD4
+
 
Foxp3
+
) increases with age and is accompanied by intensified suppressive activity of Treg in 
patients (Rosenkranz et al. 2007).  
BALB/c male mice (1~18 month of age) were used to detect differential effects of age on 
circulating and splenic mononuclear populations (Pinchuk et al. 2008). There were some age-
related differences in CD4 expression in T cells of BALB/c mice. In peripheral blood, at the 
ages of 3 and 5 months, the percentage of CD4+ cells was significantly higher than the 
percentage of CD4+ cells in 1-month old BALB/c mice. The CD4+ T cells were the lowest in 
18-month old mice. In the spleen, at the age of 5 months, the % of CD4+ cells was 
significantly lower than the % of CD4+ cells in 1-month old. The ratio CD4/CD8 decreased 
with aging in peripheral blood with the lowest at 18 months. In the spleens, the proportion of 
naïve (CD44
neg/low
) and activated and/or memory (CD44
med/high
) among helper (CD4+) and 
cytotoxic (CD8+) T cell populations was investigated. The % of CD4+/CD44
med/high 
T cells 
increased with age. 
The distribution of T cell subsets in pubertal (2 months) and post-pubertal (10 months) 
mice showed a significant decrease in the percentage of CD4+ splenocytes and peripheral 
blood lymphocytes (PBL) with age, unlike the percentage of CD8+ cells in PBL, which 
remained unchanged (Aboudkhil et al. 2003). 
Overall, aging may result in the accumulation of developmental defects in bone marrow, 
thymus and secondary lymph organs. Firstly, aged bone marrow progenitors are less efficient 
at giving rise to T-lineage cells (Zediak et al. 2007). Aging reduction in the development 
potential of intrathymic T cell progenitors was observed in early T lineage progenitor with 
higher rate of apoptosis in old mice (Min et al. 2004), which could be related to genetic loci 
on mouse chromosomes 1, 3, and 11 (Hsu et al. 2002). Secondly, age is associated with a 
reduction of CD4+ and CD8+ regulated response. The reduced proliferation of T cells with 
aging could be related to the aging associated impairment in induction of cylin-dependent 
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kinases and down regulation of P27 (Tamir and Miller 1999), aging impairs T cells-antigen 
present cell interaction (Tamir et al. 2002), and aging  is associated with a decline in JNK 
response (Kirk et al. 1999).  The most dramatic change in CD8+ T cytotoxic cells is the 
appearance of TCE with decreased flexibility, which impaired the ability of aging mice to 
mount on immune response against new antigenic challenge (Messaoudi et al. 2004, 2006). 
Thirdly, peripheral T cell number was reduced with aging (Pinchuk et al. 2008; Aboudkhil et 
al. 2003). Finally, it was reported that age was associated with reduced naive T cell 
compartment and increased T regulator (Lazuardi et al. 2005; Rosenkranz et al. 2007; 
Nishioka et al. 2006). The reduction in the size of the naïve T-cell repertoire may have an 
impact on the responsiveness of the immune system to new antigens in the elderly, wheareas 
an increase in T regulator cells could be involved in immunosuppression leading to cancer, 
neurodegeneration and infection. 
Aging and B cell production 
B cells originate from a lymphoid progenitor in the bone marrow and finish most 
development in bone marrow following these steps: lymphoid progenitor, early pro-B cell, 
late pro-B cell, pre-B cells, and immature B cell dependent on bone marrow stromal cells. 
Immature B cells express IgM in the surface. Once they leave the bone marrow, B cells are 
carried by the blood to the peripheral lymphoid tissues to further maturation by hyper-
mutation. The following is a summary on influence of aging to the primary and secondary B 
lymphocytes development. 
 Linton and Dorshkind (2004) reviewed aging result in the accumulation of development 
defects in bone marrow in B cells all development steps from pro- B cells to surface 
immunoglobulin-positive cells. The microenvironment changes such that inefficient secretion 
of IL-7 by stromal cells impaired generation of B cells in old mice. 
The effect of aging on the common lymphoid progenitor (CLP) to pro-B cell transition 
was investigated more by Min et al. (2006).  In this study, CLP and pro-B cells in young and 
old mice were characterized under steady-state conditions and after treatment of animals with 
5-fluorouracil (5-FU).  The results showed age-related defects were related to reduced 
proliferative potential of CLP and pro-B cells and differentiation potential of CLP to pre-pro-
B cells. Additionally, the growth and differentiation of myeloid progenitor were normal in 
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old mice suggested age-related changes in early B lymphopoiesis are not the result of a 
general defect in HSC or the bone marrow microenvironment that impairs development in all 
hemopoietic lineages. Instead, B cells development is sensitive to accumulated defects with 
aging. 
Despite the change in B production in bone marrow seen in some studies, not all research 
shows the same results. Rossi et al. (2003) reported B lymphopoiesis persists throughout 
adult human life. The relative abundance of pro-B, pre-B, immature, naive, and mature B 
cells among the CD19
+
 lymphocyte fraction of human bone marrow was found not to change 
appreciably over the interval between 24 and 88 years of age. Moreover, proliferation of pro-
B and large pre-B cells in adult marrow equaled that observed with fetal marrow specimens. 
 Aging results in perturbations of peripheral B cells in two ways: reducing migration to 
spleen from the bone marrow, and accumulation of B lineage cells in splenic compartments, 
and result in reduced humoral immunity with aging (Linton and Dorshkind 2004). More 
studies have been done recently to explain more on aging associated with declines in immune 
system function, or 'immunosenescence'. 
Frasca et al. (2004 a, b, c, d) did several of studies on the effect of age on the 
immunoglobin class switching. The E2A-encoded transcription factor E47 is a basic helix-
loop-helix (bHLH) protein, involved in B cell differentiation processes in the bone marrow 
and in the control of B cell functions in the periphery. Results showed that LPS-stimulated 
splenic B cells from old mice display decreased E47 DNA-binding activity as compared to 
young mice. Splenic B cells from aged mice are deficient in production of secondary isotypes 
(IgG1, IgG2a, IgG3, and IgE), class switch recombination (CSR), and expression of the 
transcription factor E47.  Impaired induction of E47, and then loss of activation-induced 
cytidine deaminase, resulted in poor CSR and secondary isotype in old mice. 
Aging reduces the primary humoral responses. Female BALB/c mice were immunized 
with hapten-protein (trinitrophenyl-bovine serum albumin). The result showed lower 
antibody levels in the primary and secondary response of old mice (72 weeks old), and young 
mice (2, 16, and 32 weeks old) maintained specific antibodies for longer period than old mice 
after primary challenge. However, a secondary challenge efficiently induced memory in old 
mice. Additionally, Splenic T cells from old mice that had or had not been immunized were 
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less responsive to concanavalin-A and showed reduced IL-2, IFN-γ and IL-10 production 
compared to young mice. Less efficiency of aged CD4 T cells could interrupt normal 
germinal center formation and promote somatic hypermutation (Simioni et al. 2007). 
Age-related changes in the antibody response have been classically associated with 
alterations in T-cells, but increasing evidence shows that intrinsic B-cell defects exist. 
Verdier et al. (2006) analyzed the apoptotic susceptibility of peripheral B-cells in female 
aged (15-21 months) and young control (2-4 months) BALB/c mice. Spleen and Peyer's 
patches (PPs) were labeled for B-cell lineage (B220
+
 cells) and germinal center B subset 
(GCs, B220
+
/PNA
+
 cells). The results showed no change in apoptosis was observed in 
compartments known to be enriched in activated B-cells (GCs and PPs). Enhanced 
spontaneous apoptosis of splenic B-cells in aged mice was found to be correlated with a 
reduction of phosphorylated Bad expression. Bad, one of members of the Bcl-2 families, 
protects cells from the deleterious effects of apoptotic stimuli. Increased apoptosis of resting 
B-cells in old mice may be determined by an altered Bad phosphorylation, which in turn 
contributes to cell death by lowering the mitochondrial threshold for apoptosis. 
Germinal center (GC) reaction is very important for antibody affinity maturation, 
memory B cell development and establishment of long-term antibody-forming cells in the 
bone marrow. Increased germinal center reaction could reduce age-associated immune 
deficiency. It was reported that immunization with immune complexes (immune complex 
containing 100 μg Hapten NP-CGG) to 20~24-month age old C57BL/6J (H-2b) mice 
reversed the age-related defect in GC formation by increased GC volume in primary and 
memory response, enhanced class-switched NP-specific antibody response in a primary 
immune response (Ig G1), enhanced secondary antibody response, and increased the number 
of long-lived plasma cells (Zheng et al. 2007). 
Although reduced function of B cells was observed above, the number of B cells and 
capacity of antigen present did not change with aging based on one study. BALB/c male 
mice (1~18 month age old) were used to detect differential effects of age on circulating and 
splenic leukocyte populations (Pinchuk et al. 2008). Percentage of B cells expressing CD19 
in mononuclear peripheral blood was lowest at 3 and 5- month old and highest at 18- month 
old. In spleen, percentage of B cells expressing CD19 was lowest at 3 and 10- month old.  
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Percentage of B cells in periphearal blood and spleen followed the same pattern. The 
percentage of MHC class II+ cells in peripheral blood (mononuclear cells) increased with age 
in the animals, peaking at 18 months, with lowest at the age of 3 and 5 months compared to 
1- month age. These results suggested the effects of aging to antigen-present cells such as B 
cells do not change with aging. 
There is some controversy on aging influence on B cell development and function. 
Generally, aging reduced early B cell lineage proliferation and differentiation in bone 
marrow and reduced germinal center production, finally resulting in increased susceptibility 
to infection in aged population.  Reduced T cell function and increased apoptosis in spleen of 
aged animals also contribute to reduced B activity (Linton and Dorshkind 2004; Min et al. 
2006; Frasca et al. 2004; Simioni et al. 2007; Verdier et al. 2006).  However, a lack of 
change in B cells development in bone marrow and peripheral blood observed in some 
studies suggested inconsistencies due to species and antibody differences (for example, 
CD19 vs CD220) used to detect possible age-related changes (Rossi et al. 2003; Pinchuk et al. 
2008). 
Aging and innate immunity 
The innate immune system defends the host from infection by other organisms in a non-
specific manner. The major functions include recruiting cells to site of infection and 
inflammation by secreting cytokines, activating complement system, removing foreign 
substances, and activating adaptive immunity through antigen presentation. 
With aging there is increased B-1 and Marginal zone B cells reported, and increased B-1 
B cells could be related increased autoimmune disease (Linton and Dorshkind 2004). 
Increased PGE2 with aging was reported due to over-expression of COX2. Ceramide 
mediates age-associated increase in macrophage COX-2 expression by elevated NF-Κb 
acitivity, and then inhibits Th1 cell responses (Wu and Meydani 2004). 
Hasegawa et al. (2006) reported attenuated allergic airway inflammation in aging mice by 
reduced activation
 
of the ERK MAPK cascade upon TCR stimulation, decreased GATA3
 
expression in developing Th2 cells, and impaired chromatin
 
remodeling of the Th2 cytokine 
gene locus based on C57BL/6, BALB/c and OVA-specific TCR β transgenic (DO.11.10 Tg) 
mice (5–6 wk vs. 8–12 mo) model. Bonville et al. (2007) observed diminished local 
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production of inflammatory mediators in bronchoalveolar lavage fluid and lung homogenates 
including MIP-1α, JE/MCP-1, IFNγ and IFNγ-induced MIG and IP-10, and IL-6 and IL-17 
after naive C57BL/6 mice at various ages (8, 14, 26, 39, 52 and 78 weeks old) infected with 
pneumonia virus. Age-dependent diminished production of proinflammatory mediators could 
be related to reduced recruitment of granulocytes and severity of clinical responses. 
Aging decreased the number of peripheral tissue monocytes/macrophage (CD11b
+
) and 
dendritic cells (CD11b
+
CD11c
+
).  BALB/c male mice (1~18 month age old) were used to 
detect differential effects of age on molecules related to antigen presentation including MHC 
II, CD11b, CD11c and double positive CD11b/c (Pinchuk et al. 2008). Increased percentage 
of MHC II+ was related to increased CD19+% with aging. The proportion of CD11b+ 
PBMC decreased with 18-month-old animals having the lowest amounts of CD11b+ 
lymphocytes. The expression of CD11b increased at the age of 3 months. There were age-
related decreases in the percentage of splenocytes expressing CD11b molecules with the 
lowest percentage of CD11b+ APC being in 18-month-old mice. Variations in the percentage 
of APC-expressing CD11c molecules were similar to the variations in CD11b expression in 
spleen. In the spleen, the fluctuations in the percentage of CD11b+CD11c+ cells declined 
with age with lowest at 18- month old. Those results suggested age-related decrease of 
monocytes/macrophages and dendritic cells. 
Overall, research on innate immunity with aging is limited. Based on above information, 
aging accumulating B-1 B cells could be related with increased autoimmunity (Linton and 
Dorshkind 2004). Aging increase COX-2 excretion (Wu and Meydani 2004), while reduce 
inflammatory response in respiratory route such as induced allergy and clinical symptoms to 
virus infection (Hasegawa et al. 2006; Bonville et al. 2007). Comparative study in BALB/c 
mice showed reduced monocytes and dendritic cells in peripherial blood with aging (Pinchuk 
et al. 2008). 
Change of aging to immune system is widespread from central immune organs (bone 
marrow and thymus) to secondary lymphoid tissue (lymph node and spleen). Age reduces 
lymphoid progenitor number and proliferation, and results in the developmental defects 
within supporting stromal cells in bone marrow and thymus. In secondary lymphoid organs, 
reduced mature T and B produced with no efficiently emigration contribute to decreased 
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homoral and cell-mediated immunity. The mechanism how aging accumulate developmental 
defects need more studies, which may help to slow down aging in human population and 
protect from severe infection, tumor, autoimmune disease, and increase the effect of 
vaccination in aged people.  
Sex related difference in immune system 
The immune system is influenced by the endocrine system and endocrine system is 
strongly related to nervous system. Therefore, it is complicated to explain sex related 
differences in immune response. Sex hormone receptors found in lymphocytes, macrophages, 
granulocytes and mast cells could adjust the direct connections between endocrine system 
and immune system. However, the intracellular mechanism of the interaction of sex 
hormones and leukocytes is still unknown. 
In most cases, females can generate stronger adaptive immune responses, which 
contribute to increased immunity in females to bacterial and viral pathogens and parasites. 
The relationship of genetic background and sex to susceptibility to infections of 
Streptococcus pyogenes in mice was reported by Medina et al. (2001). BALB/c, C57BL/10, 
and DBA/2 mice were the most resistant strains, whereas C3H/HeN and CBA/J mice were 
sensitive to bacterial infection, in which the male was more susceptible than females based 
on measuring bacterial loading and survival ratio. Hormonal and immunological mechanisms 
mediating sex differences in parasite infection were reviewed by Klein (2004). Males have 
higher parasitaemia than females in human populations. Sex hormones such as androgens, 
estrogens, progestins, and sex hormone related glucocorticoids could modulate the 
expression of target genes in immune cells, which result in sex differences in parasite 
infections. On the other hand, females have greater autoimmune diseases compared to males 
in experimental animals and humans. Sex hormones could influence the thymus gland, and 
non-thymic lymphoid organs. T cells are the primary target for sex hormone action, 
immunoregulatory T cells could be the most sensitive cell in response to sex hormones, and 
sex hormones also work on macrophage cells which could be related to autoantigen 
processing (Ansar Ahmed et al. 1985). Less sensitivity for late airway inflammation in males 
than females in BALB/c mice was reported by Hayashi et al. (2003). The late airway 
inflammation was induced by intraperitoneal injection of ovalbumin. The results showed 
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male had less severe inflammation in airway with less IL-4 mRNA level in spleen. Less 
sensitivity in male in this study suggested decreased Th2 cell response in male compared to 
female. These evidences suggested females have stronger protection capacity against 
infectious diseases and may have higher possibility for inflammatory allergy in the airway. 
On the other hand, females tend to have more controlled innate immune responses, while 
males suffer more pathology due to excessive inflammation. It was reported that immune 
suppression after injury in aged mice can be restored by estrogen treatment (Kovacs et al. 
2004).  Female BALB/c mice (3-4 month vs. 18-20 month) were induced with burn injury. 
The cellular immune responses after injury were significantly lower in aged burn-injured 
mice than young burn-injured mice by measuring delayed-type hypersensitivity and 
splenocyte proliferation. The circulating levels of IL-6 after injury were lower in young burn-
injured mice than in aged burn-injured mice. Estrogen replacement in aged mice improved 
the delayed-type hypersensitivity response in burn-injured, aged mice and decreased IL-6 
levels. Gomez et al. (2007) also reported the treatment of aged mice with a low concentration 
of estrogen markedly increased the survival rate involving decreased IL-6 level. 
The regulatory mechanism of estrogen and estrogen receptor ligands could be related to 
reduced inflammation in burn-injured mice through MAPK pathway. Some estrogen mimetic 
agents, such as environmental chemicals, induce cell signaling associated with the estrogen 
receptor and via estrogen receptor-independent mechanisms. Frigo et al. (2004) tested 
organochlorine compounds, with ability to mimic the hormone estrogen. 
Dichlorodiphenyltrichloroethane (DDT) and its metabolites induce a stress mitogen-activated 
protein kinase (MAPK) that leads to AP-1 activation. Chaturvedi and Sarkar (2004) 
investigated the interaction of TGF-beta3 and estradiol in the release of basic fibroblast 
growth factor (bFGF) from folliculostellate (FS) cells in the pituitary, and the role of the 
MAPK pathway in TGF-beta3 and estradiol interaction. The results showed estradiol and 
TGF-beta3 alone moderately activated MAPK p44/42; together they produced marked 
activation of MAPK p44/42. Estradiol and TGF-beta3, either alone or in combination, 
increased the levels of active Ras. Estrogen receptor blocker ICI 182,780 failed to prevent 
estrogen's and TGF-beta3's effects on bFGF. These data suggested an estradiol receptor-
independent protein kinase C- activated Ras-dependent MAPK pathway is involved in the 
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cross-talk between TGF-beta3 and estradiol to increase bFGF production and/or release from 
FS cells. 
How the NF-κB pathway and steroid hormone receptors interact is an interesting question. 
After binding with 17β-estradiol (E2), estrogen receptors may interact with NF-κB factors, 
via transcriptional co-factors. Cutolo et al. (2005) found that female and male sex hormones 
seem to modulate the immune/inflammatory responses by different mechanisms. Human 
macrophage cell line (THP-1) activated with IFN-γ was incubated with E2 or testosterone in 
order to investigate their role in cell proliferation and apoptosis. The results showed male 
hormone (testosterone) increased apoptosis, whereas female hormone (estrogen) had a 
protective trend on cell death. Both female and male hormones worked on macrophage cells 
by the modulator of NF-κB complex. 
Other possible mechanisms of interaction of sex hormones and immune cells could be 
related to changed cell receptor expression and cell cycle regulation by sex hormone. Sex 
hormones regulating the cell cycle finally result in changed function of immune cells. Hao et 
al. (2007) investigated the effects of estrogen on the number and cytotoxic activity of natural 
killer cells (NK cells) in vivo. Six-week old female C57BL/6J (B6) mice were grouped into 
control, sham+vehicle, ovariectomized+ vehicle and ovariectomized + E2. The results 
showed that E2 increased the number of NK cells possibly mediated by up-regulating the 
expression of minichromosome maintenance complex component 7 (MCM7) and 
minichromosome maintenance deficient 10 (MCM10), both of which are essential for the 
initiation of eukaryotic genome replication. E2 reduced NK cytotoxicity possibly by the 
down-regulation of NK cell activating receptors-CD69, NKp46, NKG2DL and 2B4 (CD244), 
which resulted in the reduced secretion of the soluble factors granzyme B and FasL. 
Aboudkhil et al. (2005) reported testosterone can alter cell cycle and modulate T cells 
distribution. After injection of testosterone into mice, the percentage of peripheral blood 
CD8+ cells was increased. Testosterone decreased tumor cells in S phase and decreased 
proliferation of leukemic cells, with accumulation of cells in G0/G1 phase. Therefore, the 
proteins related to cell cycle and receptor protein could be the targets of sex hormones on 
immune cells. 
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How sex hormones affect the immune system is a very complex question. Sex hormones, 
in particular, testosterone, 17β-estradiol, and progesterone influence immune function, and 
sex hormone receptors were found in lymphocytes, macrophages, and granulocytes which 
indicate direct connection between the endocrine and immune systems. Sex hormones 
modulate immune system gene expression (Klein 2004). The influence of X and Y 
chromosomes on immune responses have been demonstrated. For example, Torres et al. 
(2005) reported that protection from lethal endotoxic shock after testosterone depletion is 
linked to the X chromosome. Ahmed and Talal (1990) reviewed sex hormone effects on 
phagocytic cells and summarized that female rats had more macrophages than males, and 
estrogens stimulate the number of circulating monocytes. Estrogen receptor mRNA and 
receptor binding sites were found in peripheral blood monocytes in humans (Stefano and 
Peter 2001). However, the intracellular mechanism of sex hormone changes lymphocytes 
function and response need more studies. As discussed as the above, the possible mechanism 
of estrogen and its ligands interaction with leukocytes could work on the MAPK pathway, 
which is independent of estrogen receptors. The other possible mechanisms could be related 
to altered cell cycle or interaction with transcriptional factor NF-κB by sex hormones. The 
complete mechanism is still unknown as to the direct connection of estrogen and immune 
function on an intracellular level.  
Toxicokinetics and metabolism 
Biotransformation 
De-expoxidation 
De-expoxidation of DON is a main metabolism of DON in alimentary tracts due to 
microorganisms in the gastrointestinal tract. De-epoxidation is a detoxification reaction 
because the epoxide group seems to be essential for toxicity. Ruminants are less sensitive to 
the effects of trichothecenes, which may be due at least in part to differences in metabolism 
of trichothecenes by microorganisms present or difference in microbes in the alimentary 
tracts of ruminants and non-ruminants.  Rumen fluid microbial degradation of DON to 
DOM-1 (Fig 2.2) has been reported in a series in vitro incubation studies (Swanson 1987; He 
et al. 1992; Binder et al. 1998). Two microorganisms were isolated from the rumen with the 
capability of degrading DON to DOM-1). Both microorganisms were Gram-positive, the 
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active biotransforming bacterium in this coculture was a nonspore-forming, strictly anaerobic 
irregular rod (0.2 by 1-1.5 µm) occurring singly and in long chains up to 150 µm (Binder et 
al. 1997). 
The transformation DON to DOM-1 has been reported in rat, chicken and pig, but 
humans do not have this capability at least in an in vitro incubation study. Oral 
administration of 10 mg/kg of
 14
C- DON to rats resulted in the appearance of a de-epoxy 
metabolite in urine and feces. Incubation of DON with a strictly anaerobic preparation of gut 
contents resulted in the progressive appearance of de-epoxy DON during a 24 h incubation 
period. Incubation of DON with rat liver homogenate did not result in the appearance of the 
de-epoxy DON metabolite. These results indicate that the presence of de-epoxy DON in rat 
excreta, following the oral administration of DON was the result of metabolism by 
microorganisms in the gut (Worrell et al. 1989). Microbial degradation of DON in large 
intestine content of chickens and swine was investigated by He et al. (1992). They found 
microorganisms in large intestines of chickens completely transformed pure DON to DOM-1. 
Danicke et al. (2004) found gut microbes in pig had de-expoxidation activity, and de-epoxy 
DON appeared in increasing proportions from the distal small intestine and reached 
approximately 80% of the sum of DON plus de-epoxy-DON in feces collected from the 
rectum. Research by Eriksen et al. (2003) showed that no de-epoxy-DON was found in 
plasma or urine of pigs after trichothecene exposure, even in pigs having fecal microflora 
with de-epoxidation activity. No de-epoxidation activity of DON has been reported in He et 
al. study (1992). Sundstøl Eriksen and Pettersson (2003) showed that 3-Ac DON was 
metabolized to DON during the incubation period with human gut microboes. However, no 
de-epoxidated metabolites were detected in the fecal incubation. 
 
Fig 2.2: The chemical structure of de-epoxy-deoxynivalenol (DOM-1) 
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Therefore, DON can be de-epoxided to DOM-1 by microorganisms in the alimentary 
tracts in cow, chickens after in vitro incubation of DON and contents of rumen and 
gastrointestine (Swanson 1987; He et al. 1992). It was found that gut microorganisms in rats 
and pigs can transform DON to de-epoxy metabolite (Worrell et al. 1989; Danicke et al. 
2004). In human, it was reported that DON can not be degraded to de-epoxy metabolite 
(Eriksen and Pettersson 2003). 
      Glucuronidation 
Besides some evidence showing that DON can be degraded to DOM-1 by 
microorganisms in rumen and gut of ruminant animals such as cow and sheep and in gut in 
animals such as pig and chicken. DON can be transformed in liver or intestine by UDP-
glucuronosyltransferase (UGT) to DON glucuronide conjugate. At the same time, some 
evidence showed that DOM-1 can be transformed to DOM-1 glucuronide. 
Glucuronidation of DON has been found in rat liver. An isolated rat liver was perfused 
with DON at a dose of 3 mg in a recirculating perfusion system. A total of 40.4% of the 
administered dose of DON was found to be conjugated with glucuronic acid (perfusate 
20.4%, bile 19.2%, liver 0.8%), while only 1.3% of the parent DON (perfusate 1.1%, bile 
0.2%) was detected (Garesis et al. 1987). DON glucuronide was synthesized and purified by 
Wu et al. (2007), glucuronide acid was conjugated to -3 OH of DON, and no toxicity up to 
270 µM in vitro after incubation with K 562 cells for 48 h. 
Animal studies showed DON glucuronide is a mojor DON metabolite in plasma and 
urine (Table 1.3). In human, DON glucuronide was found in urine. Human urine samples 
were collected in two regions, an area of high DON exposure, and the other area of low 
exposure in China. DON could be detected in all samples and increased 1.2 to 2.8 fold after 
β-glucuronidase treatment indicating DON glucuronide was the main metabolite in humans 
(Meky et al. 2003). 
Bioavailability 
 DON bioavailability is used to describe the fraction of an administered dose of DON that 
reaches the systemic circulation. By definition, when DON is administered intravenously, its 
bioavailability is 100%. However, when DON is administered via other routes, its 
bioavailability decreases (due to incomplete absorption and first-pass metabolism).  
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Table 2.3: Animal studies show that DONGLU is a major DON metabolite in plasma or urine  
Animal 
model 
Administration routes DONGLU 
Detection 
methods 
References 
Sprague–
Dawley rats 
(n = 16) 
[
14
C] DON (5.0 mg/kg 
b.w.) by single dose 
gavage 
Major urinary 
metabolite 
HPLC 
Meky et al. 
(2003) 
Dairy cows 
(n = 3) 
Dietary 66 mg DON/kg 
for 5 d 
80% DON in urine 
as a glucuronide 
conjugate 
GC 
Cote et al. 
(1986) 
Sheep (n = 7) 
IV and oral doses, 0.5 and 
5.0 mg DON/kg, 
respectively 
IV, 21% of dose; 
oral, 75% of dose 
in plasma 
ECD/GC 
Prelusky et 
al. (1985) 
Lactating 
sheep (n = 4) 
[
14
C] DON (4.0 mg 
DON/kg b.w) by single 
dose IV administration 
13% of dose in 
plasma, 54% of 
dose in urine 
GLC/MS 
Prelusky et 
al. (1987) 
Pigs (n = 5) 
Dietary 2.5 mg 3-Ac 
DON/kg for 2.5 d 
42% of dose seen 
in plasma 
GC–ECD 
Eriksen et al. 
(2003) 
Adapted from Wu et al. 2007 Food Chem Toxicol. 2007 Oct; 45(10):1846-55.  
Following administration of a single oral 10 mg/kg dose DON in male PVG rats, 
radioactivity excreted in the urine and feces accounted, respectively, for 25 and 64% of the 
administered dose within 96 h (Lake et al. 1987). 
DON was quickly absorbed with tmax 4.0-5.3 h, but had a systemic bioavailability of only 
7.5% due in part to its rapid and efficient metabolism by rumen microorganisms after oral 
dose of 5.0 mg/kg in sheep (Prelusky et al. 1985). Feeding dairy cows DON contaminated 
diets for 5 d, approximately 20% of the DON from feed was recovered in the urine and feces 
in the unconjugated forms as DOM-1 (96% of total DON excreted) and DON (4% of total). 
Preliminary data suggest that the remaining 80% may be excreted as a glucuronide conjugate 
(at least in urine) (Cote et al. 1986).  
In swine, after consuming DON contaminated feed, DON was rapidly absorbed while 
passing through the stomach and the upper small intestine. A dynamic laboratory model 
simulating the gastrointestinal (GI) tract of healthy pigs was used to evaluate the small 
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intestinal absorption of DON. In vitro intestinal absorption of DON was 51% of 170 µg DON 
ingested through contaminated (spiked) wheat. Most absorption occurred in the jejunal 
compartment (Avantaggiato et al. 2004). Eleven castrated male pigs were fed 4.2 mg/kg 
DON over a period of 7 days. DON was rapidly and nearly completely absorbed while 
passing through the stomach and the proximal small intestine in that most of the ingested 
DON entered into digestive system and 88.5% of the DON recovered from the entire 
digestive tract was found in the stomach. Maximum serum concentration appeared 4.1 h after 
the DON-containing meal and half of the systemically absorbed DON was eliminated after 
5.8 h. (Danicke et al. 2004).  
After intragastric (0.60 mg and 0.60 µCi DON/kg) administration of 
14
C-labeled DON in 
swine, DON was very rapidly absorbed, reaching near peak plasma levels within 15-30 min. 
Levels remained elevated (63-325 ng/ml) for approximately 9 hr, and began declining slowly 
(t1/2 β = 7.1 h). The calculated systemic bioavailability was between 48 and 65% based on 
comparison of iv and intragastric AUC (Prelusky et al. 1988). Toxicokinetics of DON has 
been investigated in 16 castrated male pigs (41.5 ± 2.0 kg) through feeding DON from 
naturally contaminated wheat (5.7 mg DON/kg) after chronic exposure (5-8 weeks) or one 
single oral dose (acute) with daily intake 5.96 mg or 68.5 µg/kg b.w. per single DON 
contaminated diet. DON was rapidly absorbed following oral exposure and reached maximal 
plasma concentrations (C max) of 21.79 and 15.21 ng DON/ml serum after (t max) 88.4 and 
99.1 min in the chronic (n = 5) and acute (n = 6) fed group, respectively. The mean 
bioavailability for free DON was 89% for the chronic group and 54% for the acute oral group 
(Goyarts and Danike 2006a). 
The disposition of [
14
C] DON administered to hens as either a single oral dose or 
consumed in spiked feed over a 6-day period was determined by tracing the specific 
radioactivity of tissues and excreta. Following a single intubated dose of 2.2 mg [
14
C] DON 
with 2.4 µCi/bird, the toxin was found to be poorly absorbed; peak plasma levels (2-2.5 h 
post-treatment) accounted for less than 1% of the administered dose (Prelusky et al. 1986). 
 As a conclusion, DON has poor absorption in sheep with systemic bioavailability only 
7.5% (Prelusky et al. 1985) and poor absorption in chicken with maximum plasma levels less 
than 1% of the administered dose (Prelusky et al. 1986). Feeding cows for 5 days on DON 
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contaminated foods showed systemic bioavailability of about 1% DON in urine (Cote et al. 
1986). DON could be rapidly absorbed while passing through the stomach and the upper 
small intestine in swine (Avantaggiato et al. 2004; Danicke et al. 2004) with systemic 
bioavailability of 50% from a single oral dose or 89% from chronic intake (4-8 weeks) with 
maximal plasma concentrations (C max) of 21.79 and 15.21 ng DON/ml serum after tmax 88.4 
and 99.1 min in the chronic (n = 5) and acute (n = 6) fed groups, respectively, by fed 5.7 mg 
DON/kg naturally contaminated DON with daily intake 5.96 mg or 68.5 µg/kg b.w. per 
single DON contaminated diet(Prelusky et al. 1988; Goyarts and Danike 2006a). Therefore, 
the concentration of DON in peripheral blood was lower than the concentrations used in vitro 
cell culture studies.  
Distribution  
Distribution in toxicokinetics describes the reversible transfer of toxin from one location 
to another within the body. In the research field of DON toxicokinetics, the distribution of 
DON after DON entering  into circulation includes that how fast DON goes to tissue, what 
kind of tissue DON is distributed and tissue binding of DON. 
Sprague-Dawley rats received a single dose of [14C] DON (5.0 ± 0.1 mg/kg body weight, 
5.5 ± 0.1 microCi/kg). DON and its metabolites (DON glucuronide and DOM-1) were 
detectable in the plasma of rats with the highest levels at 8 h, at which time approximately 9% 
was bound to plasma protein (Meky et al. 2003). 
The disposition of [14C] DON administered to hens as either a single oral dose or 
consumed in spiked feed over a 6-day period was determined by Prelusky et al. (1986). 
Maximum tissue residues were measured at 3 h in all tissues (liver, kidney, brain, heart, 
spleen, proventriculus, gizzard, small intestine) except for fat, muscle, and oviduct, which 
occurred at 6 h postdosing. Among the organs, the highest activities were measured in kidney, 
liver, and spleen; however, these levels were equal to less than 500 ng DON equivalents/g 
tissue, and declined quickly. Clearance of radioactivity from tissue had an average half-life 
of 16.83 ± 8.2 h (range 7.7-33.3 h, depending on the tissue). Elimination of the labeled toxin 
in excreta occurred rapidly; recovery of radioactivity accounted for 78.6, 92.1, and 98.5% of 
the dose by 24, 48, and 72 h, respectively. In continuously dosed birds fed 2.2 mg unlabeled 
DON for 6 days followed by 2.2 mg (1.5 µCi) [
14
C] DON for 6 days, accumulation of 
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radioactivity in tissues did not occur. Maximum residual levels, which occurred in the 
kidneys, were only 60 ng DON equivalents/g. Estimated level of residues contained in the 
edible tissues amounted to only 13-16 µg DON/1.5 kg hen. 
Amuzie et al. (2008) compared the effects of oral and intranasal exposure to DON 
(5mg/kgbw) on tissue distribution in the adult female mouse (B6C3F1). Competitive direct 
ELISA was the detection method. After oral exposure, the concentrations of DON were 1 
µg/ml at 15 min and 30 min in plasma, and rapidly declined between 30 and 60 min, and 
followed by slower rate of decline with 78% of peak plasma DON being cleared by 120 min. 
DON accumulation in spleen, liver, lung and kidney followed siminar kinetics to that of 
plasma with the peak concentrations. Peak DON concentrations in spleen, liver, lung and 
kidney were 0.77, 1.10, 0.95 and 1.76 μg/g, respectively. After intranasal exposure, plasma 
and tissue DON concentrations were 1.5-3 times higher compared to oral exposure (Pestka, 
2008). 
After intravenous (i.v.) administration of DON (0.5 mg/kg) in sheep, plasma levels were 
found to decrease biexponentially, showing a rapid distribution phase (t 1/2 α = 12-23 min). 
DON was confined mainly to extracellular fluid, and did not appear to undergo any 
significant binding or uptake by tissue (Prelusky et al. 1985).   
After feeding sheep (DON tolerant animals) and pigs (DON sensitive animals) diets 
including DON, DON could be detected in their cerebral spinal fluid. After i.v. 
administration, DON was detected very rapidly (less than 2.5 min) in the CSF of both species, 
t-max occurred at 5-10 min in sheep, in swine it was 30-60 min. A good relationship between 
blood and CSF DON level was apparent in both species. The toxin could be detected in CSF 
for up to 20 h post-dosing (Prelusky 1990). 
As a result, after oral dose of DON, 9% DON could bind to plasma protein (Meky et al. 
2003), the kidney, liver, spleen and lung were main accumulation organs, but DON was 
observed to decline quickly with no binding by tissue, and no further accumulation was 
observed (Prelusky et al. 1986; Amuzie et al. 2008; Prelusky et al. 1985). DON can be 
transferred to cerebral spinal fluid (Prelusky et al. 1990). Therefore, DON distribution is 
widespread, but no accumulation of DON in main organs suggested lower accumulated 
toxicity could happen after DON exposure.   
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Transmission into eggs and milk 
It is of concern to determine if DON is transmitted to eggs and milk after cows and hens 
were fed on high DON contaminated diet. 
Corn contaminated with DON was added to the diets of three dairy cows for 5 d with 
dietary concentrations of DON averaging 66 mg/kg. Unconjugated de-epoxy DON (DOM-1) 
was present in milk at concentrations up to 26 ng/ml. DON was not detected in the milk 
(Cote et al. 1986). Fourteen ruminal and duodenal fistulated dairy cows were fed a diet 
containing Fusarium toxin-contaminated wheat. Daily DON intakes ranged from 16.6 to 75.6 
mg in the mycotoxin period at dry matter intakes of 5.6-20.5 kg. DON was almost 
completely biotransformed to de-epoxy DON (94-99%). The daily excretion of DON and de-
epoxy DON in the milk of cows fed the contaminated wheat varied between 1 and 10 µg and 
between 14 and 104 µg, respectively. From 33 to 80% of DON and from 73 to 92% of de-
epoxy DON were glucuronidated in the milk. In regard to within the range of 5.6-20.5 kg/day 
dry matter intake and milk yields (fat corrected milk) between 10 and 42 kg/day, and DON is 
very rapidly biotransformed to de-epoxy DON in the rumen, it is concluded that only 
negligible amounts of DON and de-epoxy DON were transmitted into the milk (Seeling et al 
2006). 
DON is seemingly not transmitted to egg after feeding hens DON contaminated feed. 
Twenty single comb white Leghorn hens was fed 82.8 mg/kg DON for 27 days. No 
significant DON residues were found in the yolk, albumin and eggshell (Lun et al. 1986). 
The transmission of DON and of its metabolite de-epoxy DON into eggs has been 
investigated by (Valenta and Danicke 2005). Laying hens were fed a maize-based diet with a 
DON concentration of 11.9 mg/kg dry matter for 16 weeks. Neither DON nor de-epoxy DON 
or glucuronide conjugates of both substances could be detected in any of the samples. These 
results indicate that eggs do not contribute to the dietary DON intake of humans. 
Therefore, transmission of DON into milk and eggs is negligible based on three studies 
(Cote et al. 1986; Seeling et al 2006; Valenta and Danicke 2005). 
Excretion  
Urine and feces are main excretion routes after consumption of DON contaminated diet. 
In different animals, the ratio of DON in urine and feces is different. 
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Following administration of a single dose of [
14
C] DON (5.0 ± 0.1 mg/kg body weight, 
5.5 ± 0.1 µCi/kg) in Sprague-Dawley rats, a total of 37% of the administered DON was 
excreted in the urine (Meky et al. 2003). 
After feeding dairy cows DON contaminated feed (66 mg/kg) for 5 day, urine and feces 
were the main excretion route. Detectable concentrations of unconjugated DOM-1 were 
found in urine and feces up to 72 h after the last oral dose (Cote et al. 1986). 
Excretion of DON has been studied in sheep. After iv dosing (0.5 DON/kg b.w.), urinary 
DON levels declined in a biphasic fashion with an average elimination half-life (terminal 
phase) of 1.2 h, diminishing to baseline concentrations by 8 hr. Total recovery accounted for 
only about 66.5% of the dose: 63.0% in the urine and 3.5% in bile. Following oral 
administration (5.0 mg DON/kg body wt), urinary excretion rates of the major metabolites 
(DON, conjugated DON, conjugated DOM-1) reached maximum 6-9 hr post-treatment, and 
declined exponentially with t 1/2 values of 3.2, 4.0, and 5.0 h, respectively. Urinary and 
biliary recovery of administered DON averaged approximately 7.1%: 7.0% in urine and 0.1% 
in bile (Prelusky et al. 1986). 
The excretion kinetics of DON was investigated in swine. Serum DON levels declined 
slowly with an elimination half-life (t 1/2β) of 6.28 and 5.32 h after feeding  castrated male 
pigs (n = 16, 41.5 ± 2.0 kg) on DON from naturally contaminated wheat (16.6 mg DON/kg) 
chronic exposure or one single oral dose (acute) (Goyarts T and Danike 2006). The pigs were 
fed a commercial diet with 3- acetyl DON (substitube C3-OH of DON for C3-COCH3) 
added in a concentration of 2.5 mg/kg feed for 2.5 d (fed five times with feed corresponding 
to 2% of their body weight). The excretion of DON was mainly in urine (45 ± 26% of the 
toxin ingested by the pigs) and only low amounts of metabolites of 3-Ac DON (2 ± 0.4%) 
were recovered in feces. De-epoxidated DON constituted 52 ± 15% of the total amount of 3-
Ac DON-metabolites detected in feces. The remaining part in feces was DON. DON was still 
present in the urine and feces at the end of the sampling period 48 h after the last exposure 
with concentration between 58 and 131 ng/ml (Eriksen et al. 2003).  
DON was found in human urine through collecting urine sample from women in 
suspected high and low risk region in China. DON was detected in all 15 samples following 
beta-glucuronidase treatment and immunoaffinity columns (IAC) enrichment with the 
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identity of DON being confirmed by mass spectrometry. The mean levels of DON from the 
suspected high and low exposure regions of China were 37 ng/ml (range 14-94 ng/ml) and 12 
ng/ml (range 4-18 ng/ml), respectively. This is estimated to correspond to daily DON 
exposures of 1.1-7.4 µg/kg/day and 0.3-1.4 µg/kg/day, respectively. (Meky et al. 2003) 
As a conclusion, de-epoxidation of DON is a main metabolic fate of DON in intestine, 
especially in ruminant animals. DOM-1 was observed to undergo further glucuronidation in 
cow. DON glucuronide is main metabolite in plasma and urine (Table 1). After oral dose, 
chicken has a poor absorption with maximum plasma levels less than 1% of the administrated 
dose (Prelusky et al. 1986).  The free DON in urine in cow and sheep are ~1% and 7.5% of 
dose due to de-epoxidation of DON by microbial in rumen fruit (Cote et al. 1986; Prelusky et 
al. 1985).  In pigs, the bioavailability of DON was much higher than in these animals.  The 
mean bioavailability for free DON was 89% after chronic exposure (5-8 weeks) of DON 
from naturally contaminated wheat based on the area under the curves after oral and 
intravenous application of pure DON (Goyarts and Danike 2006a). Distribution of DON to 
tissues is very quick at 3 h in all tissues, and accumulation of DON in tissues did not occur 
(Prelusky et al. 1986; Prelusky et al. 1990). At the same time, it is possible that DON is not 
transmitted to eggs and milk or the concentration is lower than detection limit in eggs or 
milks (Lun et al. 1986; Cote et al. 1986). 
DON Toxicity 
Oral LD50 values of 78 and 46 mg/kg b.w. have been reported for B6C3F1 and DDY 
mice, respectively. The characteristics of acute/subacute toxicity of DON are vomiting, feed 
refusal, weight loss and diarrhea. The LOAEL dose of reduced food uptake in pigs was 
reported at 1.0 ppm of naturally contaminated DON diet. The LOAEL dose of decreased 
growth in pigs was reported at 1.7 - 4 ppm of naturally contaminated DON diet (Pestka and 
Smonlinski, 2005 and Opinion on Fusarium toxins: deoxynivalenol in European commission, 
1999). Immunotoxicity, reproductive toxicity, organ toxicity, mucosal toxicity and potential 
genetic toxicity were reviewed as follows.   
Immunotoxicity of DON 
Acute toxicity of DON in high doses may produce necrosis in various tissues such as 
bone marrow and lymphoid tissues. Subchronic oral exposures cause immuntoxicity by 
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change of leukocyte proliferation and functions, modulation of cytokines production, and 
reduction of host resistance to pathogens. Kinser et al. (2004) reported acute exposure to 
DON modulates gene expression profiles in murine spleen by microarray analysis. B6C3F1 
mice were treated orally with 25 mg DON/kg body weight. Two hours later, the spleens were 
collected for microarray analysis. DON was found primarily to modulate genes associated 
with immunity, inflammation, and chemotaxis. In vitro studies have been done in several 
different cell lines related to B, T, macrophage cells, and in vivo studies have been done in 
several different animals, and mouse is used often to investigate host response to DON.  
 (a) Inhibition of cell proliferation  
In vitro, different cell model has been used to study DON toxicity. It is observed that 
DON inhibited lymphocyte proliferation due to apoptosis and cytotoxicity.  
It is reported that DON binds to the ribosomal peptidyltransferase site in eukaryotic cells 
and inhibits protein and DNA synthesis, consequently exposure resulting in decreased cell 
proliferation and apoptosis. Shifrin and Anderson (1999) found that selected trichothecenes 
at 10 µM strongly activate JNK/p38 kinases and induce rapid apoptosis in Jurkat T cells. 
Although the ability of individual trichothecenes to inhibit protein synthesis and activate 
JNK/p38 kinases is dissociable, both effects contribute to the induction of apoptosis. At the 
same time, the research results show the peptidyltransferase site could be a regulator of both 
JNK/p38 kinase activation and apoptosis. 
The mechanism of induction of apoptosis by DON exposure was conducted by a series 
different cells lines: pre-B lymphocyte REH and human pre-T lymphocyte Jurkat, 
(Baltriukiene et al. 2007). The results showed DON effect was dose-dependent to inhibit cell 
proliferation and increase of apoptotic cells in blood cell lines. In blood-derived REH and 
Jurkat cells, DON-induced apoptotic changes were preceded by an transient increase in c-jun 
N-terminal kinase (JNK) phosphorylation and c-Jun expression (protein) as well as p38 
MAPKs phosphorylation. Further study determined JNK does not contribute to DON-
induced apoptosis, but P38 signalling is required for apoptosis in REH cells. 
The effects of DON on the expression of the sequentially expressed activation markers 
CD69 (early activation marker), CD25 (the interleukin-2 receptor), and CD71 (transferring 
receptor) and on proliferation of human lymphocytes were studied in culture incubation 72 h. 
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After 6 h, the CD69 expression was lower in exposed cultures compared to controls. After 24 
and 48 h of exposure, an increased frequency of cells expressing CD69 was found in exposed 
cultures, indicating a delay in downregulation of CD69 expression. Stimulation of CD25 
expression was observed for doses below the IC50 value, while suppression was found for 
higher doses. The pattern was different from that detected for CD69 expression, in that an 
increased expression of CD25 never occurred after exposure to the highest concentration of 
the toxin, and in that no stimulatory effects were found after 48 h of exposure, indicating that 
the response was inhibited and not delayed. The effects of toxin exposure on CD71 
expression were in many respects similar to the effects on CD25 expression. These results 
suggested DON inhibit the cell cycle, and resulted in inhibition of proliferation in 
conjunction with CD25 expression (Johannisson et al. 1999). 
Meky et al. (2001) reported DON effectively inhibited mitogen-induced lymphocyte 
proliferation. Human peripheral mononuclear cells were obtained from healthy male and 
female blood donors. The cells were treated with phytohemagglutinin-p (PHA-p) at 10 µg/ml 
or 0 µg/ml, and DON was applied at a range 0.17-1.69 µM. Cell cultures were incubated in 
humidified chamber for 5 d and cell proliferation was evaluated by methylthiazol tetrazolium 
(MTT) assay. A decrease in proliferation was observed with DON at concentrations greater 
than 0.34 µM and 50% inhibition at 0.73µM. However; DON had no effect on the viability 
of unstimulated lymphocytes at these concentrations as measured by the MTT assay. 
In another human peripheral mononuclear cells incubation study, the lymphocytes were 
treated with 5 µg/ml PHA or 1 µg/ml Pokeweed mitogen (PWM). The lymphocytes were 
cultured for 72 h and cell proliferation was evaluated by [
3
H]-thymidine assays. The IC50s of 
DON for the proliferation responses of human lymphocytes were 0.42µM (female) and 0.44 
µM (male) after PHA and 0.38 µM for both female and male after PWM. Therefore, there 
were no statistically significant differences in sensitivity to the DON between lymphocytes 
from females and males (Thuvander et al. 1999). 
Uzarski et al. (2003) reported DON induced apoptosis and reduced B cell proliferation in 
immature (CH31, WEHI-23) and mature cells lines of B cells (CH12.LX). DON induced 
cytotoxicity and apoptosis in WEHI-23 cells after exposure at 0.34-3.38 µM for 18 h, with 
EC50 at 1.69 µM for apoptosis and 1.01 µM for cytotoxicity, respectively. Additionally, 
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immature and mature B cells are equally sensitive to DON induced cell death. Investigating 
activation marker expression among subpopulations of human T cells from freshly collected 
blood found DON inhibited lymphocyte proliferation in the early cell cycle and its inhibition 
is before or in conjunction with CD25 (the IL-2 receptor) expression (Johannisson et al. 
1999). 
U-937, a human monocyte-like histocytic lymphoma (CRL-1593.2) was differentiated 
into macrophages using PHA and was treated with different concentrations of DON for 24 h. 
The cytotoxic effects of DON on U937 macrophage cells were measured using MTT assay. 
Cell proliferation was significantly reduced at concentrations of 0.17- 3.38 µM DON (Sugita-
Konishi et al. 2001). 
The effects of DON in the human K562 erythroleukemia cell line were evaluated. DON 
inhibited K562 cell proliferation. The IC50s were 2.2 µM and 1.60 µM after measured by 
MTT colorimetric assay and BrdU uptake with 48 h treatment. Fluorescent propidium iodide 
staining and flow cytometry revealed DON induced programmed cell death at the highest 
concentration of DON (80.1 µM), particularly chromatin condensation and hyperchromasia. 
Protein synthesis inhibition may play a role in DON induced apoptosis (Minervini 2003).  
Hematotoxicity induced by xenobiotics involves altered blood cell production or function 
either in bone marrow or at the level of circulating blood cells. Human white blood cell 
progenitors, red blood cell progenitors and platelet progenitors are the targets of the cytotoxic 
effects of DON.  
In vitro toxicity induced by DON on human and rat granulo-monocytic progenitors was 
investigated by Lautraite et al. (1997). Granulo-monocytic progenitors (CFU-GM) from 
human umbilical cord blood and from rat bone marrow were cultured in the presence of 
DON from 1 µM to 10 nM for 14 days. DON rapidly inhibits human and rat CFU-GM in a 
concentration-dependent manner between 1 µM and 0.25 µM. IC50 values on days 7, 10, and 
14 were, respectively, 30, 29, and 39 nM for human CFU-GM and 0.26, 0.15, 0.16  µM for 
rat CFU-GM. Froquet et al. (2001) researched DON toxicity on human megakaryocyte 
progenitors. No cytotoxic level was detected for DON from 10 nM to 0.25 µM. Total colony 
growth was decreased to 55% compared to control in the presence of 0.25 µM DON. Rio et 
al (1997) investigated DON toxicity on human red blood cells progenitors. The result showed 
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DON exhibits cytotoxic effects at 2.5×10
-7
 M on red blood cells progenitor. Froquet et al. 
(2003) also compared the sensitivities of circulating blood cells and hematopoietic 
progenitors to DON. A 50% decrease in leukocyte number was observed for 10
-5
 M DON. In 
vitro data confirmed that DON effects were likely to be predominantly on progenitor cell 
rather than on circulating mature blood cells. Further research will be needed to determine if 
the effect of DON is on differentiation or proliferation of progenitor cells, or both.  
Take together; DON effects were predominantly on progenitor cell rather than on 
circulating mature blood cells, especially granulo-monocytic progenitors, with IC50s 30 nM 
for human progenitors, were more sensitive than plantlet progenitors and red blood 
progenitors (Lautraite et al. 1997; Froquet et al. 2001; Rio et al. 1997; Froquet et al. 2003). 
Human peripheral mononuclear cells were inhibited at 0.42 µM (Thuvander et al. 1999) or 
0.34 µM (Meky et al. 2001) with mitogen stimulation. The mechanism of apoptosis induced 
by DON possibly through the p38 MARK signaling (Shifria and Hnderson 1999; 
Baltriukiene et al. 2007). The mechanism of antiproliferative action induced by DON was 
possibly through inhibiting the early cell cycle conjunction with CD25 expression 
(Johannisson et al. 1999).  
(b) Inhibition of macrophage/dentritic cells/NK cells activity  
Macrophage phagocytosis of microorganisms is important in host immunity and activated 
macrophages kill ingested pathogens by production of reactive oxygen and nitrogen 
metabolites. DON shown previously to exert immunosuppressive effects on the immune 
system was examined for in vitro effects on some functions of murine peritoneal 
macrophages (Ayral et al. 1992). Peritoneal exudate cells (macrophage cells) in peritoneal 
cavity of Swiss Female mice (6 ~ 8 weeks) were collected. The cells were pre-incubated for 4 
h with the mycotoxin (0.3 nM ~3.38 µM). At concentrations that did not affect cell viability 
(based on Specific Lactate Dehydrogenase test), DON suppressed microbicidal activity of 
phagocytic cells against model microbes, opsonized Saccharomyces cerevisiae. DON 
inhibited phagocytosis, microbicidal activity and superoxide anion production at 3.3 nM 
whereas phagosome-lysosome fusion was reduced above 0.34 µM. These results suggested 
that microbicidal activity inhibition by DON was independent of non-oxidative pathway 
(phagosome-lysosome fusion) impairment. 
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Dendritic cells as professional antigen-presenting cells are primarily responsible for 
initiating or suppressing immune responses, and are therefore likely mediators for the 
suppressive effects of DON on the immune system. Monocyte-derived dendritic cells were 
incubated with DON at concentrations 1 nM, 10 nM, 100 nM and 2 μM. The viability of cells 
was decreased to 60% at 2 μM DON, no inhibition was observed at 100 nM DON. The 
exposure to DON at 10 nM during dendritic cell maturation upon addition of LPS or TNF-
alpha markedly inhibited the up-regulation of maturation markers such as CD-86, HLA-DR 
and CCR7. Features of LPS or TNF-alpha mediated maturation of dendritic cells, such as IL-
10 and IL-12 secretions and endocytosis, were also impaired in response to DON treatment. 
These results suggest DON have adverse effects on dendritic cells and dendritic cell 
maturation process (Hymery et al. 2006). 
Bimczok et al. (2007) investigated the immune-suppression to dentritic cells after DON 
exposure in pigs for 5 weeks. The daily DON intake ranged from 0.083 to 0.213 mg/kg b.w.. 
Mono-dentritic cells (MoDC) were isolated from pig peripheral blood fed DON or DON free 
diets. In DON feeding group pig, MoDC failed to up-regulate MHC-II in response to 
LPS/TNFα. Endocytosis of FITC-dextran of MoDC was inhibited while their T cell 
stimulatory capacity was not altered. ERK1/2 and JNK were constitutively activated in 
MoDC from pigs fed the DON-diet.  In summary, DON disrupts porcine dentritic cells 
function in vivo, which might contribute to the immunosuppressive effects of this mycotoxin. 
Berek et al. (2001) investigated the effects of DON on ADCC+ natural killer (NK) cell 
activity. In the ADCC test, 
51
Cr labelled freshly collected Rh (D, C) - positive O red blood 
cells (RBC) were used as target cells and PBMC macrophages as an effector in a 1:10 ratio. 
The reaction was mediated by RBC-specific anti-D antibodies. The amount of released 
51
Cr 
in supernatant was determined using a gamma counter after incubation at 37°C for 16 h.  In 
NK assay, 
51
Cr- labeled K562 cells were used as the target and PBMC used as effector in a 
1:50 ratio. The amount of radioactivity released into culture supernatants was determined and 
the results were expressed as percentage of inhibition after incubation at 37°C for 4 h. The 
results showed that DON exerted immunosuppressive effects on human peripheral blood 
mononuclear cells in vitro manifested as depressed T or B lymphocyte activity and inhibited 
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NK cell activity at 0.17 µM DON, suggesting that protection against tumor development may 
also be attenuated. 
Taken together, these results show DON exposure exerted an inhibitory effect on resident 
macrophage cells, dentritic cells and NK cells. Natural killer cells are an early component of 
the host response to virus infection. Inhibition of NK cell activity occurs after DON exposure; 
the levels of some viruses may be much higher in the early days of the infection if the host is 
exposed to DON. Macrophage cells as phagocytic cells provide a first line of defense against 
infection and act as one of the important antigen-presenting cells. Inhibition of macrophage 
cell activity and lymphocyte activity will cause inhibition of microbicidal killing and 
alteration of TH1-TH2 balance. Dendritic cells (DC) as antigen-presenting cells are primarily 
responsible for initiating or suppressing immune responses, and are therefore likely 
mediators for the suppressive effects of DON on the immune system. Activation of mitogen-
activated protein kinases ERK1/2, and JNK in DC plays an important role in DC maturation, 
which is in turn crucial for DC function, and are potential molecular targets for action of 
DON. 
(c) Modulation of cytokine production and inflammatory genes 
A number of studies suggest that mycotoxins are potent immunomodulators. Depending 
on the dose, timing and route of exposure, mycotoxins can be immunostimulatory or 
immunosuppressive agents. Immune modulation is related to changes in cytokine production. 
Elevated cytokine expression may play an important role in the pathophysiologic effects of 
DON and other trichothecenes. Cytokine superinduction by protein synthesis inhibitors is 
likely to involve transcriptional and/or post transcriptional mechanisms. 
 Cell culture study 
Evidence for cytokine dysregulation was found by Meky et al. (2001). Human 
mononuclear cells were isolated and incubated with or without phytohemagglutinin-p with 
DON at 0, 0.34, 0.68, and 1.35 µM. The result showed that human mononuclear cells without 
mitogen simulation did not produce cytokines. Short-term treatment of PHA-stimulated 
lymphocytes with DON modulated the kinetics of IL-2, IL-4 and IL-6 production. IL-2 levels 
were up to 12-fold higher in comparison to control levels at DON concentrations of 0.68 and 
1.35 µM 72 h after treatment. IL-4 levels were only slightly elevated and IL-6 levels were 
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slightly inhibited by these DON concentrations. At the lower DON concentration of 0.68 µM, 
IL-2 levels were elevated with a concomitant mild elevation in IFN-γ. At 1.35 µM, IL-2 
levels were significantly elevated until 6 d post treatment. 
Effects of DON on the production of the cytokines have been investigated in a human 
macrophage model (Sugita-Konishi et al. 2001). U-937, a human monocyte-like histocytic 
lymphoma, was differentiated into macrophages by incubating with PHA. In the absence of 
LPS, DON at 1.69 or 3.38 µM upregulated TNF-α production as early as 3 h and up to 6 h, 
whereas 0.34 to 3.38 µM of DON significantly increased production of IL-6 from 3 to 24 h 
and IL-8 from 6 to 48 h. In the presence of LPS, DON at 1.69 or 3.38 µM markedly induced 
TNF-α and IL-8 production. However, for IL-6, 0.34 µM of DON potentiated LPS-induced 
IL-6 production, while 1.69 or 3.38 µM ng/ml of DON suppressed the LPS-induced IL-6 
production. As a result, DON induces or superinduces cytokines production even at DON 
concentrations that are cytotoxic at 0.17 µM. 
Pestka and Zhou (2006) found preexposure to Toll-like receptor agonist 
lipopolysaccharide (LPS, minimum concentration 1 ng/ml) significantly increased DON-
induced IL-1β, IL-6, and TNF-α mRNA expression as compared to LPS or DON alone; LPS 
priming also potentiated IL-1β mRNA induction by DON in human whole-blood cultures. 
Preexposure to Toll-like receptor agonists including zymosan (TLR2), poly (I: C) (TLR3), 
flagellin (TLR5), R848 (TLR7/8), and ODN1826 (TLR9) also sensitized RAW 267.4 cells to 
DON-induced proinflammatory gene expression. These results suggested prior Toll-like 
receptor activation might increase sensitivity of macrophage to DON exposure resulting in 
greater induction of proinflammatory cytokine gene.  It was reported by Mbandi and Pestka 
(2006) that DON amplified inflammatory responses to Listeria monocytogenes and 
Salmonella typhimurium in RAW 264.7 murine macrophages. With Listeria, the minimum 
DON concentrations for induction of macrophage inhibitory protein 2 (MIP-2), IL-β, IL-6, 
and TNF-α were 0.034, 0.034, 3.38, and 3.38 µM (P < 0.05) and for Salmonella the 
minimum DON concentrations were 0.034, 0.034, 0.34, and 0.34 µM, respectively (P < 0.05). 
Induction of all four mediators by both pathogens was potentiated by DON (at 0.34 and 0.84 
µM); observed responses were significantly greater than predicted additive responses (P < 
0.05). 
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In another macrophage cell incubation study, the monocytic U937 cells were used as a 
model for human alveolar macrophages. The IL-8 cytokine in U937 cells peaked (0.6 ± 0.2 
µg/ml) at the very same DON concentration (0.84 µM) that inhibited 50% of the cells‟ 
protein synthesis (Instances and Hetland 2004). 
To better understand molecular mechanisms by which DON superinduces cytokine gene 
expression, Li et al. (1997) studied the posttranscriptional effects of DON on IL-2 gene 
expression in murine EL-4 thymoma cells stimulated with phorbol 12-myristate 13-acetate 
and ionomycin (PMA + ION). Northern analysis revealed that doses of 0.17 to 1.69 µM 
DON superinduced IL-2 mRNA expression in a dose- and time-dependent manner in a 
synchronous model where DON was added at onset of PMA + ION stimulation. In 
accordance with the mRNA levels, IL-2 production was significantly elevated in the presence 
of 0.17 to 0.84 µM DON. Superinduction of IL-2 mRNA was also observed in a delayed 
synchronous model (DON added 20 h after PMA + ION stimulation) and an asynchronous 
model (DON added 20 h after PMA + ION stimulation and removal). To assess the effects of 
DON (1.69 µM) on IL-2 mRNA half-life, three transcriptional inhibitors (Actinomycin D, 5, 
6-dichloro-beta-D-ribofuranosyl-benzimidazole, cyclosporin A) were used in the delayed 
synchronous model. The results suggest that DON can superinduce IL-2 at both the mRNA 
and the protein level and that this superinduction can be explained, in part, by 
posttranscriptional mechanisms such as enhanced mRNA stability. 
Transcription factor NF-κB plays a critical role in regulation of transcription of several 
cytokine genes. DON exposure can enhance NF-κB binding activity by inhibiting the 
synthesis of IκBα, which is one member of a family of cellular proteins that function to 
inhibit the NF-κB transcription factor. Besides NF-κB, activator protein-1(AP-1) is another 
critical transcription factor involved in transcriptional regulation of IL-2 and IL-6 gene 
expression. AP-1 is composed of members of the Jun (JunB, c-Jun and JunD) and Fos 
families (c-Fos, FosB, Fra-1 and Fra-2), which bind to the TPA response element (AP-1 site). 
It was demonstrated by gel supershift assay that DON (0.84 µM) preferentially affected 
phosphorylated c-Jun, JunB, c-Fos and Fra-2 binding activities, whereas it did not alter Jun D 
and Fra-1 binding. These increasing binding activities are associated with enhanced AP-1 
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transactivation, which may contribute to cytokine dysregulation and immunotoxic effects 
associated with exposure to trichochecene mycotoxins such as DON (Li et al. 2000). 
The mechanisms of chemokine interleukin (IL-8) induction by DON were investigated in 
the U937 human monocyte model. A series of experiments was conducted to test the 
hypothesis that DON modulates transcriptional and posttranscriptional regulation of IL-8 
expression. The results suggested DON-induced IL-8 expression is likely to be mediated at 
the transcriptional level by nuclear factor kappa B (NF-κb), specifically p65 subunit, but does 
not appear to involve mRNA stabilization (Gray and Pestka 2007). 
DON and other trichothecene mycotoxins mediate a broad range of immunotoxic effects 
via the induction of inflammation-associated genes in leukocytes. Moon and Pestka (2002) 
tested the hypothesis that DON induces cyclooxygenase-2 (COX-2) gene expression in 
macrophages and they determined that DON-increased COX-2 is regulated at the level of 
mitogen-activated protein kinases (MAPKs). Exposure of the murine macrophage cell line 
RAW 264.7 to 0.17-0.84 µM DON for 24 h markedly enhanced the production of 
prostaglandin E 2 (PGE2), a major COX-2 metabolite. PGE2 elevation was preceded by 
increases in COX-2 mRNA (2 h) and COX-2 protein (15 h) in DON-treated cells. DON 
induced rapid (15 min) and persistent (up to 240 min) phosphorylation of extracellular, signal 
regulated protein kinases 1 and 2 (ERK1/2) and p38 MAPK as well as a rapid (15 min) but 
transient (up to 60 min) phosphorylation of c-Jun N-terminal kinases 1 and 2 (JNK1/2). The 
ERK inhibitor PD98059 and p38 inhibitor SB203580 suppressed DON-induced PGE2 and 
COX-2 protein expression, whereas impairment of JNK function by transient transfection 
with a dominant negative (dn) JNK vector had no effect on COX-2 protein expression after 
DON treatment. In cells transfected with a COX-2 promoter-luciferase construct, PD98059- 
and SB203580-, but not dnJNK-treatment, suppressed DON-induced luciferase transcription. 
DON also increased COX-2 mRNA stability, and this was inhibited by PD98059 but not by 
SB203580. Taken together, these results indicate that DON-induced PGE2 production and 
COX-2 expression by elevating transcriptional activity and mRNA stability. Enhanced 
transcriptional activity was modulated by ERK and p38 signaling pathways, whereas mRNA 
stability was promoted exclusively by DON-activated p38 phosphorylation. These data 
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provide insight into possible general mechanisms by which DON and other trichothecenes 
upregulate proinflammatory genes and impart immunotoxicity. 
Taken together, IL-2 was markedly increased in human mononuclear cells stimulated by 
PHA at 0.68 and 1.35 µM DON (Meky et al. 2001). TNFα, IL-6 and IL-8 were increased in 
human macrophage model without mitogen stimulation (Sugita-Konishi et al. 2001). 
However, mitogen stimulation such as LPS, and pathogens such as Listeria monocytogenes 
and Salmonella Typhimurium increased MIP-2, IL-β, IL-6, and TNF-α secretion at 0.34 µM 
DON, and the effect of combination of DON and Listeria. and Salmonella. was more than 
additive (Mbandi and Pestka 2006).  DON (0.17-0.84 µM) induced PGE2 and COX 
production through enhanced mRNA stability and enhanced ERK and p38 signaling (Moon 
and Pestka 2002). Enhanced mRNA stability and enhanced trans- activation of activator 
protein-1 could be the mechanism of increased IL-2 and IL-6 in human cells after DON 
treatment (Li et al. 1999 and 2000). The enhanced transcription factor, NF-γB, specifically 
p65 could mediate increased IL-8 in macrophage cells after DON treatment (Gray and Pestka 
2007). 
Animal studies of DON-mediated cytokine changes 
 Of course, stimulation of cytokine production by DON has been observed in macrophage 
cells and peripheral blood mononuclear cells with mitogen stimulation. In vivo, cytokine 
stimulation by DON has been observed in several animal studies. 
Zhou et al. (1997) found acute oral DON (5 and 25 mg/kg b.w.) exposure enhances 
mRNA expression of several cytokines, including IL-1β, IL-2, IL-4, IL-6, IFN-γ and IFN-α 
in spleen and Peyer‟s patches (indicators of systemic and mucosal immune compartments, 
respectively), and other organs in male B6C3F1 mice. The effects were more pronounced in 
spleen than in the Peyer's patches. Serum levels of IFN-α, IL-6, and IFN-γ were elevated 3 h 
after exposure to 25 mg/kg DON, thus suggesting that elevation of splenic and Peyer's patch 
mRNA abundance correlated with increases in systemic production of these cytokines. 
LPS increased inflammatory cytokine production by DON has been reported in human 
whole blood culture (Pestka and Zhou 2006). In vivo, LPS priming sensitized a host to DON-
induced proinflammatory cytokine production and apoptosis in mice. Male B6C3F1 Mice (7 
weeks) were primed with LPS (1 mg/kg b.w.) i.p. and were treated with DON (0.5 to 25 
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mg/kg b.w) orally 8 h later. For cytokine protein and mRNA determination, blood was 
collected at 2 h after DON treatment. The results show the minimum DON doses for 
inducing IL-1α, IL-β, IL-6 and TNF-α serum proteins and mRNAs in spleen were 
significantly lower than the DON doses required for vehicle-primed mice. DON doses from 2 
to 25 mg/kg b.w. significantly induced plasma IL-1β, and LPS pre-treatment lowered the 
threshold for DON to 0.5 mg/kg.  An identical pattern was observed for IL-6 in plasma.  
DON at 12.5 and 25 mg/kg b.w. but not lower doses induced TNF-α; LPS-pre-treatment 
lowered this threshold to 2 mg/kg in plasma. Although IL-1α was not detectable in serum of 
any experimental group, thresholds for induction of splenic IL-1α mRNA by DON alone was 
12.5 mg/kg b.w.; thresholds for DON-induced IL-1α mRNA decreased to 5 mg/kg following 
LPS priming. Increased apoptosis in the thymus was observed in mice primed with LPS i.p. 
at DON concentration of 12.5 mg/kg. As a result, LPS potentiated the effects of DON in vivo 
and in vitro (Islam and Pestka 2006). These results indicate DON exposure could increase 
sensitivity to pathogen infection in chronically sick or malnourished individuals. 
Li et al. (2007) reported DON exacerbates viral bronchopneumonia induced by 
respiratory reovirus infection. Female BALB/c mice (5 weeks old) were orally gavaged with 
DON (10 mg/kg body weight [bw]) or saline vehicle and then intranasally instilled with 
reovirus serotype 1, strain Lang (T1/L). At 10-day postinstillation (PI), both viral titers and 
reovirus L(2) gene expression were 10-fold higher in lungs of DON-treated mice than in 
saline controls. The lowest observed effective DON dose that impaired viral clearance was 2 
mg/kg bw.. Lung and bronchoalveolar lavage fluid (BALF) were also assayed for effects of 
DON on cytokines. The results showed reduced expression of IFNαβ receptor and type 1 
IFN-mediated gene in the lung might contribute to DON impairment of pulmonary reovirus 
clearance, whereas exacerbation of bronchopneumonia and IgA responses corresponded to 
increased MCP-1, TNF-α, and IL-6 expression. All these studies suggested that exposure to 
DON could sensitize the immune system to pathogen. 
Nine-ten wk old female B6C3F1 mice were gavaged or administered intranasally with 5 
mg/kg b.w. DON. The proinflammatory cytokines include TNF-α; IL-1β, and IL-6 were 
measured by real time-PCR in spleen, liver and lung. Oral exposure to DON induced robust 
proinflammatory cytokine gene expression after 60 and 120 min. In contrast, induction of IL-
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1β, IL-6 and TNF-α mRNAs in nasally exposed mice were 2-10, 2-5 and 2-4 times greater, 
respectively, than those in the tissues of orally exposed mice, whereas plasma and tissue 
DON concentrations were 1.5-3 times greater following intranasal exposure as compared to 
oral exposure as measured by ELISA (Amuzie et al. 2008). 
Take together, increased cytokine production was observed in DON treated mice, and 
serum cytokine concentration were related to systemic production (Zhou et al. 1997). LPS 
(an indicator of bacteria) and respiratory virus sensitized a host to DON-induced 
inflammatory cytokine production (Islam and Pestka 2006; Li et al. 2007). In harvest season, 
exposure to DON by inhalation could cause systemic inflammatory response, influenced by 
higher DON bioavailability by inhalation than by oral exposure (Amuzie et al. 2008)  
(d) Changes in immunoglobulin 
Human peripheral mononuclear cells were stimulated by the pokeweed mitogen and 
incubated with DON for 7 d. Antibody production was tested using ELISA kit. The results 
show that immunoglobulin (Ig) A, IgG and IgM production were inhibited by exposure to 
DON. The IC50 of inhibitory effects of DON on Ig production was 0.37 μM, 0.39 μM, 0.4 
μM, for IgG, IgM and IgA, respectively (Thuvander et al. 1999). Another study in pigs 
showed similar results. ConA stimulated pig peripheral blood mononuclear cells were 
exposed to DON for 72 h with IC50 of inhibitory effects on Ig production of 0.41 μM, 0.28 
μM and 0.24 μM, respectively (Goyarts et al. 2006b). 
However, in vivo study (animals were fed DON and Ig levels measured in plasma or 
serum) or in vivo-vitro study (animals were fed DON, lymphocytes removed, and Ig levels 
measured in supernatant of cultured lymphocytes), IgG, IgM and IgA  levels were inhibited 
or increased after DON exposure depending on species and exposure dose and time. In 
C57BL6 mice, a subchronic dose of 0.071~1.774 mg DON/kg b.w. for 3 d per week for 4 
weeks orally administered (corresponding to daily mean intakes of 0.2 ppm, 1 ppm and 5 
ppm contaminated feed applied for four consecutive weeks) provoked increases in plasma 
IgA, and no change in IgG and IgM (Gouze et al. 2006). In German Landrace x Pietrain pigs 
(both sexes), serum IgA levels were significantly increased after they were fed wheat 
naturally contaminated with DON (6.5 mg/kg diet) for 11 weeks ad libitum with feeding 
intake 2.90 kg/d and 2.47 kg/d for control and DON group, respectively, with no change in 
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restrictively fed pigs fed DON with feeding intake 1.94 and 1.93 kg/d for restrictive control 
and restrictive DON group, respectively (Goyarts et al. 2005b). The restrictive feeding was 
introduced to assure the same amount of feed intake for all animals of both the control group 
and of the DON group, which is important to compare the effects on the measured 
parameters between control and DON feeding group without impact of feeding intake level. 
In the follow-up study, Goyarts et al. (2006) found IgA, IgM and IgG in the supernatant of 
cultured lymphocytes were not significantly affected after dietary DON exposure (5.7 mg/kg 
diet, 550 g diet) over 4 weeks or as a single dose (pigs fed restrictively). However, serum 
IgM and IgG were significantly increased in pigs fed a single dose of DON, although IgA 
was not affected. 
Several reasons could explain unrepeatable results. 1) In in vitro incubation studies, the 
IC50 for DON to inhibit immunoglobins production was ~0.4 µM. In vivo, pig exposure to 
DON at 5.7 mg/kg or 6.5 mg/kg could not reach plasma concentration to of 0.4 µM. Goyarts 
and Danike (2006 a) reported the maxium plasma concentration after 5.7 mg/kg DON for 5 
~8 weeks was ~0.07 µM. Pestka et al. (2008) reported the plasma concentration was ~ 0.12 
µM after mice were fed 5 ppm DON for 4 weeks. Therefore, no inhibition of IgG and Ig M 
was observed in mice and pigs exposed to DON at 5 ~ 6.5 ppm (Gouze et al. 2006; Goyarts 
et al. 2005b; Goyarts et al. 2006). 2) Based on these studies, Ig A could be stimulated by 
DON (Gouze et al. 2006; Goyarts et al. 2005b). The dose to increase Ig A was 0.2 ppm and 
6.5 ppm for mice and pig, respectively, indicating that mice were more sensitive to DON in 
Ig A production. 
(e) Antibody response to immunization 
The evaluation of antibody development following vaccination is one of the standard 
tests relevant to human immuntoxicology.  
DON contaminated feed could alter vaccine immune response, which was observed in 
pig subcutaneously immunized with ovalbumin (Pinton et al. 2008). Twenty-four pigs 
received for 9 weeks either control feed or feed naturally contaminated with 2.2–2.5 mg 
DON/kg. At days 4 and 15 of the experiment, the animals were subcutaneously immunized 
with ovalbumin. The results showed DON affects widespread immune response. In the serum, 
DON increases the concentration of total IgA and, in vaccinated animals, DON also increases 
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the concentration of ovalbumin-specific IgA and IgG. In the mesenteric lymph node, a 
significantly lower expression of both TGF-β and IFN-γ mRNA expression levels were 
observed in animals fed with DON when compared with control piglets. These results 
suggested DON exposure in humans and animals may lead to the occurrence of disease even 
in properly vaccinated populations. 
 (f) Immunotoxicity in mice model and challenge against infectious agents 
Mice are used often to monitor immunotoxicity of DON. In our lab, BALB/c mice were 
the model to investigate biomarkers of low dose dietary DON exposure. The challenge of an 
organism‟s immune system by an infectious agent represents the ultimate assay to assess the 
immunocompetence of a host. 
Weanling male Swiss Webster mice were administered by gavage 0.75, 2.5, and 7.5 mg 
of DON per kg body weight once per day for 5 weeks. Administration of 7.5 mg/kg b.w. of 
DON resulted in deaths in all animals of this group within 3 weeks. Serum IgM levels in 
response to sheep red blood cells were significantly reduced in the treatment groups 
compared to the control groups (p< or =0.001). Plaque-forming cell (PFC) numbers were 
also lower in the treated groups compared to the control groups (r=0.68). Furthermore, DON 
at a dose of 0.75 mg/kg b.w. resulted in a significant increase in the albumin, 
albumin/globulin ratio and a decrease in the alpha-2 globulin fraction compared to the 
control groups, although no change in protein was observed in other groups. Thymus and 
spleen weight were significantly reduced in test groups. These findings indicate a potential 
effect of DON on the immune system which could have serious implications for humans 
(Tryphonas et al. 1984). 
In a follow-up study, Tryphonas et al. (1986) gave male Swiss Webster mice sublethal 
doses (0, 0.25, 0.5 and 1 mg/kg b.w./day corresponding to 0, 1, 2 and 4 ppm of DON in feed 
for 5 weeks (beginning at day 21) to study DON effects on humoral and cellular immunity, 
and fed control diet for 40 d after 5 weeks DON treatment to investigate the possible 
reversibility of the effects of DON.  The results showed PFC frequency and antibody titer to 
SRBC did not change after DON treatment, and no effects on the spleen and thymus weights. 
The treatment effects were significant on the serum proteins. DON at 1.00 and 0.50 mg/kg 
resulted in a statistically significant reduction in the serum protein fraction. The effect of 
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DON on protein was not observed reversibly, although different protein fractions were 
influenced after 5 weeks DON or followed 40 d “wash out”. DON at 1.00 mg/kg reduced in 
feed consumption and body weight gain, and 0.50 mg/kg dose of DON resulted in a 
significant reduction of feed consumption was evident only during Week 4. Similarly, body 
weight gain in this group of mice was significantly reduced during Week 2 but increased to 
normal levels during Week 3 and remained parallel to the control for Week 4 and 5. Both 
levels (0.50 and 1.00 mg/kg) of DON resulted in a reduced, dose-related, time-to-death 
interval following a challenge with L. monocytogenes and increased proliferative capacity of 
splenic lymphocyte cultures stimulated with the phytohemagglutinin P (PHA-P) mitogen 
compared to the control group of mice. The 0.25 mg/kg dose of DON did not have any 
significant effects on the parameters studied. A reasonable estimation of a 'no effect' level for 
immunologic effects in mice based on these and previous studies would seem to be between 
0.25 and 0.50 mg/kg b.w. /day. 
Male BALB/c mice (4~6 weeks old) were used to investigate the immunosuppressive 
effect of DON. Mice were daily fed DON for 1 or 2 weeks at doses of 2.5 to 100 ppm in the 
diet (pair-fed controls). The 100 ppm dietary exposure of DON was lethal to all animals 
within a few days. After oral administration of DON to mice, liver and kidney weights were 
not changed whereas thymus weight was reduced significantly at concentrations >10 ppm. 
The thymus was more sensitive to DON than spleen in that the spleen weight was reduced 
less than thymus weight and the stimulation of B and T cells by mitogens was depressed 
more for thymic cells than for splenic cells. Serum levels of anti-sheep red blood cell 
antibodies were significantly reduced with dose-response effect. In vitro, DON inhibited cell 
proliferation estimated by [
3
H] thymidine incorporation: murine splenocytes were more 
sensitive than XP human fibroblasts. These results indicate that the immune system is the one 
of targets of DON toxicity (Robbana-Barnat et al. 1988). 
B6C3F1 female mice (8-10 wk old) were fed 25 ppm DON continuingly for 12 weeks, 
the serum IgA and Ig G levels were monitored at 4 , 8 and 12 weeks after feeding. Relative B 
and T cells in spleen and Peyer‟s patches were investigated. The result showed DON at 25 
ppm increased serum Ig A levels from 4 to 12 weeks, whereas Ig G level was inhibited only 
at 8 weeks. After pooling all 4, 8 and 12 week data, the results showed relative CD4+ T cells 
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and B cells in Peyer‟s patches were increased; relative CD4+ T cells and CD8+ cells in 
spleen were increased after DON treatment; the ratio of CD4/CD8 was increased in both 
Peyer‟s patches and spleen in DON treatment group compared to control; increased B cells in 
Peyer‟s patches were related to increase higher percentage of Ig A positive cells. These 
results indicated increased lymphocytes in Peyer‟s patches and spleen after 25 ppm DON 
along with increased serum IgA in mice (Pestka et al. 1990). 
Weanling female B6C3F1 mice were fed semi-purified DON at 0, 0.5, 2, 5, 10, 25 ppm 
DON for 8 weeks. Zearalenol (ZEA) at 10 ppm or 10 ppm plus 5 ppm DON was used to 
evaluate estrogen effect of ZEA on DON toxicity. The results showed 2 ppm DON or greater 
inhibited body weight gain, whereas 25 ppm inhibited food consumption (food rejection 
shown at 0.5 ppm). No change in thymus weight occurred at less than 25 ppm DON, 
decreased spleen weight occurred at 25 ppm DON, decreased liver weight at 10 and 25 ppm 
DON, decreased kidney weight at 5, 10, and 25 ppm DON, and decreased brain weight at 25 
ppm DON were observed. Decreased WBC at 10 and 25 ppm DON, decreased lymphocytes 
at 25 ppm DON and decreased monocytes at 10 ppm DON, and increased PMN at 25 ppm 
DON, were also noticed. Serum Ig M was decreased at 25 ppm DON and serum IgA 
increased at 2~10 ppm DON. Additionally, 10 ppm ZEA had no additive or synergistic effect 
on DON toxicity based on these measurements (Forsell et al. 1986). 
Male BALB/c (8 week old) mice were fed control diet or 2 ppm dietary DON for 14 d. 
Con-A stimulated spleen cell proliferation, B cell response to T cell dependent antigen 
(hemolytic plaque assay), and cytokine analysis were monitored. The results showed that 2 
ppm DON inhibited Con-A stimulated splenocyte proliferation, and IL-4 increased after 48 h 
incubation. No change by DON was observed in plaque forming cells in spleen to sheep RBC 
(Landgren et al. 2006). 
Male BALB/c mice (12-14 weeks) were dietary fed 0, 1.0 ppm DON plus 0.9 ppm 3- Ac 
DON and 2.0 ppm DON plus 1.8 ppm 3- Ac DON for 28 d. Splenic NK cytotoxicity assay, 
Con-A stimulated lymphocyte proliferation, hemolytic plaque assay and cytokines were 
performed. Peripheral blood lymphocytes were counted. The results showed 2 ppm DON 
plus 1.8 ppm 3-Ac DON reduced weight gain and increased feed intake. The concentration of 
lymphocytes was decreased at 1 ppm and 2 ppm DON + 3 ADON (no difference 1 vs 2 ppm). 
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2 ppm of DON/1.8 ppm 3-Ac DON reduced red blood cells count and percentage of 
hematocrit. The results indicate 1 ppm DON/ 0.9 ppm 3-Ac DON stimulated NK cells 
function and increased IFN-γ release from spleen cells. No change in IL-4 release was seen 
after fed DON exposure for 28 d compared to increased IL-4 after 14 d, suggesting BALB/c 
mice adapted to DON exposure (Landgren et al. 2005). 
A two year feeding study was conducted with female and male B6C3F1 mice fed DON at 
0, 1, 5 and 10 ppm. The main measurements included hematology, clinical serum chemistry, 
bone marrow smears, and pathology. The results showed 5 and 10 ppm DON decreased body 
weight gain significantly, no change in food intake in female, whereas, 5 and 10 ppm DON 
decreased both body weight gain and food intake in male mice. Organ weights adjusted for 
body weights showed no effects of DON in females, however, in males, there was a trend for 
decreased liver weight (p<0.001), decreased spleen weight (p=0.04) and increased testes 
weight (p=0.002) in DON-fed mice. In males, there was a dose-response decreased trend in 
blood calcium concentration, significantly decreased at 5 and 10 ppm DON. There were 
some sporadic differences in hematological parameters. There were trends toward increased 
lymphoid cells in females and decreased myeloid cells in males in bone marrow. The 
pathology results showed dose-related decrease in liver preneoplastic and neoplastic lesions 
in males as the dose level of DON increased. This negative trend probably results from 
reduced food intake in male and appearance of spontaneous hepatic preneoplasms in mice 
with aging (Iverson et al. 1996). 
Salmonella enteritidis, a bacterium causing food-borne infection, is often used for 
studying mechanisms of bacteria invasion into intestinal cells in vivo and in vitro. S. 
enteritidis infects intestinal cells at first, and then transfers to the other organs via blood 
stream. The effect of DON on Salmonella enteritidis infection was investigated in male 
BALB/c mice. Mice were given water containing 2 ppm DON or no toxin for 3 weeks. The 
results showed that Salmonella increased more rapidly in the mesenteric lymph node, liver 
and spleen of the DON-treated mice than in untreated mice. These finding suggest that DON 
promotes invasion or/and growth of Salmonella in the lymph node, liver and spleen (Hara-
Kudo et al. 1996). 
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Atroshi et al. (1994) investigated the effect of dietary exposure to DON on host resistance 
and serum immunoglobins of normal and lactating inbred Han:NMRI mice that develop 
mastitis. The influence of DON on mastitis was evaluated by examining, pathologically and 
immunologically, the degree of infection in the presence of S. hyicus and M. avium. After 
feeding a single dose of DON (12.5 mg/kg b.w.) or a week of dosing of DON (6.25 mg/kg 
b.w. per day), the mice were infected to produce mastitis. The levels of serum IgA, IgG and 
IgM were increased in mice fed 12.5 mg/kg b.w. DON. A single treatment of DON and 
infection did not show significantly difference from control, whereas one-week treatment of 
mice with DON had a significant mitigating effect on the severity of mastitis. Macroscopic 
examination of the mammary glands revealed severe mastitis in 70% of the glands of control 
mice, compared with only 20% in the glands of the DON treatment mice. Increased Ig, 
especially IgA, could help reduced mammary gland inflammation. 
The effects of dietary exposure to DON and ZEA at naturally occurring levels (DON 0.5, 
5 and 25 ppm; ZEA 10 ppm; DON 0.5 ppm or 10 ppm plus ZEA 10 ppm) on immune 
function were evaluated for 2-3 and 8 week feeding periods in B6C3F1 weanling female 
mice, and the effects of immune parameters after exposure to DON and ZEA in combination 
were evaluated. The immune assays included resistance to Listeria monocytogenes, plaque-
forming cell (PFC) response to sheep blood cells and delayed hypersensitivity response by 
measuring the degree of footpad swelling response to keyhole limpet hemocyanin. The 
results showed that dietary DON depressed the plaque-forming response to sheep red blood 
cells, the delayed hypersensitivity response to keyhole limpet haemocyanin and the ability to 
resist Listeria monocytogenes after 2 weeks feeding. Resistance to Listeria was reduced to a 
greater extent by co-administration of DON and ZEA than by DON alone, whereas the 
ability of DON to inhibit the delayed hypersensitivity response was significantly lessened in 
the presence of ZEA. The effects of DON or DON plus ZEA in resistance to Listeria and 
delayed hyersensitivity response were observed in 2 weeks treatment, but disappeared after 8 
weeks, which indicated mice adapted to mycotoxin exposure (Pestka et al. 1987). 
Taken together, DON exposure reduced liver, kidney, thymus, spleen weights, but 
sensitivity of organs was different. Robbana-Barnat et al. (1988) reported immune system is 
the primary target of DON, and thymus is more sensitive than spleen, spleen is more 
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sensitive than fibroblasts.  Forsell et al. (1986) reported sensitivity order after DON exposure 
was kidney>liver>spleen=brain>thymus based on organ weight.  Male BALB/c mice were 
used by Robbana-Barnat et al. while female B6C3F1 were used by Forsell et al. could 
contribute to different results. The “no observed effect dose” was set up at 1~2 ppm DON 
based on body weight gain, food intake and serum protein excretion (Tryphonas et al. 1986; 
Forsell et al. 1986; Landgren et al. 2005). No significant toxicity after a 2 year feeding study 
(Iverson et al. 1996), disappearance of effects of DON in resistance to Listeria and delayed 
hypersensitivity response after 8 weeks (Pestka et al. 1987), and no change in IL-4 levels 
after 28 d (change in 14d), suggested that mice adapted to DON exposure, but the 
mechanisms of adaptation are not clear (Landgren et al. 2005, 2006). 
DON and mucosal toxicity 
DON and other trichothecene mycotoxins mediate a broad range of epithelial injury 
including atrophic growth inhibition and inflammation in the human gastrointestinal and 
respiratory tracts. 
Instanes and Hetland (2004) reported that DON did not increase levels of allergen-
specific IgE or IgG1 in a mouse model (female Balb/c mice, 6-8 weeks old). However, DON 
reduced cellular protein synthesis, proliferation and survival rate dose-dependently in human 
colonic (Caco-2) and lung (A549) cell lines, which suggested that DON may have toxic 
effect on human epithelial cells in lungs and colon. So DON may have some potential 
environmental problems at work places where cereals are processed and food harvest. 
The Caco-2 cell line was exposure to DON at concentrations up to 33.78 µM in 
combination or not with the inflammatory mediators IL-1β (25 ng/ml), TNF-α (100 ng/ml) or 
LPS (10 μg/ml). DON inhibited cell proliferation at 0.84 µM and up to 33.78 µM, but the 
inhibition was not dose-responsive, inflammatory mediators did not decrease proliferation. 
Dose-dependent increases in NF-κB activity and IL-8 secretion were observed, 1.69 µM 
DON, 0.84 µM DON significantly increased NF- κB activity and IL-8 secretion, respectively. 
Pro-inflammatory agents activated NF-κB and increased IL-8 secretion and increase 
sensitivity of Caco-2 cells to DON (Van De Walle et al. 2008). 
Effects of combinations of Fusarium mycotoxins, DON, ZEA, and FB1 on Caco-2 cells 
were investigated by Kouadio et al. (2007). The mixtures of mycotoxins reduce cellular 
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viability in increasing order: [FB1+ZEA] < [FB1+DON] < [ZEA+DON] < 
[FB1+DON+ZEA]. Mixtures of ZEA or FB1 and DON displayed synergistic effects in lipid 
peroxidation. The mixture of ZEA and FB1 displayed antagonistic effect and resulted in 
improving Caco-2 cell viability compared to their individuals. The ability of the toxins to 
inhibit DNA synthesis was 45%, 70%, and 43% for 10 µM of ZEA, DON, and FB1, 
respectively. Their binary mixtures (at 10 µM each) inhibited DNA synthesis by 35%, 62%, 
and 65%, far less than additive effects. Surprisingly, the tertiary mixture (10 µM each) only 
inhibited DNA synthesis by 25%. DNA fragmentation was observed and mixture of these 
mycotoxins damaged DNA to a greater extent. Each individual mycotoxin (10 µM) raises the 
percentage of 5-methylcytosine (m5dC) in DNA from 4.5% to 9%, while the combination 
did not increase this rate any further (Kouadio et al. 2007). The results suggest mixtures of 
Fusarium toxins exhibited some synergistic or antagonistic effects in human intestinal cells 
based on measurement endpoints and the combination of toxins. 
The effects of DON to the glucose transport capacity in chickens‟ jejunum and its 
permeation by DON was investigated by Awad (2007a). Intestinal segments (jejunum) of 
chicken were incubated in chamber with buffer solutions. The baseline of glucose uptake was 
3.28 +/- 0.53 nmol/cm(2) x min. DON (3.38, 16.89, or 33.78 µM) in mucosal side decreased 
(P < 0.05) the glucose uptake to 1.81 +/- 0.24 nmol/cm(2) x min, which could be related to 
inhibition of Na(+)-D-glucose cotransport . DON passes across the chicken intestinal 
epithelium by passive diffusion. In another study done by Awad (2007b), duodenum, 
jejunum, ileum, caecum and colon were tested. Jejunum is the segment that is the best 
prepared for Na (+)-D-glucose co-transport. 33.78 µM of DON significantly reduce glucose 
absorption. These results suggested DON contamination may have some adverse effects on 
animal health and performance. 
The mechanism of how DON traverses the intestinal epithelial barrier was studied using 
several epithelial cell lines: Caco-2, LLCPK1 and MDCKII wild-type cells, LLCPK1 cells 
transfected with human P-glycoprotein (P-gp, MDR1, ABCB1), and MDCKII cells 
transfected with human multidrug resistance protein 2 (MRP2, ABCC2). Using Caco-2 cells, 
DON transportation was time- and concentration –dependent and not saturable between 5 and 
30 µM DON. Intracellular DON accumulation was increased by ATP depletion by P-
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glycoprotein inhibitor and by multidrug-resistance-associated protein 2 inhibitor. DON 
accumulation was decreased in cell lines transfected with human p-glycoprotein and 
multidrug-resistance-associated protein 2. These results suggest that DON is a substrate for 
p-glycoprotein and multidrug-resistance-associated protein 2 (Videmann et al. 2007). 
 Maresca et al. (2008) also investigate DON-induced intestinal inflammation using 
differentiated Caco-2 cells as model and interleukin 8 (IL-8) as an indicator of intestinal 
inflammation. The results showed that DON induced IL-8 secretion (10-15 fold increase) 
directly, and potentiated the effect of IL-1beta on IL-8 secretion (ranging from 35% to 138% 
increase) and increased the transepithelial passage of Escherichia coli (ranging from 12- to 
1544-fold increase).  The mechanism of DON to evoke the pro-inflammatory cytokine 
interleukin-8 was investigated in the human epithelial intestine 407 cells (Moon et al. 2007). 
The results showed DON markedly elevated the phosphorylated extracellular signal-
regulated protein kinases 1 and 2 (ERK1/2) mitogen-activated protein kinase (MAPK) which 
mediated DON-induced interleukin-8 (IL-8) production. DON activated ERK1/2 also 
mediated the production of early growth response gene 1 (EGR-1) with positive regulatory 
effect on the IL-8. Yang et al (2008) tested DON alters the cell cycle progress possibly 
related to the pathogenesis in the human epithelium. The result showed DON arrested 
epithelial cell cycle at G (2)/M phase via elevated p21 gene expression. 
Cytotoxicity, metabolism and cellular uptake of DON in human lung fibroblasts (NHLF) 
were studied at concentrations of 0.1~100 µM. Cell viability, apoptotic and necrotic cell 
death, collagens I, III and IV as well as fibronectin secretion were determined. In NHLF cells, 
0.1 µM DON decreased cell viability, 0.1 µM decreased protein content, 1~10 µM DON 
increased caspase-3 activity, no significantly toxicity based on LDH release, 10 µM DON 
reduced colleage IV secretion, and 1 µM decreased fibronetin secretion. Therefore, DON has 
a distinct cytotoxic effect on human primary cells and caused mainly apoptotic cell death in 
fibroblasts. At the same time, the authors also determined DON was not metabolized by 
NHLF using LC-MS/MS. DON did enter into cells and no accumulation of DON occurred in 
the cell (Königs et al. 2007). 
Therefore, DON exposure could cause or exacerbate intestinal inflammation and affect 
macromolecular synthesis and nutrition absorption, especially inhibition glucose absorption 
56 
 
(Award et al. 2007). The mechanism of inflammation in intestine to increase IL-8 production 
related to DON could be through MAPK pathway (Moon et al. 2007) and altering cell cycle 
progress (Yang et al. 2008). DON exposure by inhalation could be related to apoptotic cell 
death in lung fibroblasts (Königs et al. 2007). 
Physiological effects 
DON inhibition of protein synthesis in vitro by binding at the 60S subunit of eukaryotic 
ribosomes and changes in metabolism and performance in different animals were observed. 
Pigs are the most DON sensitive species. Ingestion of naturally contaminated DON 
induced vomiting and reduced feed consumption. Goyarts et al. (2005) investigated the 
effects of a chronic DON intoxication on performance, hematological and serum parameters 
of pigs when diets were offered either ad libitum or restrictively. In the restrictive groups, 
each diet was restricted to an amount consumed by all animlas, which was equivalent to the 
maximum level consumed by the pigs fed DON contaminated diet. The daily feed amount 
was given in two equal portions at 7 AM and 2 PM. Finally, the calculated feed intakes per 
day were 2.90, 2.47, 1.94 and 1.93 kg for ad libitum control, ad libitum DON, restrictive 
control, and restrictive DON, respectively. DON concentrations were 0.395 mg/kg and 
16.643 mg/kg for control group and DON contaminated group, respectively. Pigs fed DON 
ad libitum, consumed 15% less feed and gained 13% less live weight, while the feed to gain 
ratio was unaffected. The feed to gain ratio for ad libitum control and DON were 2.77 and 
2.73 kg/kg, respectively; whereas the feed to gain ratio for both of restricted control and 
DON was 2.48 kg/kg. The sex of pigs significantly affected live weight gain and feed intake. 
Castrated males of the ad libitum fed groups had a significantly higher feed consumption and 
live weight gain than the females, while under restrictive feeding conditions there were no 
marked differences between castrated pigs and immature female pigs. The serum DON 
concentration were 9~27 ng/ml for DON ad libitum group, whereas 11~19 ng/ml for DON 
restricted group. Additionally, serum concentrations of alkaline phosphatase significantly 
lower in the ad libitum DON group than its counterparts. The no significant difference in 
feed consumption, sex, and serum clinical chemical parameters were observed after DON 
feeding in feed restricted animals, and significant differences in these terms between DON 
and control ad libitum fed groups were observed, which suggested change of these terms in 
57 
 
ad libitum fed groups were not influenced by DON itself, and reduced food intake or 
nutrition intake influenced hematological parameters. 
Contaminated wheat was added to basal diet to make diets containing 5.7 mg DON/kg. 
Castrated pigs (n=25) were fed DON contaminated diet (n=8) and control diet (n=17) for 28 
d. Pigs recruited from the control group were treated with acute oral (n=7) and intravenous 
DON (n=5) for 7 d. In the 35th day, DON feding was stopped for all groups of pigs. Protein 
synthesis expressed as fractional synthesis rate was significantly reduced in kidneys, spleen 
and ileum of DON-exposed pigs with effects being less pronounced in the acute oral DON-
group. Serum plasma concentration of DON were 18.7 ng/ml, 18.0 ng/ml, 44.5 ng/m 
following the DON dose for animals exposed chronically (77 µg/kg b.w), acutely (83 µg/kg 
b.w) and intravenously (53 µg/kg b.w), respectively (Dänicke et al. 2006). 
The effects of combination of DON (1 mg/kg in diet) and ZEA (0.25 mg /kg in diet) to 
weaning piglets were studied for 6 weeks period (Chen et al. 2008). DON and ZEA caused 
levels of total protein, albumin, and globulin in sera to decrease (p < 0.05) by 14.5%, 6.5% 
and 11.3%, respectively, and at the same time increased (p < 0.05) the serum enzyme 
activities of gamma-glutamyltransferase, aspartate aminotransferase and alanine 
aminotransferase by 72.0%, 32.6% and 36.6%, respectively. In addition, DON and ZEA 
decreased (p < 0.05) the level of anticlassical swine fever antibody titers by 14.8%. Real-time 
PCR showed that DON and ZEA caused mRNA expression levels of IFN-gamma, TNF-
alpha, and IL-2 to decrease (p < 0.05) by 36.0%, 29.0% and 35.4%, respectively. 
Histopathological studies demonstrated that DON and ZON caused abnormalities in the liver, 
spleen, lymph nodes, uterus, and kidney. These results indicate young piglets were sensitive 
to mycotoxin exposure in concentrations close to FDA guildelines for human final 
consumption. 
Feeding broiler breeder hens (n=42) DON contaminated diets at 12.6 mg/kg for 12 weeks 
decreased eggshell thickness. No significant effect on egg production and feed consumption 
and body weight were observed. The feeding of contaminated grains decreased antibody 
titers against infectious bronchitis virus at the end of wk 12, although no effect of the diet on 
serum antibody titers against Newcastle disease virus was observed. It was concluded that the 
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feeding of blends of grains contaminated with Fusarium mycotoxins could affect 
performance and immunity in broiler breeder hens (Yegani et al. 2006). 
The effects of DON on the performance, metabolism and immunity of dairy cows were 
investigated by Korosteleva et al. (2007). Wheat, corn, and hay were the contaminated 
feedstuffs used in the study. DON was the major contaminant at levels of up to 3.6 mg/kg of 
dry matter. Total serum protein and globulin levels increased significantly in cows fed the 
contaminated diet compared with cows fed the control diet at 42 d, whereas the 
albumin:globulin ratio decreased. Serum urea concentrations were significantly elevated 
throughout the experiment (56 d) in cows fed the contaminated diet compared with those fed 
the control diet. Serum IgA concentrations decreased significantly in cows fed the 
contaminated TMR at 36 d of feeding. Serum sodium concentration and osmolality levels 
were increased throughout the experiment in all cows fed the contaminated diets. Feed 
naturally contaminated with DON can affect the metabolic parameters and immunity of dairy 
cows. 
Male C57BL6 mice (6 weeks old) were fed low doses of DON through 4 wks 
corresponding to daily average intakes of 0.05, 0.2, 1 and 5 ppm of contaminated feed. 
Pentoxyresorufin O-depentylase (PROD) activity in liver was increased in 0.05, 0.2 and 1 
ppm DON treatment groups. Cytochrome P450 (P450) 2b subfamily expression was 
significantly increased in the liver of mice receiving 0.2 and 1 ppm DON, and P450 2b 
expression had significant correlation with PROD activity.  Western Blot analysis of 
cytosolic GST α, µ or π subfamilies expression demonstrated an induction (56-65%) of the 
GST π subfamily in liver of mice receiving these doses of DON, a slight increase in GST α 
expression was observed at 1ppm DON, whereas GST µ remains unchanged.  These results 
also indicate that a subchronic low dose exposure could cause changes in the liver 
metabolism of xenobiotics (Gouze et al. 2006). 
Dietary DON exposure influenced hematological parameters and reduced protein 
synthesis in pig at 5.7 mg DON/kg or 1 mg DON/kg DON combined with 0.25 mg/kg ZEA 
and in cows at 3.6 mg DON/kg dry matter (Goyarts et al. 2005; Chen et al. 2008; Korosteleva 
et al. 2007). Feeding broiler breeder hens DON at 12.6 mg/kg reduced eggshell thickness and 
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reduced antibody titer to virus (Yegani et al. 2006). Additionally, liver biotransformation 
enzymes were induced by low concentration of DON exposure in mice (Gouze et al. 2006). 
Liver and kidney toxicity 
 High concentrations of DON could accumulate in liver and kidney as discussed in the 
section of “distribution of DON”. Several cell culture studies have been done to investigate 
potential toxicity of DON in liver and kidney. 
 Mikami et al. (2004) demonstrated the cytotoxicity of DON in porcine primary cultured 
hepatocytes and analyzed the mode of cell death. Livers were obtained from healthy 1-month 
old Landrace x Large White x Duroc crosses piglets and porcine hepatocytes were cultured in 
vitro. The primary hepatocytes were treated with 337.84, 33.78, 3.38, 0.34 or 0.03 µM DON. 
Cell viability was measured by MTT assay. Transmission electron microscopy was employed, 
and lactate dehydrogenase (LDH) release and caspase-3 activity were measured to analyze 
the mode of cell death. The cell death of the hepatocytes was observed with DON at 337.84 
and 33.78 µM groups starting at 6 h after DON was added. There was dose-dependent effect 
of cell death after 24 h treatment for all tested concentrations. The dead hepatocytes showed 
characteristics of apoptosis based on LDH release and caspase-3 activity. Additionally, 
albumin secretion was reduced in all treatment groups, and the concentrations of albumin in 
the medium in DON 337.84, 33.78, and 3.38 µM groups were similarly low. The reduction of 
albumin secretion from the hepatocytes medium was due not only to the loss of hepatocytes 
by apoptosis but also to the inhibition of protein synthesis. Decreased concentrations of 
serum protein and albumin may be secondary to the reduced feed uptake. These results 
indicate that DON induced apoptosis through the caspase-3 activation pathway and caused 
functional disorder in porcine hepatocytes. 
Rat liver clone-9 cells were used as a model for investigating hepatoxicity of DON by 
Sahu et al. (2008). Varying concentrations of DON (0.03-337.84 µM) were incubated with 
cells for 48 h. after incubation, cytotoxicity, double-stranded DNA (ds-DNA) content, 
oxidative stress and mitochondrial function were observed as hepatotoxic endpoints. The 
concentration-dependent toxicity of DON, as measured by cytotoxicity and ds-DNA content, 
was observed from 1.69~337.84 µM.  DON also induced a significant concentration-
dependent increase in oxidative stress at DON concentrations starting at 33.78~337.84 µM. 
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Mitochondrial function of the treated cells was not significantly different from that of control 
value. Overall results of this study suggest that acute DON exposure has early mild cytotoxic 
effects on hepatocytes in vivo that are expressed as severe effects in rat liver clone-9 cells in 
vitro. 
Cytotoxicity, metabolism and cellular uptake of DON in human proximal tubule cells 
(RPTEC) was studied at the concentration 0.1~100µM by Königs et al. (2007). In RPTEC 
cells, 0.5 µM DON decreased cell viability, 10 µM decreased cell protein content, no 
significantly toxicity based on caspase-3 endpoint, 5 µM DON increased LDH release, no 
significantly toxicity based on collagen IV secretion, and 0.1µM DON inhibited fibronetin 
secretion. Therefore, DON caused mainly necrotic cell death in kidney cells. DON did enter 
into cells with higher intracellular amount in kidney cells than in lung fibroblasts, and no 
accumulation of DON occurred in the cells. 
In cell culture, DON caused hepatocyte apoptosis at a lowest concentration of 1.69 µM 
and reduce albumin secretion at 3.38 µM after 24~48 h incubation (Mikami et al. 2004; Sahu 
et al. 2008). However, in vivo acute dose at 10 mg/kg b.w. caused only mild hepatotoxicity. 
Severe effects in vitro and mild effect in vivo suggest DON passes through liver very quickly. 
DON caused mainly necrotic cell death in kidney cells based on one study (Königs et al. 
2007).  Therefore, DON exposure could cause dysfunction of the two important oragns and 
interrupt body‟s metabolism food and drink or some other xenobiotics.  
Reproductive toxicity 
Reproductive toxicity of DON includes the toxicity to mother‟s reproductive system and 
the toxicity to embryo and infant after DON transferred from mother. 
Direct acute effects of DON on the chick immune-related embryo tissues such as 
embryonic liver and spleen was investigated by direct DON administration (2µg DON/g egg) 
into the embryonic eggs caused toxin accumulation in liver in a time-dependent manner. 
Fatty cyst accumulation was observed and more fat was accumulation if hatched chicken was 
exposure again.  Fatty change was also observed in splenocytes. Cell proliferation in spleen 
was suppressed. Therefore, acute direct exposure to DON in chick embryo caused toxic- 
histological alterations in the liver and spleen and suppressed in vitro lymphoblastogenesis 
(Moon et al. 2007). Exposure of oocytes (a female germ cell involving reproduction) to the 
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Fusarium toxins ZEA and DON causes aneuploidy and abnormal embryo development in pig. 
DON (3.12 µM) inhibited oocyte maturation and caused approximately 34% of the oocytes 
to form an aberrant spindle. And the effects of ZEA and DON are not synergistic 
(Malekinejad et al. 2007). 
However, direct effects of DON to oocytes and embryo tissues should allow DON was 
circulated to oocytes and transferred from mother and up to the toxicity level.  Two in vivo 
studies were done in different pregnant animals in order to test how DON exposure to mother 
cause toxicity to embryo. Tiemann et al. (2008) fed pregnant Landrace sows for 35 days with 
natural contaminated DON and ZEA up to 9.57 and 0. 358 mg/kg diet, respectively. On day 
110, the offspring were delivered and their liver and spleens were examined. At necropsy 
there were no macroscopic lesions observed in any organ of either sows or piglets. 
Histopathological evaluation of tissues from sows of the treated group revealed changes in 
liver and spleen tissues, whereas no significant changes were observed in these tissues in 
their piglets. No adverse effect was observed in offsprings when DON and ZON were up to 
9.57and 0. 358 mg/kg. The other study was done by Dänicke et al. (2007) in order to 
investigate DON and ZEA transferred from mother to piglet during the last third of gestation.  
Pregnant sows were fed DON (9.57 mg/kg) and ZEA (0.358 mg/kg) diet from day 75 to 110 
of gestation.  In these piglets, spleen weights, hemoglobin concentration and hematocrit were 
significantly lower. DON and de-epoxy-DON, and ZEA were observed in liver, bile and 
serum of piglets, which suggest that the developing fetus is exposed to DON, ZEA and their 
metabolites when the sows were fed a Fusarium toxin contaminated diet. 
 In vivo and in vitro effects of the mycotoxins ZEA and DON on different non-
reproductive and reproductive organs in female pigs were reviewed by Tiemann and Dänicke 
(2007). In vivo, the feeding of pigs with a 9 mg/kg contaminated diet can act on protein 
synthesis, humoral and cellular immune response depending on dose, exposure and timing of 
functional immune assay, and affect liver and spleen cell structures. In vitro, application of 
DON to uterine cells inhibits their proliferation rate and modulates the process of translation 
at a different molecular level when compared with the in vivo application. The review 
suggested DON affects reproduction in pigs via indirect effects such as reduced feed intake, 
resulting in reduced growth or impairment of function in vital organs such as liver and spleen. 
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Effects of DON on steroid production by porcine granulose cells were evaluated by 
Ranzenigo et al. (2007) in an in vitro study. DON inhibited progesterone production at 0.337 
µM and 3.37 µM but at 0.0337 µM was without effect. DON at 3.37 µM (but not at 
0.0337µM) completely inhibited FSH plus IGF-I-induced CYP19A1 and CYP11A1 mRNA 
abundance. The concomitant treatment of ZEA had little effect on the dose response to DON. 
DON increased IGF-I-induced cell numbers at 0.0337 and 0.337 µM and inhibited cell 
numbers at 3.37 µM, whereas ZEA had no effect on GC numbers. Only a combined 
treatment of DON and ZEA increased serum-induced cell proliferation. In conclusion, 
mycotoxins have direct dose-dependent effects on GC proliferation, steroidogenesis and gene 
expression. These direct ovarian effects could be one mechanism whereby contaminating 
Fusarium mycotoxins in feedstuffs could impact reproductive performance in swine. 
In vitro studies could make a decision that DON exposure could cause embryo toxicity in 
spleen and liver, and DON was also observed to inhibit steroid production without 
synergistic effect with ZON (Moon et al. 2007; Malekinejad et al. 2007; Ranzenigo et al. 
2007). However, in vivo experiments found DON and ZON up to 9.57 and 0. 358 mg/kg did 
not show consistent toxicity to piglets when pregnant sow was fed toxins for 35 d (Tiemann 
et al. 2008; Dänicke 2007). More studies should be done to test potentical reproduction 
toxicity of DON to embryo and NOAEL should be developed based on this endpoint.   
Genotoxicity  
Genotoxicity of DON was observed in both dividing and differentiated Caco-2 cells 
based on Comet assay. The results showed dividing cells were found to be more sensitive to 
DON than differentiated cells and the lowest IC10 (0.5 µM) obtained for dividing cells 
exposed for 72 h was used as the highest working concentration in the genotoxicity study. 
Both differentiated and dividing cells responded with a dose-dependent relationship to DON 
in terms of DNA damage in the 0.01-0.5 µM range. The results suggested DON could be 
genotoxic at low concentrations (Bony et al. 2006). The mechanism of genetoxicity of DON 
need more studies. 
As a conclusion, in vitro and in vivo studies showed DON exposure could inhibit 
lymphocytes and monocytes proliferation, interrupt the functions of antigen present cells and 
phagocytotic cells, stimulate/ inhibit cytokines and imflammtory genes expression, which 
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results in higher senstivity of host  to infectious diseases. In mucosal surface, DON interrupts 
glucose absorption and mediates epithelial injury by increasing IL-8 secretion. Because liver 
and kidney were important detoxification and excretion organs, DON concentration in liver 
and kidney was higher than other organs, in vitro studies determined DON caused apotosis in 
liver and necrotic cell death in kidney. Further, DON could be transferred from mother to 
embryo, which resulted in innate suppression of immune system of embryo. Additionally, the 
protential genetoxicity of DON need more studies to investigate the mechanism.  
DON exposure 
DON exposure was investigated and reported all over the world. DON occurs 
predominantly in grains such as wheat, barley, oats, rye, and maize, and less often in rice, 
sorghum, and triticale. Because it is a stable compound it has also been detected in a range of 
processed cereal products including breakfast cereals, bread, noodles, infant foods, malt and 
beer. Extrusion cooking was observed lower reduction in DON with maximum reduction 
55%, whearas extrusion cooking can reduce fumonisins up to 100% (Castells et al. 2005).   
The cause of head blight (scab) of wheat and barley has emerged as the plant disease with 
the greatest impact on U.S. agriculture and society during the past decade. Scab has occurred 
frequently in the Midwest because of recurrent cool rainy weather during wheat and barley 
flowering (McMullen et al. 1997; Windels 2000). Unusual wet and cool weather conditions 
during the 1994 growing season in Maryland and Delaware resulted in a severe outbreak of 
Fusarium graminearum on sweet corn ears prior to harvesting and canning. The number of 
ears visibly infected with Fusarium spp. ranged from less than 5% to 25% in some fields. 
Kernels from the visibly moldy area of the ears contained DON at levels of approximately 
446 mg/g DON on average; whereas in the non-visibly infected portion of the ears adjacent 
to the moldy tips, DON levels averaged approximately 10 mg/g. Sections of ears closest to 
the base contained no detectable DON or less than 1 µg/g (Wetter et al. 1999). A total of 562 
wheat-based products from the 1993 crop year were collected by 21 U.S. Food and Drug 
Administration District Offices and analyzed in Kansas City, Seattle, and New Orleans 
District Laboratories. The numbers of samples with DON contamination > or = 1 mg/kg from 
163 bran, 272 white flour, 90 whole wheat flour, and 37 miscellaneous test samples were 20, 
28, 14, and 2, respectively. About 52, 50, 40, and 27% of the same test samples were 
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contaminated with DON at levels > 0.01 mg/kg (Trucksess et al. 1996). Another 
investigation on DON contamination of wheat and barley from the 1993 crop year was done 
by Trucksess et al. again (1995). DON contamination in the 483 wheat samples averaged 2.0 
mg/kg and ranged from < 0.5 to 18 mg/kg. DON contamination in the 147 barley samples 
averaged 4.2 micrograms/g and ranged from < 0.5 to 26 mg/kg. About 40% of the wheat 
samples and 57% of the barley samples contained DON levels that were greater than the U.S. 
Food and Drug Administration 1982 advisory level of 2 µg/g for DON in wheat designated 
for milling (human consumption). 
 DON exposure and investigation were done in Canada. Three hundred and sixty-three 
samples of cereal-based infant foods were collected from the Canadian retail marketplace 
over 3 years. The samples included oat-, barley-, soy-, and rice-based infant cereals, mixed-
grain infant cereals, teething biscuits, creamed corn, and soy-based formulas. Overall, DON 
was the most frequently detected mycotoxin--it was detected in 63% of samples analyzed 
with maximum concentration 980 ng/g in barley based cereal (Lombaert et al. 2003). 
Another three year survey done in Canadian and samples were from breakfast cereals at 
Canadian market. The results showed that DON was the most frequently detected mycotoxin 
and can be detected in over 40% of all samples analyzed (Roscoe et al. 2008). 
Three hundred and twenty samples from the 1999 UK harvest comprising wheat (201 
samples), barley (106) and oats (13) were analyzed. DON was detected in 88% of all samples, 
with 83% below 100 µg/ kg; the maximum level was 600 µg/kg. Nivalenol (NIV) was also 
detected at levels of 50 µg/kg or higher in 18 of 20 samples where DON was confirmed 
(MacDonald et al. 2004). 
   A total of 45 samples of soy food including whole beans, roasted soy nuts, flour and 
flakes, textured soy protein, tofu, protein isolate including infant formulas and fermented 
products (soy sauce) were randomly collected in food and health food stores and analyzed for 
Fusarium toxins in Germany. The concentration of DON was up to 260 µg/kg, and six of 
forty-five samples were detectable for DON (Schollenberger et al. 2007). Mycotoxin 
contents of Fusarium-damaged winter wheat kernels were estimated in Northern Germany 
between 2001 and 2006 (Beyer et al. 2007). The relationship between DON content and 
percentage of Fusarium-damaged kernels was vey strong (R
2
=0.93-0.99). Fusarium-
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damaged kernels contained between 0.21 and 2.39 µg DON per kernel. DON concentration 
in Fusarium-damaged kernals was a lot of higher than 15AcDON, NIV, 3AcDON. The 
results suggested 4.27% of damaged kernals will cause 1.25 mg/kg DON in grain, which is 
grain limit for unprocessed cereals in the EU. Therefore, grading systems for separating from 
damaged kernels would be needed. 
The occurrence of mycotoxins in barley, sorghum, teff (Eragrostis tef) and wheat from 
Ethiopia has been studied. DON occurred in barley, sorghum and wheat at 40-2340 µg/ kg 
with an overall incidence of 48.8% among the 84 mainly 'suspect' samples analyzed; NIV 
was co-analyzed with DON and was detected at 40 µg/ kg in a wheat sample and at 50, 380, 
and 490 µg/ kg in three sorghum samples (Ayalew et al. 2006). 
Trichothecenes and mycoflora exposure in Argentina in wheat were investigated 
(González et al. 2008).  Alternaria alternata, Fusarium graminearum, Fusarium poae and 
Fusarium semitectum were the predominant fungal species identified as endogenous 
mycoflora. Based on 120 samples the incidences were 21.7% for 3-AcDON, 22.5% for HT-2, 
27.5% for T-2 triol and 85% for DON. The range of trichothecene positive samples were 
between 7 and 2788 µg/kg with levels of DON between 7 and 2438 µg/kg. 
Trichothecene chemotype and associated geographical distribution and species of the 
Fusarium were investigated in China (Zhang et al. 2007). Two hundred and thirty-one of 299 
samples are from F.asiaticum (95% from regions > 15°C), which produce DON and 3-
AcDON; DON and 15-AcDON; and NIV and 4-Ac NIV, with 3-Ac DON being the 
predominant chemotype. However, sixty-eight of 299 samples are from F.graminearum (59% 
from regions<15°C), which only produced 15-AcDON. 
 DON exposure in cereal grains harvested in 2004 and 2005 in Lithuania was tested by 
Mankeviciene et al. (2007). DON was most frequently detected in all tested materials (wheat, 
barley, oats, rye, and triticale) compared to zearalenone and T-2 toxin. In 2004, the incidence 
rate of 98.0~100% and the concentration of DON was up to 691 µg/kg.  In 2005, the 
incidence rate of 62.5-94.0%, and the concentration of DON was up to 1121 µg/kg. Variation 
in relative air-humidity exerted some effect on the incidence of Fusarium spp. fungi and 
mycotoxin content in wheat grain. 
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DON exposure and Fusarium species in maize for direct human consumption was tested 
in Nigeria (Adejumo et al. 2007). In 180 samples, Fusarium verticillioides was the most 
commonly isolated fungi (71%), followed by F. sporotrichioides (64%), F. graminearum 
(32%), F. pallidoroseum (15%), F. compactum (12%), F. equiseti (9%), F. acuminatum (8%), 
F. subglutinans (4%) and F. oxysporum (1%). Sixty-six samples (36.3%) were contaminated 
with DON (mean: 226.2 µg/kg; range: 9.6-745.1 µg/kg). 3-AcDON (mean: 17.3 µg/kg; range: 
0.7-72.4 µg/kg) and diacetoxyscirpenol (DAS) (mean: 16.0 µg/kg; range: 1.0-51.0 µg/kg) 
were detected in 22%, 17% and 9% of total samples, respectively. 
A survey of the natural occurrence of DON in barley harvested in Uruguay from 1996 to 
2002 was conducted (Pan et al. 2007). Between 26 and 100% of the samples were positive 
for DON, and annual maximum levels ranged from 1.9 mg/kg to 10 mg/kg. A positive 
correlation between DON levels and precipitation (heavy rainfall during the flowering period) 
was seen. 
DON exposure in organically and conventionally produced beers sold on the Belgian 
market was investigated (Anselme et al. 2006). The overall incidence of DON was 67 and 80% 
in conventional and organic beers, respectively. DON concentrations ranged from 2 to 22 
µg/L (mean = 6 µg/L) in conventional beers, while organic beers ranged from 2 to 14 µg/L 
(mean=4 µg/L).  Variation was found between different batches and also was observed 
between different brands. 
In contaminated cereals 3- and 15-Ac DON can co-occur in significant amounts with 
DON. 3-Ac DON is prevalent in Europe; 15-Ac DON is prevalent in North America. These 
toxins are often present at the levels of 10-20% that of DON (Christian Larsen et al. 2004). It 
is possible that these toxins can be degraded to DON due to microbial in the alimentary tracts 
of ruminants and non-ruminants (Binder et al. 1998; Eriksen et al. 2003). 
Survey results showed DON dominated exposure in wheat, barley and corn and product 
of bran, wheat flour, beer with NIV, 3-Ac DON, and 5-Ac DON coexpoxure (MacDonald et 
al. 2004; Zhang et al. 2007; Christian Larsen et al. 2004).  These investigations indicated 
there was high correlation between recurrent cool raining weather in growing season/ 
humidity and DON exposure (Pan et al. 2007; Mankeviciene et al. 2007; Wetter et al. 1999). 
Take the event in 1994 for example; unusual wet and cool weather conditions during the 
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1994 growing season in Maryland and Delaware caused almost 5% to 25% ears infected 
Fusarium spp. with DON concentration up to 446 mg/g in area with visible moldy (Wetter et 
al. 1999). At the same time, there is higher correlation between DON content and percentage 
of Fusarium damaged kernel. 4.27% of damaged wheat kernals could cause 1.25 mg/kg 
DON in grain (Beyer et al. 2007). Therefore, the contaminated levels of DON could be 
forecasted by weather and separation of moldy ears and damaged kernel from normal grain 
could reduce DON levels. 
Austria, Canada, U.S. and the European Union (EU) have guideline limits for DON. US 
Food and Drug Administration voluntary advisory levels for DON stipulate no more than 1 
mg/kg for bran, flour, and germ for human consumption, 5 mg/kg for swine and other animal 
species (except cattle and chickens); not to exceed 20 percent of the diet for swine and not to 
exceed 40 percentage for other animal species, and 10 mg/kg for cattle older than 4 months 
and for chickens; not to exceed 50% percent of the diet (FDA/CFSAN Chapter 7). Several 
European guidelines recommend maximum levels of DON of 500 ng/g for cereal products as 
consumed and 750 ng/g for flour used as raw materials in food products and raw cereals 
(Codex Alimentarius Commission FAO/WHO 2003). 
Detection methods 
Sensitive methods have been developing to detect DON in variety of matrices including 
grain and biological samples. In order to increase the detection limit, fast and specific extract 
method, and sensitive detect instrument were employed in laboratory. 
Sample extraction method from matrix is very important in order to get high recovery and 
clean samples. Generally, DON was extracted from cereals using aqueous solvent mixtures 
such as methanol and water or acetonitrile and water (acetonitrile: water 84:16, v/v, Landgren 
2005). The main procedures employed for clean up in trichochecene analysis are liquid-liquid 
partitioning, solid-phase extraction (SPE), column chromatography, and use of 
immunoaffinity column (IAC) and multifunctional clean-up columns (Gareis et al. 1987). 
Liquid-liquid partitioning can be employed by shaking the sample extract with an immiscible 
solvent in a tube, such as ethyl acetate Column chromatography can be performed on a 
variety of stationary phases. Sep-pak cartridge (C18) has been successfully used to clean up 
DON in our laboratory. The most frequently employed column packing material for DON is a 
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mixture of charcoal, alumina, and celite with ratio of alumina: celite: charcoal (0.35 + 0.25 + 
0.4 g) (Omurtag and Beyoglu 2003) or alumina: charcoal: celite (7 + 5 + 3) (Fernandez 1994). 
Commercial multifunctional Mycosep® clean-up columns are available to clean several 
trichothecenes simultaneously Use of an immunoaffinity column to extract DON was based 
on DON binding to DON-specific antibodies linked to an organic carrier material, and then 
DON could be eluted by use of pure organic solvents (Brenn-Struckhofova et al. 2007). Most 
recently, one molecular modeling and computational design polymers was designed with 
itaconic acid as monomer with higher affinity towards DON through electrostatic, 
hydrophobic, van der Waals forces and dipole–dipole interactions. Samples were extracted 
with PBS/0.1M EDTA solution and cleaned up through a cartridge containing blank IA-based 
polymer (Pascale et al. 2008). Additionally, treatment of barley grain with 1.25 N 
trifluoroacetic acid for 54 min at 133 ºC can release bound DON, resulted in an additional 58% 
DON and an increase of 9-88% in a set of verification samples (Zhou et al. 2007). 
After DON was extracted from samples, it could be detected by TLC (Scott et al. 1995), 
HPLC with UV detector (Kotal and Radova 2002; Landgren 2005; Janes and Schuster 2001) 
or MS detector (Razzazi-Fazeli et al. 2003; Berthiller et al. 2005; Meky et al. 2003), and GC 
with ECD detector (Electron Capture Detector) (Cote et al. 1986) or MS detector (Yoshizawa 
et al. 2004). C18 reversed phase columns with methanol-water mixture or acetonitrile-water 
mixture as mobile phase were used for HPLC. GC-ECD and GC-MS are available to detect 
DON with detection limit 20 ng/g. The advantage of this is that other related compounds can 
be determined simultaneously with high sensitivity. The disadvantages are that DON is non-
volatile and must be derivatized to form a stable compound suitable for analysis. Expensive 
equipment and skilled operators are required for GC-MS. ELISA assays and cell proliferation 
assays have been developed for quick and simple screening (Ngundi et al. 2006). The limit of 
ELISA could due to cross-reactivity of DON with 3-Ac DON, 15-Ac DON, and 3, 15, di-Ac 
DON (Krska et al. 2001). Cell proliferation assays have been used to screen DON 
contamination in grains in that DON could inhibit cell proliferation in sensitive cell lines 
(Widestrand et al. 2003). 
As a result, the method of choice depends on the instrumentation available, the required 
detection limit, matrix composition and the properties of the analyte. ELISA assay has the 
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lowest detection limit with 0.2 ng/ml in buffer without clean up after extraction (Ngundi et al. 
2006), however, ELISA has crossreactivity between DON and other trichothecenes (Krska et 
al. 2001). Immunoaffinity column enrichment and HPLC-MS/UV detector has a very low 
detection limit at 12-20 ng/ml and can detect individual compounds specifically (Janes and 
Schuster 2001; Meky et al. 2003). The cheapest method is clean up using alumina and 
charcoal SPE column combined with cell proliferation assay. At the same time, it was 
reported that this method has a good correlation with an HPLC method (Landgren 2005).  
Detoxification strategies 
It is difficult to get rid of DON from grain once formed, and DON was found in some 
final product for human consumption (section „DON exposure). Detoxification strategies 
include developing transgenic crop to reduce DON in the beginning, physical and chemical 
method to reduce DON contamination for final human consumption; and biological method 
to degrade DON to less toxicity of metabolites.  
Plant breeding strategies 
Genetic engineering provides an approach to enhance the level of resistance to 
pathogenicity of fungus to plant and reduce DON concentration by introducing protection 
genes to plant or changing the gene of Fusarium. 
The –OH group at C3 could play a role in DON toxicity. Some evidence has shown less 
toxicity in DON-related compounds without –OH groups at carbon 3. Sundstol Eriksen 
reported (2004) that 3-Ac DON was less toxic than DON and 15-acetyl DON and 15-acetyl 
DON was equal in toxicity to DON in Swiss mice 3T3 fibroblasts cells. Plant breeding 
strategies include the expression of DON acetyltransferase gene or UDP-glucosyltransferase 
gene in plant to transfer acetyl group or glucose to C3-OH of DON (Fig 3). Poppenberger et 
al. (2003) reported that UDP-glucosyltransferase, which catalyzes the transfer of glucose 
from UDP-glucose to the hydroxyl group at carbon 3 of DON, is able to detoxify DON. To 
reduce the effects of DON on wheat, Okubara et al. (2002) introduced FsTR1101, a 
Fusarium sporotrichioides gene into the regenerable cultivar Bobwhite. Accumulation of 
FsTR1101- encoded acetyltransferase in the plant determined to partial protection against the 
spread of F. graminearum in inoculated wheat heads. However, selection pressure to escape 
these reactions may lead to more mycotoxins in the plant. 
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Bioengineering Fusarium graminearum mutants could reduce DON production and 
reduce pathogenicity of fungus to plant. Cuzick et al. (2008) developed two isogenic 
transformants lacking either the mitogen-activated protein kinase MAP1 gene or the 
trichodiene synthase TRI5 gene. Wild-type strain inoculations caused high levels of disease 
in both plant species and significant DON production. The map1 mutant caused minimal 
disease and DON accumulation in both hosts. The tri5 mutant, unable to produce DON, 
exhibited reduced pathogenicity on wheat ears. Genetic engineering provides an alternative 
approach to enhance the level of resistance to Fusarium head blight (FHB) and reduce DON 
concentration. 
Mackintosh et al. (2007) developed transgenic wheat overexpressing the defense 
response genes alpha-1-purothionin, thaumatin-like protein 1 (tlp-1), and beta-1, 3-glucanase. 
The lines carrying the alpha-1-purothionin, tlp-1, and beta-1, 3-glucanase transgenes, 
respectively, that had statistically significant reductions in FHB severity. A beta-1, 3-
glucanase transgenic line had enhanced resistance, showing lower FHB severity, DON 
concentration, and percent VSK compared to Bobwhite. The results indicated genetic 
engineering wheat with overexpression of defense response genes could enhance the FHB 
resistance and reduce DON production. 
Food processing strategies 
Physical and chemical methods have been developed to reduce DON concentrations. 
House et al. (2003) researched the efficiency of DON removal from barley samples through 
the use of an abrasive pearling procedure at varying levels of contamination. The results 
showed that pearling was an effective means of reducing the DON content of barley. 
However, the need to reduce the DON content of contaminated barley to less than 1 ppm for 
swine will necessitate the removal of a significant amount of the grain mass for heavily 
contaminated samples. Additional pearling resulted in a linear decline of grain mass. 
The effects of electron beam irradiation on DON levels in distillers dried grain and 
soluble and in production intermediates were investigated by Stepanik et al. (2007). Wheat 
contaminated with DON, and distillers dried grain and solubles (DDGS) obtained after 
ethanol production from the contaminated wheat, were irradiated to doses ranging from 2.0 
to 55.8 kGy using an electron accelerator The three production intermediates showed dose-
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dependent reductions in their DON contents ranging from 47.5 to 75.5% at the highest doses. 
Electron beam treatment produced a 17.6% reduction in the DON level of wheat at the 
highest dose used, but had no effect on DON in DDGS. 
Soaking in 0.1 M Na2CO3 solution (pH 11) with subsequent boiling was tested as an 
effective method to reduce DON. Boiling contaminated wheat kernels in water reduced the 
DON content of the grain by 70%. The mechanism of decontamination due to boiling is 
probably a leaching of DON out of the grain into the boiling medium. A combined treatment 
of soaking in 0.1 M Na2CO3 solution with subsequent boiling reduced the DON content of 
the grain by 93%, which could be related to degradation of DON in alkaline (Ragab et al. 
2007). 
Stability of mycotoxins during food processing was reviewed by Bullerman and 
Bianchini (2007).The various food processes that may have effects on mycotoxins include 
sorting, trimming, cleaning, milling, brewing, cooking, baking, frying, roasting, canning, 
flaking, alkaline cooking, nixtamalization, and extrusion with highest temperatures having 
greatest effects. Extrusion processing at temperatures greater than 150 degrees ºC was 
observed to give good reduction of ZEN, moderate reduction of alfatoxins, variable to low 
reduction of DON and good reduction of FUM.  However, Scudamore et al. (2008) reported 
DON, NIV and ZEN were little changed by extrusion and the effect did not appear to be 
temperature-dependent. The authors suggested the apparent loss of mycotoxins was either 
due to binding or inability to extract the residue. Bretz et al. (2006) investigated the thermal 
degradation products and compared their cytotoxicity to DON. After heating of DON and 3-
AcDON, especially under alkaline conditions, gave seven compounds. Three of these 
compounds were already known (norDON A, norDON B, and norDON C), while four were 
new and named 9-hydroxymethyl DON lactone, norDON D, norDON E, and norDON F. 
NorDON A, B, and C were detected in 29-66% of the samples in mean concentrations 
ranging from 3 to 15 µg/kg with almost 100 time less cytoxicity compared to DON using 
IHKE cells. These results suggested degradation of DON under thermal treatment might 
reduce the toxicity of DON. 
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Food additives 
Additives, such as absorptives, probiotics, and nucleotides, were added to DON 
contaminated diet to investigate their detoxification effect. 
The effect of probiotic feed additive (PB, Eubacterium sp.) with the ability to 
deepoxidize DON was studied in broiler chickens at 1 day of age (Award et al. 2006). The 
DON (10 mg/kg) for 6 weeks altered small intestinal morphology, especially in the 
duodenum and jejunum, where villi were shorter and thinner (P < 0.05). The addition of 
Eubacteria to the DON-contaminated feed of the broilers effectively alleviated the 
histological alterations caused by DON and led to comparable villus length as in the control 
group. 
Binding of Fusarium mycotoxins by fermentative bacteria in vitro was tested by 
Niderkorn et al. (2006). The results showed lactic bacteria could remove DON up to 55%. 
Binding, not biodegradation appeared to be the mode of action, as no toxin derivatives were 
observed and removal was not impaired in nonviable bacteria. Binding was not affected by 
pH. The binding ability of selected strains could be used to decrease the bioavailability of 
toxins in contaminated silages. 
Niderkorn et al. (2007) also screened fermentative bacteria for their ability to bind and 
biotransform DON in vitro. Most test strains (total 202) were able to bind Fusarium toxins. 
The most effective genera were Streptococcus and Enterococcus, capable of binding up to 33, 
49, 24 and 62% of DON, ZEN, FB(1) and FB(2), respectively. No biotransformation 
happened for DON. Turnera et al (2008) also proved probiotic bacteria Lactobacillus 
rhamnosus strain GG (GG) can bind DON, and therefore potentially restrict bioavailability of 
this toxin and restore the differentiation process in Caco-2 cells, using alkaline phosphatase 
(ALP) activity as a marker of differentiation in Caco-2 cell. 
The effectiveness of standard Q/FIS (a carbon/aluminosilicate-based product) in reducing 
mycotoxin absorption was investigated in a laboratory model to simulate in vivo 
gastrointestinal tract (Avantaggiato et al. 2007). DON was quickly absorbed in the proximal 
part of the small intestine at level of 74%. Addition of standard Q/FIS was ineffective in 
reducing DON uptake, but effect in reducing aflatoxin, ZEN, FB1 and FB2, and ochratoxin A 
in a dose-dependent manner.  
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To evaluate the potential of dietary nucleotides in reduction of toxin-induced DON 
damage in spleen, male broiler chickens were fed 10 mg/kg feed with or without nucleotides 
for 17 days. The results showed dietary nucleotides did not have the potency to reduce the 
DNA damage for DON exposure, although some benefit was observed for T-2 toxin 
exposure (Frankic et al. 2006). 
Díaz-Llano and Smith (2006) tested the effect of polymeric glucomannan mycotoxin 
adsorbent on reproductive performance and serum chemistry of pregnant gilts. The results 
showed the feeding of contaminated grains + GMA increased (P = 0.026) the percentage of 
pigs born alive compared with gilts fed the contaminated diets. Díaz-Llano and Smith (2007) 
conducted another experiment to tested GMA effect on lactation, metabolism, and 
reproductive performance after weaning of first parturition sows. The results showed the 
effect of GMA was little in that weight loss and reduced total serum protein by DON was 
maintained after GMA treatment. Increased weaning to estrus interval in sows was observed 
after DON and DON with GMA treatment (Díaz-Llano and Smith 2007). Dänicke et al. 
(2007) also observed the inefficiency of GMA in decreasing DON absorption on piglets.  An 
in vitro assessment of adsorbents to prevent DON and ZEN was done by Sabater-Vilar et al. 
(2007). Binding efficiency was indirectly confirmed by the reduction of toxicity in the in 
vitro bioassays. It was reported none of the tested substances was able to bind DON in an 
appreciable percentage, some of the selected smectite clays, humic substances and yeast-wall 
derived products efficiently adsorbed ZON (>70%). No binding DON by tested substances 
may explain minimal effect of absorptive in diets was observed in feeding studies. 
Nonstarch polysaccharide hydrolyzing enzymes (NSP) is getting attention recently. It 
was hypothesized that Fusarium infection-related increases in NSP hydrolyzing enzyme 
activities could compensate for the deleterious effects of the fungal-origin mycotoxins such 
as DON and tested in broiler chickens fed control and DON contaminated diet at 0.045 and 
2.5 mg/kg for 35d (Dänicke et al. 2007).  
Biological detoxification strategies 
Biological detoxification strategies include the use of exogenous enzymes or bacteria to 
hydrolyze the 12-13 epoxide ring, which is responsible for the toxicological properties of 
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DON. The incubation of DON-contaminated corn with microflora could reduce the anorectic 
potential of the corn and improved the performance of swine.  
He et al. (1992) found that microorganisms in large intestines of chickens (MLIC) 
completely transformed pure DON. A single metabolite was isolated and identified as de-
epoxy DON, DOM-1 (Fig 2.2). However, DON in the moldy corn was not transformed when 
MLIC were added to corn without culture medium. Biotransformation of DON was 
completely inhibited when the pH in the medium was lowered to 5.2. The result indicates 
that control of the pH in the incubation medium is critical for further transformation. As a 
result, incubation of MLIC and moldy corn for 96 h can partial biotransform DON to de-
epoxy-DON. Chicken intestinal microbes have the capability to degrade trichothecene 
mycotoxins by deacylation for the monoacetyl trichothecenes 3-Ac DON, 15-Ac DON, and 
fusarenon X and deepoxidation for 4-DON, NIV, and verrucarol (Young et al. 2007) 
DON can also be transformed to DOM-1 by microorganisms in rumen fluid and soil. 
Binder et al. (1998) found DON and 3-Ac DON were transformed by ruminal 
microorganisms to a single metabolite, which was identified by GC-MS as DOM-1. DOM-1 
from either trichothecene showed a significant reduction in toxicity against Saccharomyces 
cerevisiae. Aerobic biotransformation of DON and 3-Ac DON by microorganisms in soil, 
respectively, gave five new metabolites as indicated by HPLC and TLC determination. These 
five new metabolites were unknown. 3-Ac DON was de-acetylated to DON within 24h; the 
following reactions also produced five new metabolites by soil microorganisms just like 
DON as original mycotoxin. The toxicity of these metabolites against S .cerevisiae was 
reduced. 
DON can be transformed to 3-keto-4-deoxynivalenol by some bacteria in soil (Fig 2.3). A 
soil bacteria, strain E3-39, Agrobacterium-Rhizobium group, was isolated by Shima et al. 
(1997). This bacterium completely eliminated exogenously supplied DON from culture 
medium after incubation for 1 day. The main metabolite was identified as 3-keto-4-
deoxynivalenol by mass spectroscopy and 
1
H and 
13
C nuclear magnetic resonance analysis. 
This compound exhibited a remarkably decreased (to less than one tenth) 
immunosuppressive effect evaluated by means of a bioassay based on the mitogen-induced 
and mitogen-free proliferations of mouse spleen lymphocytes.  
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Under aerobic conditions, Volkl et al. (2004) found that DON was biotransformed to 3-
keto-4-deoxynivalenol by a microorganism after screening 1285 microbial cultures from 
farmland soil, cereal grains, insects and other sources. One mixed culture transformed DON 
into two chromatographically separable products. The main product of the transformation 
was determined to be 3-keto-4-deoxynivalenol. The DON-transforming mixed culture 
survived and retained its transforming activity during a starvation period of six months at 20° 
C. Trichothecenes 15-acetyl DON, 3-Ac DON and fusarenon-X were also transformed. 
 
Fig 2.3: The chemical structure of 3-keto-4-deoxynivalenol 
Additionally, physical, chemical and biological methods are reviewed on inhibition of 
growth of the mold to produce DON (Wolf-Hall 2007). Irradiation works to prevent 
Fusarium growth during malting, but further study should evaluate malt quality and DON 
production from surviving mold. Chemical treatments such as ozonation, which would not 
leave residual chemical in the beer also appear to be promising. Ozonation also worked to 
incorporate detoxifying genes into fermentation yeasts to detoxify wort when mold growth.  
Essential oil can be used as anti-fungus, which was investigated by Velluti et al. (2004). 
The efficacy of essential oil fraction, cinnamon, clove, lemongrass, palmarose and oregano 
oils, on growth rate and DON production by F. graminearum was tested in irradiated maize 
grain at different water activities and temperature conditions. At 0.995 water activity, all 
essential oils tested had an inhibitory effect on growth rate of F. graminearum at 20 and 
30 °C. At this water activity, DON production in general was significantly inhibited by all 
essential oils at 30°C compared to control.  Therefore, essential oils should be considered as 
alternative post-harvest natural fungicides.  
In conclusion, physical, chemical, biological methods to detoxify DON have been 
reviewed. Firstly, plant-breeding strategies including the expression of DON 
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acetyltransferase gene or UDP-glucosyltransferase gene in plant to transfer acetyl group or 
glucose to C3-OH of DON (Poppenberger et al. 2003; Okubara et al. 2002), developing 
Fusarium Graminearum mutants (Cuzick et al. 2008), and developing transgenic wheat 
overexpressing the defense response genes (Mackintosh et al. 2007) could reduce DON 
production and reduce pathogenicity of fungus to plant. At the same time, DON itself is 
phytotoxic. Phytotoxic effects of DON on the growth and morphology of Arabidopsis 
thaliana was investigated by Masuda et al. (2007). DON (10 µM) preferentially inhibited 
root elongation, and DON-treated roots were less organized compared with control roots. 
Preferential inhibition of root growth by DON was also observed in wheat plants. Ohsato et 
al. (2007) reported DON was not toxic to transgenic plants encoding trichothecene 3-O-
acetyltransferase, while root growth of wild-type rice plants was severely inhibited by DON. 
Secondly, physical methods including pearling (House et al. 2003), electron bean irradiation 
(Stepanik et al. 2007), soaking inn 0.1 M Na2CO3 with boiling (Ragab et al. 2007) and high 
temperature bake (Scudamore et al. 2008) were reviewed. The results showed boiling in 
water with extra soaking in 0.1 M Na2CO3 was most effective up to 93% DON reduced. 
Thirdly, probiotic, nucleotide, mycotoxin adsorptent were added to animal feeds to 
investigate their influence on DON toxicity. There were ineffective to reduce DON toxicity if 
a carbon/aluminosilicate (Avantaggiato et al. 2007), nucleotide (Frankic et al. 2006), 
polymeric glucomannan mycotoxin adsorptent ((Díaz-Llano and Smith, 2007; Dänicke et al. 
2007) were added to animal feeds. However, fermentative bacteria through binding DON, 
resulted in reduced absorption, were observed in some in vitro studies (Niderkorn et al. 2006 
and 2007) and chicken feeding study (Award et al. 2006). Fourthly, some exogenous 
enzymes in bacteria from chicken big intestine, rumen fluid, soil could transfer DON to less 
toxic metabolites, deepoxy DON or 3-keto-4-DON (He et al. 1992; Young et al. 2007; 
Binder et al. 1998; Shima et al. 1997; Volkl et al. 2004). Preincubation animal feeds with 
these bacteria could reduce DON concentration and increase animal performance. Finally, 
the strategies to destroy moldy were discussed. Essential oil, ozonation, irradiation, 
incorporation detoxification genes into fermentation yeasts could inhibit fungus growth and 
result in reducing DON production (Wolf-Hall 2007; Velluti et al. 2004). 
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DON epidemiological studies 
Outbreaks of DON mycotoxicosis are associated with consumption of mold damaged 
food products all over the world, in countries such as India and China. The main clinical 
symptoms are nausea, vomiting, dizziness, abdominal pain and diarrhea; some cases show 
headache and fever (Pestka et al. 2005). In an epidemiological study, an outbreak in India in 
1989 was associated with the consumption of bread made from mold-damaged wheat. The 
disease was not age or sex specific. Evidence of mold damage of wheat consisted of the 
presence of fungi, such as Fusarium sp. and trichothecene mycotoxins, such as DON.  
Urine DON was developed as a biomarker to indicate DON exposure in humans. 
Investigation of DON exposure through detection of DON and its glucuronide in human 
urine in high risk region found that the concentrations of DON were lower at 37 ng/ml (this 
amount included DON glucuronide) (Meky et al. 2003). It was reported in UK adult that the 
level of urinary DON decreased from 7.2 ng DON/mg creatinine (4.9-10.5 ng/mg) to 0.6 
ng/mg (0.4-0.9 ng/mg) when wheat-based food intake was reduced from 322 g/day (131-542 
g/day) to 26 g/day (0-159 g/day) (Turner et al. 2007). In a follow-up study done by Turner et 
al. (2008), a survey was conducted to compare 24 hr urinary DON excretion with cereal 
intake. The results showed cereal intake was significantly associated with urinary DON (p < 
0.0005), with the geometric mean urinary levels being 6.55 µg DON/day [95% confidence 
interval (CI), 5.71-7.53]; 9.63 µg/day (95% CI, 8.39-11.05); and 13.24 µg/day (95% CI, 
11.54-15.19) for low-, medium-, and high-intake groups, respectively. In multivariable 
analysis, whole meal bread (p < 0.0005), white bread (p < 0.0005), "other" bread (p < 
0.0005), buns/cakes (p = 0.003), high-fiber breakfast cereal (p = 0.016), and pasta (p = 0.017) 
were significantly associated with urinary DON. Whole meal bread was associated with the 
greatest percent increase in urinary DON per unit of consumption, but white bread 
contributed approximately twice as much as whole meal bread to the urinary DON levels 
because it was consumed in higher amounts. These researches suggested urinary DON is 
valuable tool to investigate DON exposure, some individuals could ingest DON at greater 
than recommended TDI (1 µg/kg b.w.) 
Intake of DON through beer consumption in Belgium was investigated (Harcz et al. 
2007). Beer consumption was assessed using a food survey and the data of DON levels in 
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conventionally and organically produced beers in 2003-04. Average consumption of organic 
beer led to daily intakes of 0.05 and 0.04 µg DON/kg b.w. in 2003 and 2004, respectively, 
whilst for conventional beer, daily intakes were 0.07 and 0.05 µg DON/kg b.w. The results 
showed that DON intake through beer consumption is below the recommended TDI (1 µg/kg 
b.w.). 
Exposure of DON in wheat flour 1998-2003 related to human intake was described in 
Denmark (Rasmussen et al. 2007). Samples (n=151) were collected from mills and the retail 
market. Maximum of average concentration of DON in 2002 with mean was 255 µg/kg and 
highest value was 705 µg/kg related highest amount of precipitation around flowering time. 
The lowest level of DON was found in 2001 harvest related to a dry season during flowering. 
Calculation of chronic or usual intake by a deterministic approach showed that intake did not 
exceed the TDI of 1 microg kg/ b.w. / day. 
Human intake of DON related to winter wheat grown in Belgium from 2002-2005 was 
described (Harcz et al. 2007). Intake was estimated based on cereal-based products such as 
flour, bread, breakfast cereals, dough and pastry.  The results show daily intakes of DON 
were 0.56 µg, and 0.99 µg for consumer of organic or conventional foodstuffs, respectively, 
lower than TDI. 
Based on several investigations in European countries, human exposure to DON through 
beer, bread, and wheat flour, in most cases, was lower than TDI (1µg/kg b.w.). Urine DON 
was developed as a biomarker to indicate DON exposure in humans. However, in some 
Asian countries and developing countries, outbreaks of DON mycotoxicosis were reported 
very often. Getting rid of moldy grain and access to a variety of food could help to reduce 
DON exposure in humans. 
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CHAPTER 3 DEOXYNIVALENOL SUPPRESSES CIRCULATING AND SPLENIC 
LEUKOCYTE SUBPOPULATIONS IN BALB/c MICE: DOSE RESPONSE, TIME 
COURSE AND SEX DIFFERENCES 
To be submitted to Food Additives & Contaminants: Part A  
Xianai Wu, Marian Kohut, Joan Cunnick, Ted Bailey, Suzanne Hendrich 
Abstract 
It was hypothesized that suppression of peripheral blood leukocyte subsets were markers 
of exposure to dietary deoxynivalenol (DON), a Fusarium graminearum mycotoxin in grains 
worldwide, at 1.0 mg kg
-1
 but not at lesser doses in BALB/c mice. Groups of 10 female and 
10 male BALB/c mice were fed 0, 0.25, 0.5, 1.0, and 2.0 mg kg
-1
 DON for 14 and 28 days. 
By flow cytometry with staining for leukocyte surface markers, the percentage of CD19
+
 
leukocytes (B cells) in peripheral blood was decreased in both sexes of BALB/c mice after 
14 days of exposure to 1.0 or 2.0 mg kg
-1
  DON whereas exposure to DON over 28 days did 
not inhibit B cells, compared with the control diet. The percentage of mononuclear cells in 
peripheral blood was decreased in female BALB/c mice fed 1 and 2 mg kg
-1
 DON after 14 d, 
and the percentage of CD11b
+
 leukocytes (monocytes) in peripheral blood and total CD11b
+
 
splenic leukocytes were decreased only in female mice fed 1.0 and 2.0 mg kg
-1
 DON after 28 
days compared with control diet, which showed greater sensitivity to DON in females 
compared with males. As a conclusion, BALB/c mice seemingly adapted to DON exposure 
because peripheral blood cellular effects of DON at 14 d disappeared by 28 d with the 
exception of monocyte changes in females. This suggests that female sex hormones 
potentiate one potential marker of DON immunotoxicity in BALB/c mice.  
Key words: deoxynivalenol, BALB/c mice, cell surface markers 
Abbreviations: F14: female BALB/c mice fed control diets and DON over 14 days; M14: 
male BALB/c mice fed control diet and DON over 14 days; F28: female BALB/c mice fed 
control diets and DON over 28 days; M28: male BALB/c mice fed control diets and DON 
over 28 days. 
Introduction 
Deoxynivalenol is a mycotoxin commonly found in wheat, barley, corn and oats. 
Fusarium graminearum and F. culmorum produce DON in temperate regions such as North 
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America, Asia and Europe (Christian Larsen et al. 2004; Lombaert et al. 2003). 
Concentrations of DON in contaminated crops ranged from less than 1 mg kg
-1
 to 26 mg kg
-1
 
in wheat during a survey in 1993 in the United States (Trucksess et al. 1995). US Food and 
Drug Administration (FDA) has a voluntary action level of 1 mg kg
-1
 DON in finished wheat 
products for human consumption, whereas the EU recommended a level of 0.5 mg kg
-1
 for 
cereal foods (Codex Committee on Food Additives and Contaminants, 2002).  
After feeding 8 week old BALB/c male mice with 2 mg kg
-1
  purified DON for 14 days, 
Con-A stimulated splenocyte proliferation was inhibited (Landgren et al. 2006). One mg kg
-1
 
DON plus 0.9 mg kg
-1
 3-Ac DON (toxins from culture material) fed for 28 days inhibited 
peripheral blood lymphocytes in 14 week old male BALB/c mice (Landgren, 2005). Three-
Ac DON can be deacetylated to DON rapidly in vivo. After pigs were fed 2.5 mg kg
-1 
3-Ac 
DON for 2.5 days, DON was detected at the plasma as early as 20 min after feeding. No 
traces of 3-Ac DON could be found in plasma, urine and feces (Eriksen et al. 2003). 
Landgren (2005) showed that dietary 1-2 mg kg
-1
 DON inhibited peripheral blood 
lymphocytes, which may be a useful biomarker of low doses of DON immunotoxicity. 
Decreased blood lymphocytes may be due to decreased production in lymphoid organs 
such as bone marrow, apoptosis, and disturbed migration of mature lymphocytes (Parent-
Massin 2004, Picker and Butcher 1992). DON may have greater toxicity in hematopoietic 
progenitors than in mature blood cells. After 24 h incubation in vitro, 10
 μM DON caused a 
50% decrease (IC50) in peripheral blood leukocytes (Froquet et al. 2003), whereas an IC50 of 
30 nM DON was observed after 7 day incubation with human leukocyte progenitors 
(Lautraite et al. 1997). DON was much less toxic in mature lymphocytes than in progenitor 
cells. Human granulo-monocytic progenitors (CFU-GM) were more sensitive to DON 
exposure than were red blood cell (BFU-E) and megakaryocyte progenitors (CFU-MK). The 
IC50 for DON in CFU-GM was 38 nM, whereas similar DON concentrations had no 
cytotoxic effect on CFU-MK and BFU-E cells (Froquet et al. 2001). DON exposure could 
induce mature lymphocyte apoptosis via a mechanism known as the 'ribotoxic stress 
response' (Pestka 2008a). In vitro, 68 nM DON exposure induced apoptosis in HL-60 human 
promyelotic leukemia cells after 24 h incubation as indicated by DNA fragmentation (Ueno 
et al. 1995). Nuclear staining with propidium iodide in K562 human erythroleukemia cells 
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showed apoptosis after 48 h incubation with 80 μM DON (Minervini et al. 2003). 
Fluorescence microscopy in WEHI-231 B cells showed apoptosis from 3.4 μM DON 
(Uzarski and Pestka 2003). DON exposure could interrupt cell migration between circulation 
and secondary lymphoid organs but few studies have examined this. In our study, spleen and 
peripheral blood were collected after DON was fed to BALB/c mice in order to determine if 
DON inhibited the numbers of both peripheral and splenic leukocytes and subpopulations, 
which would indicate leukocyte progenitor inhibition, or if DON inhibited only peripheral 
blood and not splenic leukocytes, indicating altered migration response. 
These hypotheses are based on in vitro cell culture studies. The concentration of DON in 
peripheral blood after mice were fed low doses of DON may not match the concentrations 
used in vitro. DON was rapidly absorbed while passing through the stomach and the upper 
small intestine in swine (Avantaggiato et al. 2004; Danicke et al. 2004). DON glucuronide 
and de-epoxy DON (DOM-1) were the main metabolites (Worrell et al. 1989; Meky et al. 
2003). DON glucuronide was not toxic (Wu et al. 2007). Therefore, in this study, we also 
developed an LC/MS/MS method to better assess the reaction between DON and DOM-1 
toxicity to peripheral leukocyte subsets.  
 CD19, CD4, CD8, CD11b are cell surface antigens commonly used as B cells, T helper, 
T cytotoxic and monocyte markers (Luster et al. 1996). CD11b is also a marker for 
neutrophils which can be separated from monocytes due to different intercellular granularity. 
BALB/c mice were used to study DON immunotoxicity due to their sensitivity to this 
mycotoxin as previously shown (Landgren et al. 2006). Our study attempted to answer if 
DON doses, exposure time, and sex of mice altered leukocyte surface maker expression. 
Based on mouse peripheral blood immune cell biomarkers that might be useful in assessing 
human DON exposures, we expected to distinguish lowest observed adverse effect level 
(LOAEL) and no observed adverse effect levels (NOAEL) for dietary DON in BALC/c mice 
over 14 and 28 day exposures.  
Methods 
Toxin 
Purified DON, 3α, 7α, 15-trihydroxy-12, 3-epoxy-trichothec-9-en-8-one, was purchased 
from Sigma (purity >98%. St Louis, MO, USA) and stored at 4 °C.  
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Diets, animals, and experiment design 
The control diet was AIN-93G (Reeves, 1997). All components were purchased from 
Harlan Teklad (Madison, WI). After mixing basal diet, DON in aqueous solution was added 
at 0, 0.25, 0.5, 1.0 and 2.0 mg kg-1. The diets were mixed with 20% water to form a dough, 
and then cut into 10-15 g bars, which were air dried for two days until the bar weight showed 
no further change. Diets were made at the beginning of the experiment and stored in sealed 
plastic bags at -20°C. When making diets, disposable masks and gloves were used as 
protection. All items contaminated with DON were rinsed in 10% bleach before washing. 
Two hundred 6-7 week old BALB/c mice were purchased from Jackson Laboratory (Bar 
Harbor, ME). Mice were housed individually in plastic cages at 20°C, 12 h light/dark cycle. 
Low dust absorptive bedding was changed twice per week. Feed and water were provided ad 
libitum. Feed consumption and body weights were recorded once a week and mice observed 
daily for any signs of illness. Mice in the experiments were fed control or test diets for 14 or 
28 days in a randomized complete block design with 20 treatments (female vs. male; feeding 
intervals at 14 d or 28 d; DON doses at 0, 0.25, 0.5, 1 and 2 mg kg
-1
 ) and 10 replications. 
This project was approved by the Iowa State University Institutional Animal Care and Use 
Committee. 
Collection of blood and tissue samples 
All procedures were performed aseptically at room temperature. Mice were killed with 
carbon dioxide. Blood was collected into 1cc heparinized syringe by cardiac puncture and 
transferred to 1.5 ml microfuge tubes.  
Spleens were removed and immediately placed into 15 ml centrifuge tubes containing 5 
ml of RPMI medium (50 µg/ml gentamicin, 5% heat inactivated fetal bovine serum). 
Splenocyte single cell suspensions were made by gently grinding spleens between two 
frosted microscope slides; cell suspension was mixed by Pipetman™ (1 mL tip) several times 
until no obvious tissue fragments were observed. Single cell suspensions were settled out for 
about 5 min and transferred to 1.5 ml microfuge tubes for staining and counting. 
Hematology and cells counts  
Hematological analysis of mouse blood was performed using MASCOT™ multispecies 
hematology system, HEMAVET 850 (CDC Technologies Inc., Oxford, CT). Red blood cells 
98 
 
(RBC, x10
6/μl), hemoglobin (Hb), hematocrit (HCT, %), mean corpuscular volume (MCV, 
Fl), mean corpuscular hemoglobin (MCH, pg), mean corpuscular hemoglobin concentration 
(MCHC, %), relative red blood cell distribution width (RAW) and platelets (PLT, x10 e 3/μl). 
Concentrations of mononuclear cells in spleen were also determined by this automated cell 
counter.  
Antibodies 
Monoclonal antibodies purchased from BD Biosciences Pharmingen ™ (San Diego, CA) 
were used for flow cytometric analysis: Fluorescein isothiocyanate (FITC)-conjugated rat 
anti-mouse CD11b (integrin αM chain, Mac-1α chain), phycoerythrin-Cy5 (PE-Cy5)-
conjugated rat anti-mouse CD4 (L3T4), allophycocyanin-Cy7 (APC-Cy7)-conjugated rat 
anti-mouse CD19 and R-phycoerythrin (R-PE)-conjugated rat anti-mouse CD8a (Ly-2). 
Background staining was evaluated using isotype controls: FITC-conjugated rat Ig G2b, κ; 
PE-Cy5-conjugated rat IgG2a, κ; APC-Cy7-conjugated rat IgG2a, κ and R-PE-conjugated rat 
IgG2a, κ. 
Flow cytometric analysis 
Samples were run on a FACSCanto flow cytometer (Becton-Dickinson, San Diego, CA) 
with blue (488 nm, air cold, 20mW solid state) and red (633 nm, 17mW HeNe) excitation 
sources. Dimmest emission signals were collected first, starting with the longest wavelength 
(APC-Cy7), and finishing with the shortest wavelength (FITC) to enhance sensitivity. Data 
was collected for 30,000 cells. A sample of unstained cells was used to calibrate the 
cytometer. Four different compensation tubes contained blood or spleen cells that were 
stained with only one of the 4 fluorescent antibodies. Isotype-matched antibodies were used 
as negative controls. Forward scatter in a plane parallel to the laser path distinguished live 
from dead cells. Side scatter in a plane perpendicular laser path measured intracytoplastic 
granularity. Data were collected using FACSDiva software. 
Whole blood (50 µL) or 5 x 10 
5
 splenocytes in RPMI medium were transferred to 12 x 
75 tubes with 100 µL 10% normal rat serum (Jackson ImmunoResearch, West Grove, PA), 
0.1% PBS-azide, and incubated for 15 min. Antibody cocktail including 0.125 µg/mL PE 
CD8, 0.4 µg/mL APC-Cy7 CD19, 0.02 µg/mL PE-Cy5 CD4 and 0.15 µg/mL FITC-CD11b 
(determined by antibody tittering) was added to each tube, tubes vortexed gently and placed 
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on ice in the dark for 30 min. Lysing solution (2 mL, 1x, fresh daily by tenfold dilution of 1.5 
M NH4Cl, 100 nM NaHCO3 and 10 nM EDTA disodium was added to each tube in order to 
remove hemoglobin. PBS (2 mL) was used to wash cells. Finally, 200 µl of 
PBS/formaldehyde (final concentration 1%; PolySciences, Inc. Warrington PA) was added to 
fix cells. All cells were kept at 4°C until flow cytometric analysis within 4 days.  
Detection of DON and (DOM-1) by LC/MS/MS 
Plasma samples within the same treatment were combined by sex and feeding interval to 
obtain 1 mL samples for extraction. DON and DOM-1 were extracted with 84:16, v/v, 
acetonitrile: plasma. The extracts were centrifuged for 10 min at 1100 rpm to remove 
denatured protein. Clean up was performed with solid phase extraction columns, 1.5 g 
alumina (80-200 mesh) 60:1 with ground charcoal in a 5 ml syringe barrel with filter paper 
frits at the bottom and top of the packing. Clear extracts were evaporated under a stream of 
nitrogen. The residues were concentrated fivefold by dissolving in 200 µl acetonitrile: water 
(1:4) and filtered with 0.45 µm PDF filter; 20 µL analyzed by LC/MS/MS (Agilent 
Technologies 1100 HPLC Tandem Mass Spectrometer). The mass spectrometer was operated 
in the ESI+ mode using multiple reaction monitoring (MRM). Tune nebulizer was set at 30.0 
psi and dry gas and dry temperature were set at 10.0 L/min and 350°C. The mobile phase 
consisted of 0.1% acetic acid in water (solvent A) and acetonitrile (B) at a flow rate of 0.3 
ml/min. The elution gradient was 95% solvent A to 70% solvent A at 20 min. An Ascentis™ 
C18 (10 cm x 2.1 mm, 3 µm) column was used. Under these conditions, the retention times of 
DON and DOM-1 were 7.5 min and 10.7 min. To detect the recovery of DON and DOM-1 
from mouse blood, blank plasma was spiked with DON and DOM-1 and extracted as above. 
Statistical analysis 
Absolute cells numbers in spleen and percentages of leukocytes in peripheral blood, and 
hematology were tested with a three-way factorial design of ANOVA: 
yijkl = μ+ρi+αj +βk +rl + αβjk + βrkl + αrjl + αβrjkl +eijklh where µ represented the general 
mean, ρi represented block, αj represented diet type (control, 0.25, 0.5, 1 or 2 mg kg
-1
), βk 
represented sex of mice (female or male), rl represented different feeding day (14 or 28 d), 
αβjk + βrkl + αrjl + αβrjkl represented interactions between dose and sex, between dose and day, 
100 
 
between sex and day, and among dose, sex and day; eijklh represented the experimental error. 
Data were analyzed using SAS (Cary, NC) PROC MIXED program. Linear trends were 
described for each group of mice (F14, M14, F28, and M28) if there was any interaction of 
sex, dose, feeding intervals. If no interactions occurred, only linear trend was described for 
mean values across groups. For comparisons of two treatments within group, student‟s t-test 
was used.  For multiple comparisons within group, one way ANOVA and Duncan‟s 
procedure were performed. Values in the tables are least square means. Statistical tests were 
applied at the 5% significant level.  
  Results 
Body weight and food intake 
All 200 mice (10 mice/dose/sex/14 days or 28 days) grew normally with no gross signs of 
illness. There was no significant difference in initial body weight and final body weight 
within sex and within day. The initial body weights were 17.2 ± 0.5 g and 22.1 ± 0.5 g for 
females and males, respectively (mean ± SEM). After 14 days, the body weights were 17.8 ± 
0.5 g and 22.6 ± 0.5 for females and males, respectively. After 28 days, the body weights 
were 18.4 ± 0.5 g and 23.4 ± 0.5 g for females and males, respectively. There was no 
significant difference in food intake of animals fed DON compared with controls except that 
food intake was decreased significantly in female mice fed 2 mg kg
-1
  DON for 28 days (3.13 
± 0.05 g/d) compared with control females (3.34 ± 0.05 g/d). 
Phenotyping of peripheral blood leukocytes 
Peripheral blood leukocytes labeled with PE-Cy5 CD4, APC-Cy7 CD19, PE CD8a and 
FITC CD11b were analyzed by flow cytometry using gates based on the two major cell type 
clusters: mononuclear cells and granulocytes. Differences in fluorescence of labeled 
mononuclear cells were identified in order to detect if dietary DON affected numbers of T 
helper cells (CD4
+
), T cytotoxic cells (CD8a
+
), B cells (CD19
+
) and monocytes (CD11b
+
 
mononuclear cells). Neutrophils had the same CD11 b surface markers, but were detected 
with a different gate from that of monocytes. Therefore, the signal of FITC CD11b within the 
granulocyte gate indicated the number of peripheral blood neutrophils. Pasche et al. (2005) 
showed that less than 10% of peripheral blood cells were granulocytes in normal BALB/c 
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mice after staining peripheral blood with Gr-1
+
 antibody, similar to our study (data not 
shown). 
DON doses, time of treatment and sex all influenced leukocyte phenotyping (Table 3.1). 
There were interactions in day * sex in percentage of mononuclear cells, in day * sex and day 
* dose in percentage of CD11b
+
 mononuclear cells (monocytes), and in day * sex in 
percentage of CD11b
+
 granulocytes (neutrophils). Sex differences were found in peripheral 
blood leukocyte phenotypes, independent of DON dose (Table 3.1). Males showed a greater 
percentage of neutrophils, whereas mononuclear cells, monocytes, T cytotoxic cell and T 
helper cells were present in greater percentages in females (p<0.001), with no sex difference 
in B cells (p=0.23). In comparing 14 and 28 day treatment intervals, T cytotoxic cells were 
not different over time (p=0.164), percentages of T helper increased (p=0.02), neutrophils 
and B cells decreased (p=0.0036, p=0.01, respectively).  
After BALB/c mice were fed DON for 14 days, differences in peripheral blood leukocyte 
phenotypes were observed in both sexes (Table 3.1, Table 3.2). In female BALB/c mice, 
percentages of mononuclear cells were decreased at 1 and 2 mg kg
-1
 DON with strong linear 
trend with doses (p=0.0057) (Table 3.1). After feeding animals DON for 14 days, the 
numbers of B cells were decreased at 1 and 2 mg kg
-1
 DON regardless of sex (Table 3.2).  
Differences in peripheral blood leukocyte phenotypes were also observed in female 
BALB/c mice fed DON for 28 days (Table 3.1). In female BALB/c mice, the percentage of 
monocytes (CD11b
+
 mononuclear cells) was decreased in strong correlation with dose (p = 
0.03). Monocytes in female mice fed 1 and 2 mg kg
-1
 DON were significantly less than in 
controls (p<0.001). Greater percentages of monocytes were observed in females than in 
males after 28 d. DON exposure of male mice over 28 days did not influence lymphocyte or 
monocyte phenotype.  
Phenotyping of spleen mononuclear cells 
Single spleen cell suspensions were labeled with PE-Cy5 CD4, APC-Cy7 CD19, PE 
CD8a and FITC CD11b. Only mononuclear gates were set because there are few 
granulocytes in spleen. After statistically analyzing the influence of sex and feeding interval 
on all leukocyte subpopulations, no such differences were seen in percentage of CD4
+
, 
CD8a
+
 and CD19
+
 splenic cells. Total CD11b+ splenic cells were decreased at 1 and 2 mg 
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kg
-1
 DON in female BALB/c mice after 28 d compared to control mice with same feeding 
interval and sex, but no significant linear dose response was observed (Table 3.3). There 
were no significant differences in total spleen mononuclear cells, B cells, T cytotoxic cells or 
T helper cells across doses within sex and within days (data not shown). The total spleen 
mononuclear cells were 10.76 ± 0.15 x 10
7
 cells/ mouse as detected by HEMAVET.  
Hematology 
Feeding interval did not affect RBC, HCT, MCV, MCH, MCHC, RAW, and PLT, 
whereas males had greater RBC, HCT, and PLT counts and females greater MCV, MCH, and 
MCHC (data not shown). Hemoglobin (Hb) was sensitive to DON exposure in BALB/c mice.  
In comparison with their controls, Hb was significantly lower at 0.25, 0.5 and 1 mg kg
-1
 
DON in female mice fed for 14 days (p<0.01, table 3.4), but no linear dose-response was 
observed. There was a linear dose response to decrease Hb in female mice after 28 d (p=0.03), 
but the values of Hb were still in normal range for DON doses 0-2 mg kg
-1
. 
DON and DOM-1 in mouse plasma by LC/MS/MS   
LC/MS/MS was used to detect DON and its possible metabolite, DOM-1 in mouse 
plasma. The recoveries of DOM-1 and DON were 98.1% and 110% after 500 ng/mL of each 
compound was spiked into blank mouse plasma samples. A typical LC/MS/MS 
chromatogram of DON and DOM-1 (62 ng/mL standards) showed the major product ions, 
249.1 and 233.0, used for quantitative detection of DON and DOM-1, respectively (Fig. 3.1). 
The detection limit was 10 ng/mL (20 µL injection) for DON and DOM-1 by LC/MS/MS. 
Based on the analysis of four pooled samples (males or females at 14 or 28 days) 
concentrated fivefold, DON concentrations in plasma at 1 mg kg
-1
 and 2 mg kg
-1
 dietary 
exposure were 2 ng/ml and 4 ng/ml, respectively. DOM-1 was not detected. 
Discussion 
This is the first research on low dose DON immunotoxicity in mice in which peripheral 
blood and splenic mononuclear cells and granulocytes were detected by flow cytometry. Two 
exposure times and both sexes were studied. The doses studied, 0.25-2 mg kg
-1
, represented a 
range of natural occurrence of DON in cereals and wheat products (Lombaert et al. 2003; 
Roscoe et al. 2008; Schollenberger et al. 2002; Cirillo et al. 2003). 
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Only females fed 2 mg kg
-1
 DON for 28 d had reduced food intake compared with 
controls fed no DON. DON reduced food intake after 1 week exposure to 2.5 mg kg
-1
 in 
weanling male BALB/c mice (p<0.005), but significant weight reduction was observed only 
at ≥10 mg kg-1 DON (p<0.005, Robbana-Barnat et al. 1987). Weanling male Swiss Webster 
mice fed 0, 1, 2 and 4 mg kg
-1
  DON for 5 weeks only showed decreased food intake when 
fed 2 mg kg
-1
  (p=0.004) whereas weight gain was not influenced significantly (Tryphonas et 
al. 1986). Our study is partly consistent with previous findings in showing decreased food 
intake at 2 mg kg
-1
 dietary DON over 28 days without diminishing weight in female BALB/c 
mice. Sex difference in response to DON has been reported in B6C3F1 mice. In a two -year 
feeding study conducted with female and male B6C3F1 mice fed 0, 1, 5 and 10 ppm DON, 
the results showed 5 and 10 ppm DON decreased body weight gain significantly, with no 
change in food intake in females, whereas, 5 and 10 ppm DON decreased both body weight 
gain and food intake in males (Iverson et al. 1995). The mechanism of suppression of food 
intake remains to be determined. Different mouse strains of BALB/c and B6C3F1 may result 
in the different response in food intake. 
Few studies reported the effects of subchronic low doses of DON, which simulated real 
human exposures in comparison with advisory guidelines for DON ranging from 0.5-2 mg 
kg
-1
 across the EU, Canada, China and US (Pestka and Smolinski, 2005). DON induced 
hepatic cytochrome P4502b, GST α and π isoezymes when 6-week-old C57BL6 male mice 
were orally administrated 0.071 mg and 0.355 mg DON/kg b.w. (3 days/week) for 4 weeks 
(corresponding to 0.2 and 1 mg kg
-1
 DON contaminated feed). However, enzyme induction 
by DON was not found at 1.774 mg kg
-1
 b.w. (corresponding to 5 mg kg
-1
 contaminated feed, 
Gouze et al. 2005). Decreased plasma α-globulin was found in young swine fed 0.75, 1.5 and 
3.0 mg kg
-1
 DON for 28 days (Rotter et al.1994) and in mice fed 2 mg kg-1  DON for 5 
weeks (Tryphonas et al. 1986). The health significance of these markers of exposure to low 
doses of DON is uncertain. 
Blood leukocytes are important markers of immune function. In adult individuals, T cells 
numbers are maintained through division of mature T cells outside of the thymus, whereas 
new B cells can be produced from the bone marrow. Once lymphocytes leave the central 
lymphoid tissues (bone marrow and thymus), they are carried in the blood to peripheral 
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lymphoid organs (e.g., spleen and lymph nodes) and recirculate via lymph and blood until 
they either encounter antigens or die.  
In our study of peripheral blood immune cell subpopulations as DON biomarkers, the 
relative number of mononuclear cells was inhibited at 1 and 2 mg kg
-1
 of DON in female 
mice for 14 d (Table 3.1). The percentage of CD19
+
 (B cells) was decreased in BALB/c mice 
fed 1 and 2 mg kg
-1
 DON for 14 days (Table 3.2) but not in mice fed DON for 28 days. 
Widespread lymphoid inhibition could be due to decreased differentiation of lymphoid 
precursors from stem cells, which could be related to changes in transcriptional regulation 
and hematopoietic cytokines (Zhu and Emerson, 2002).  
In the current study, the mechanisms underlying dose/responses to DON that caused 
decreased subpopulations of lymphocytes were probably related to reduced production of 
mature lymphocytes in bone marrow, and not due to apoptosis or homing to spleen. DON 
concentrations in plasma were close to 2 ng/ml (6.8 nM, see results). In vitro, progenitor cells 
were more sensitive to DON exposure than mature leukocytes.  For example, DON did not 
influence the viability of mature circulating blood cells at 1 µM (Froquet et al. 2003). 
However, DON rapidly inhibited and destroyed human cord blood and rat bone marrow 
granulo-monocytic progenitors (CFU-GM) with IC 50 values of 29 nM for human CFU-GM 
and 15 nM for rat CFU-GM over 10 days (Lautraite et al. 1997). The minimum effective 
DON dose to induce DNA fragmentation in HL-60 cells was 68 nM over 24 h (Ueno et al. 
1995). Le Dréan et al. (2005) reported that DON did not induce apoptosis at concentrations 
of DON between 0.01-1.0 μM after incubation for 12 hr of human cord blood CD34+ 
hematopoietic progenitor cells. Therefore, apoptosis by 'ribotoxic stress response' by high 
dose of DON was probably not involved in the effects of DON in our study (Pestka, 2008). 
In our observation of inhibition of B cells in peripheral blood (Table 3.2), no increase in 
splenic B cells was observed over 14 d feeding. This suggests that DON inhibited CD19
+
 
progenitor cells or newly made mature B cells in bone marrow. But lymphocyte subsets in 
peripheral blood might not all migrate to spleen. B cells tend to migrate into Peyer‟s patches 
as well (Picker and Butcher, 1992). This possibility should be assessed in the future. 
Hematological values have been found to change in female BALB/c mice. Hemoglobin 
was decreased at 0.25~1.0 mg kg
-1
 DON after 14 d, but the dose-response had a polynomial 
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trend with hemoglobin at 0.5 and 1.0 mg kg
-1
 DON less than at 2.0 mg kg
-1
 (Table 3.4). 
Iverson et al. (1995) showed that male B6C3F1 mice had increased red blood cell and 
hematocrit at 1 mg kg
-1
 DON and increased RAW at 10 mg kg
-1
 DON. No hematological 
changes were found in female B6C3F1 mice. Different mouse strains seemingly respond 
differently between sexes in the effects of DON on red blood cells. 
Most of the effects of DON occurred in mice fed for 14 d. The effect did not persist after 
28 d (Tables 3.1, 3.2 and 3.4) with the exception of the effect to suppress monocytes in 
females (Tables 3.1 and 3.3), which indicated that BALB/c mice adapted to DON. Time-
dependent differences in immunotoxicity after DON exposure were also reported by Pestka 
(1987). In his study, effects on resistance to Listeria monocytogenes and delayed 
hypersensitivity were detected in B6C3F1 female mice fed DON and zearalenone for 2-3 
weeks, whereas these effects disappeared after 8 weeks of exposure. Mice may adapt to DON 
exposure due to induction of detoxification processes. DON glucuronidation and 
deepoxidation (DOM-1) are major detoxification routes (Wu et al. 2007; Sundstol Eriksen et 
al. 2004). 6 week-old C57BL6 male mice exposed to 0.5 mg kg
-1
 and 1 mg kg
-1
 DON for 4 
weeks had increased liver microsomal pentoxyresorunfin depentylase and cytosolic 
glutathione transferase activities (Gouze et al 2005). Hedman (1997) observed that no 
metabolites of nivalenol (NIV) were formed in anaerobic incubation of the toxins with pig 
feces. However, after one week on a diet containing 2.5 or 5 mg kg
-1
 NIV, nearly all excreted 
NIV in feces had been de-epoxidated. Thus, microbial adaptation to NIV and perhaps to 
DON as well might occur after exposure to these toxins. Prolonged exposure to DON could 
alter detoxification enzymes or gut microbes in the lower gut. Additionally, UDP-
glucuronosyl-transferases (UGTs) are found in lymphocytes. Decreasing total 
glucuronidation correlated with a decreased covalent binding and enhanced cytotoxicity of 
benzo[a]pyrene in human lymphocytes (Hu and Wells, 2004). UGTs in mouse lymphocytes 
could detoxify DON and might be induced by prolonged exposure to DON. This should be 
examined in future studies, as well as possible deepoxidation by gut microorganisms. The 
apparent absence of DOM-1 from murine plasma appearing several hours after DON 
ingestion does not preclude DON metabolism to DOM-1 and rapid excretion of that 
metabolite. 
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In this study, sex-dependent differences were found in the responses of 
monocytes/macrophage cells to DON. Greater percentages of monocytes or numbers of 
macrophages were found in control female mice than in males in peripheral blood and spleen 
after female mice were fed test diets for 28 d, which could be the effect of 17β-estradiol and 
progesterone. In other studies, testosterone decreased macrophage numbers and their 
functions, female rats had more adrenal macrophages than males, and estrogen-treated male 
rats developed increased numbers of macrophages compared with normal males; estrogens 
stimulated the number of circulating monocytes (Klein 2004; Ansar Ahmed and Talal 1990).  
In the present study, after BALB/c female mice were fed DON for 28 days, monocytes in 
peripheral blood and total monocytes in spleen were decreased at 1 mg kg
-1
  and 2 mg kg
-1
  
(Tables 3.1 and 3.3), which suggested that DON delayed monocyte or macrophage 
maturation. Administration of zearalenone, which has estrogenic effects in many species 
(Kuiper-Goodman et al. 1987), and DON in combination caused a more reduced host 
resistance to infection of Listeria monocytogenes than did DON alone (Pestka et al. 1987). T 
cell- independent macrophages play an important role in the early defense against 
intravascular bacteria. The possible reduction of macrophage function by the combination of 
an estrogen (zearalenone) and DON seems to be similar to our study in that reduction of 
peripheral blood and spleen monocytes was found only in female mice. Pasche et al. (2005) 
found that female C57BL/6J, BALB/c, C3H/HeN and CBA/J were more susceptible to L. 
monocytogenes than males. The increased severity of infection in females correlated with 
elevated interleukin-10 levels, lower frequencies of granulocytes and more pronounced 
lymphopenia. Because interleukin-10 inhibits macrophages, this may explain the increased 
sensitivity in females to L. monocytogenes. The influences of sex hormones on the immune 
system come through receptors. The possibility of DON interacting with sex hormone 
receptors in monocytes in peripheral blood and spleen deserves study. Estrogen receptor 
mRNA and receptor binding sites were found in peripheral blood monocytes in humans 
(Stefano and Peter, 2001). Therefore, estrogen binding to estrogen receptors in monocytes 
may have interacted with DON toxicity in female mice, contributing to inhibition of 
peripheral blood and spleen monocyte numbers. 
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We attempted to explore the relation of DON effects to bioavailability. The 
concentrations of DON and DOM-1, a metabolite of DON produced by gut microorganisms 
(Worrell et al. 1989), were less than 10 ng/ml when detected by LC/MS/MS. BALB/c mouse 
UDP-glucuronosyl-transferases (UGTs) in liver or intestine may have reduced the 
concentrations of DON and DOM-1 in plasma after dietary DON exposure for 14 and 28 d. 
Only ~0.4% of a dose of DON was found in plasma at peak after 8 h (291 ± 47 ng DON/ml) 
after a single dose of 5.0 ± 0.1 mg DON/kg, b.w. was given by gavage to Sprague–Dawley 
rats (Meky et al. 2003). A dose of 5 mg DON/kg b.w. to mice would be similar to a dietary 
dose of 0.1 mg/mouse per day or ~29 mg kg
-1
 (assuming dietary intake of 3.5 g/d and body 
weight of 20 g).  This dose is ~15 times greater than the dose fed in our study, and a bolus 
dose would result in a greater peak plasma concentration than that achieved by dietary intake. 
The present result showing mouse plasma concentrations of DON of 2-4 ng/ml after 
ingestion of 1-2 mg kg
-1
 DON were roughly consistent with the finding of Meky et al. (2003). 
Male B6C3F1 mice (7 week old) fed 2 mg kg
-1
 DON for 4 weeks had plasma DON of ~20 
ng/ml by ELISA (Pestka et al. 2008b), and our result on plasma DON concentrations were 
close to the result of Pestka et al (2008b). 
 Other DON metabolites probably did not contribute to DON toxicity in the present study, 
because the cytotoxicity of DOM-1, undetectable in the present study, was 55 times less than 
DON in Swiss mouse 3T3 fibroblasts (3T3 cells) (Sundstol Eriksen et al. 2004). DON 
glucuronide was not toxic at up to 270 µM in K562 cells, model lymphocyte/erythrocyte 
progenitor cells (Wu et al. 2007). 
Peripheral B cells were inhibited in both female and male BALB/c mice by 1 mg kg
-1
 and 
2 mg kg
-1
 DON. However, prolonged exposure did not result in increased immune system 
alteration. Induction of detoxification enzymes in host might contribute to this effect. Further 
study should examine differences over time in production of DON glucuronide and DOM-1. 
The peripheral blood mononuclear cells were decreased in female BALB/c mice fed 1 and 2 
mg kg
-1
  DON after 14 d , and monocytes in peripheral blood and macrophage cells in spleen 
were decreased in female mice fed 1 and 2 mg kg
-1
 DON after 28 d, which suggested female 
BALB/c mice were more sensitive to dietary DON exposure. Peripheral and spleen 
monocytes were inhibited by DON in female mice in our study and host resistance to L. 
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monocytogenes was lower in female than in male (Pasche et al. 2005), which indicates DON 
exposure could increase susceptibility to infection in female BALB/c mice. Therefore, the 
role of female sex hormones in potentiating DON immunotoxicity and diminishing infection 
resistance needs further research. As a conclusion, the observed changes of leukocyte subsets 
in peripheral blood and spleen may not alter immune system function in normal life, but in 
infectious conditions, reduced lymphocytes, especially B cells and monocytes, could lessen 
humoral and innate immunity.  
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Table 3.1: Phenotyping of peripheral blood leukocyte subsets in young adult BALB/c 
mice fed DON at 0-2 mg kg
-1
 over 14 d and 28 d. 
Parameter Group 
DON doses ( mg kg
-1
)    
0 0.25 0.5 1 2 Mean
#
 Linear trend Probability
¥
 
Mononuclear 
cells % 
F14 84.0 81.4 81.7 78.8
*
 75.9
*
 81.0 
y= -3.8+83.2 
(P=0.0057) 
Dose(0.0145) 
Sex(<0.0001) 
Day*sex 
(0.0439) 
M14 73.8 73.2 73.5 71.4 71.5 73.3 NS 
F28 81.6 82.4 81.9 81.6 80.9 81.1 NS 
M28 75.4 76.8 78.5 77.5 75.1 76.0 NS 
mean
€
 78.7 78.5 78.9 77.3 75.8    
CD11b+ 
granulocytes 
% 
F14 7.3 8.5 8.6 8.5 9.0 8.4 NS Day (0.0036) 
Sex(<0.0001) 
Day*sex 
(0.0038) 
M14 12.8 14.2 13.9 15.9 14.2 14.2 NS 
F28 4.8 5.3 7.0 5.4 6.6 5.9 NS 
M28 9.1 10.6 7.0 7.7 9.6 8.8 NS 
mean 8.5 9.7 9.1 9.4 9.8    
CD11b+ 
mononuclear 
cells% 
F14 7.7 8.5 8.7 8.3 8.5 8.3 NS 
Sex(<0.0001) 
Day*dose 
(0.0435) 
Day*sex 
(0.0011) 
M14 6.2 8.0 6.4 6.4 6.5 6.7 NS 
F28 13.4 11.9 11.1 9.7
*
 9.1
*
 11.0 
y= -2.0+12.5 
(p=0.03) 
M28 7.6 7.3 7.0 6.4 6.7 7.0 NS 
mean 8.7 8.9 8.3 7.7 7.7    
CD4+% 
F14 26.1 24.3 25.1 25.4 21.6 24.8  Day(0.0200) 
Sex(<0.0001) 
 
M14 18.5 20.5 21.0 18.7 21.0 20.3  
F28 30.0 30.0 30.9 34.0 32.4 31.0  
M28 25.1 28.0 26.3 30.1 25.0 26.5  
mean 24.8 25.9 25.8 26.8 25.0  NS  
CD8+% 
F14 10.4 9.7 10.2 10.6 8.6 9.9  
Sex(<0.0001) 
 
M14 9.4 7.7 7.5 6.8 7.9 7.9  
F28 10.1 10.8 10.9 11.0 10.9 10.7  
M28 8.8 8.9 8.8 9.8 8.3 8.9  
mean 9.7 9.3 9.3 9.5 8.9  NS  
*: significantly different from control within group. 
#: mean across doses 
¥: only significant difference in factors and interactions were listed  
€: mean across groups 
NS: not significant 
 
 
113 
 
Table 3.2: CD19
+
 leukocytes (B cells) in peripheral blood were inhibited in BALB/c mice 
fed DON at 1 and 2 mg kg
-1
 after 14 d, not by 28 d.  
parameter group 
DON doses ( mg kg
-1
)    
0 0.25 0.5 1 2 Mean
#
 Linear 
trend 
Probability
¥
 
CD19+% 
14 days 33.7
a
 31.5
ab 
30.0
ab 
28.6
b
 28.3
b
 30.4 NS Day (0.0168) 
Dose 
(0.0196) 
 
28 days 24.3 24.8 24.7 21.0 23.1 23.6 NS 
mean
€
 29.1 28.2 27.3 24.8 25.7  NS  
Comparison across row, different letters significantly different from each other 
#: mean across doses 
¥: only significant difference in factors and interactions were listed  
€: mean across groups 
NS: not significant 
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Table 3.3: Phenotyping of CD11b
+
 splenic cells (macrophage cells) in young adult 
BALB/c mice fed DON at 0-2 mg kg
-1
 over 14 d and 28 d. 
Parameter Group 
DON doses ( mg kg
-1
)    
0 0.25 0.5 1 2 Mean
#
 Linear trend Probability
¥
 
Total 
CD11b+ 
splenic 
leukocytes 
(x 106) 
F14 3.7 3.7 3.7 3.4 3.6 3.6 NS Day (0.0012) 
Sex (<0.0001) 
Day*sex 
(<0.0001) 
M14 3.2 2.9 3.1 2.9 2.8 3.0 NS 
F28 5.6
a 
5.2
ab
 5.0
ab 
4.7
b
 4.7
b 
5.0 NS 
M28 3.8 3.5 3.4 3.4 3.2 3.5 NS 
Mean
€
 4.1 3.8 3.8 3.6 3.6    
Comparison across row, different letters significantly different from each other 
#: mean across doses 
¥: only significant difference in factors and interactions were listed  
€: mean across groups 
NS: not significant 
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Table 3.4: Hemoglobin values in young adult BALB/c mice fed DON from 0 to 2 mg kg
-1
 
over 14 d and 28 d. 
parameter group 
DON doses ( mg kg
-1
)    
0 0.25 0.5 1 2 mean
#
 Linear trend Probability
¥
 
Hemoglobin 
F14 18.3 16.8* 16.2* 16.2* 17.0 16.9 NS Dose 
(0.0119) 
Day*dose 
(0.0264) 
M14 16.9 16.5 16.3 16.3 16.9 16.6 NS 
F28 16.6 16.7 16.7 16.5 16.0 16.5 y=-0.34+16.8 
(p=0.0259) 
M28 17.0 17.2 16.6 16.6 16.5 16.8 NS 
mean
€
 17.2 16.8 16.4 16.4 16.6    
*: significantly different from control within group. 
#: mean across doses 
¥: only significant difference in factors and interactions were listed  
€: mean across groups 
NS: not significant 
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Fig 3.1: LC/MS/MS detection of DON and DOM-1. (A) The retention times were 6.8-7.2 
min and 10.1-10.5 min for DON and DOM-1, respectively; (B) The product ions (m/z) were 
249.1 and 203.1 for DON; (C) and 233.0 and 137.0 for DOM-1. 
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CHAPTER 4 DEOXYNIVALENOL SUPPRESSING CIRCULATING AND SPLENIC 
LEUKOCYTE AND ALTERING CELL MIGRATION MARKERS WITH TIME COURSE 
AND DOSE RESPONSE IN BALB/c MICE  
To be submitted to Toxicology and Applied Pharmacology 
Xianai Wu, Joan Cunnick, Marian Kohut, Ted Bailey, Suzanne Hendrich 
Abstract 
It was hypothesized that deoxynivalenol (DON) changed leukocyte subset numbers and 
their migration potential in peripheral blood with interaction of age and sex.  These leukocyte 
markers could be functional biomarkers of DON exposure in humans. In BALB/c mice fed 
DON at 0, 1.0 and 2.0 ppm, age, sex and feeding interval altered immune response of 
peripheral blood (PB) and splenic leukocytes, as measured by flow cytometry using cell 
surface markers. In 2-3 month old female mice, after feeding DON for 14 d, PB granulocytes 
were increased at 1 and 2 ppm DON, but not after 28 d. Also, a decreased percentage of PB 
CD4
+
 cells and a decreased percentage of CD11b
+
 (macrophage) splenic leukocytes at 2.0 
ppm DON were seen after 14 d only. An increased percentage of CD19
+
 cells occurred at 2.0 
ppm DON after 14 and 28 d. In old females, decreased PB CXCR5
+
 B cells were noted after 
feeding 2.0 ppm DON for 14 d, and 1.0 ppm DON decreased splenic CD11b
+
 cell %, but no 
dose-response in these cells was observed. In old male mice, 1.0 and 2.0 ppm DON increased 
granulocytes and CD29
+
CD11a
+
 neutrophils after 14 d and 2.0 ppm DON increased CCR9
+
 
T cytotoxic cells after 28 d suggested that DON stimulated digestive system inflammation in 
old male mice. DON caused no changes to immune cell markers in young male mice. As a 
conclusion, low-dose DON changed leukocyte balance in peripheral blood and spleen, and 
interrupted B cell, neutrophil, and T cell migration in interaction with sex and age.  
Key words: deoxynivalenol, BALB/c mice, cell surface markers 
Abbreviations: YM14: Young male fed DON for 14 d; YF14: young female fed DON 
for 14 d; OM14: old male fed DON for 14 d; OF14: old female fed DON for 14 d; YM28: 
Young male fed DON for 28 d; YF28: young female fed DON for 28 d; OM28: old male fed 
DON for 28 d; OF28: old female fed DON for 28 d.  
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Introduction 
Deoxynivalenol (DON, vomitoxin) is a type B trichothecene. The occurrence of DON is 
associated primarily with Fusarium graminearum (Gibberella zeae) and F. culmorum, both 
of which are important plant pathogens which cause Fusarium head blight in wheat and 
Gibberella ear rot in maize (Christian Larsen et al. 2004; González et al. 2008). DON 
exposure was investigated and reported all over the world. DON occurs predominantly in 
grains such as wheat, barley, oats, rye, and maize (MacDonald et al. 2004, Ayalew et al. 
2006; Mankeviciene et al. 2007). These investigations indicated there was high correlation 
between recurrent cool rainy weather in growing season and high humidity and DON 
exposure (Pan et al. 2007; Mankeviciene et al. 2007; Wetter et al. 1999). For example; 
unusual wet and cool weather conditions during the 1994 growing season in Maryland and 
Delaware caused 5% to 25% of ears to be infected with Fusarium spp. with DON 
concentration up to 446 mg/g in area with visible moldy (Wetter et al. 1999). There was a 
high correlation between DON content and percentage of Fusarium damaged kernels. 4.27% 
of damaged wheat kernels was associated with 1.25 mg DON /kg in grain (Beyer et al. 2007). 
Because DON is a stable compound it has also been detected in a range of processed cereal 
products including breakfast cereals, bread, infant foods, malt and beer (Lombaert et al. 2003; 
Roscoe et al. 2008; Anselme et al. 2006; Lancova et al. 2008). U.S. Food and Drug 
Administration voluntary advisory levels for DON stipulate no more than 1 mg/kg for bran, 
flour, and germ for human consumption and several European guidelines recommend 
maximum levels of DON of 0.5 mg/kg for cereal products as consumed (U.S. FDA 1993; 
Codex Alimentarius Commission FAO/WHO 2003). 
Outbreaks of DON mycotoxicosis are associated with consumption of mold damaged 
food products all over the world (Pestka and Smolinski 2005). Urinary DON detection was 
developed as a biomarker to indicate DON exposure in humans, and higher urinary DON was 
associated with higher bread intake (Meky et al. 2003; Turner et al. 2007; Turner et al. 2008). 
Acute toxicity of DON in high doses may produce necrosis in various tissues such as bone 
marrow and lymphoid tissues (Opinion on Fusarium toxins: deoxynivalenol in European 
commission 1999). DON exposure could change immune system function by changing 
leukocyte proliferation (Meky et al. 2001) and functions (Ayral et al. 1992), modulation of 
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cytokine production (Sugita-Konishi and Pestka 2001; Zhou et al. 1997), and diminishing 
host resistant to pathogens (Pestka et al. 1987). 
 In order to accurately predict the risk of immunotoxic exposure to DON in human 
populations, quantitative experimental and clinical immune tests of human health effects 
should be established. Rodent species and non-human primates are common models for 
human immune functional studies. Testing schemes proposed by the World Health 
Organization (WHO 1996) for human immunotoxicology includes surface analysis for CD4 
and CD8. U.S. Food and Drug Administration et al. (1999) developed immunotoxicity 
guidance in cooperation among six different agencies for evaluating potential adverse 
immunological effects of medical devices and constituent materials. Cell surface markers 
(phenotyping) were recommended to evaluate humoral and T cells immune response 
capability.  In the Office of Prevention, Pesticides and Toxic Substances of EPA guidelines 
intended to meet testing requirements of the Federal Insecticide, Fungicide and Rodenticide 
Act, enumeration of subpopulations of T and B lymphocytes was listed as a Tier II test. 
Therefore, to evaluate immuntoxicity of xenobiotics, phenotyping of leukocyte 
subpopulations by flow cytometry is a test recommended by FDA, EPA, and WHO.  
Enumeration of peripheral blood lymphocytes and innate cells is especially practical in that 
the method could be transferred from animals to human populations. 
CD19, CD4, CD8, CD11b  were the cell surface antigens commonly used as B cell, T 
helper, T cytotoxic and monocyte markers in human populations (Luster et al. 1996). In our 
study, these markers were selected for enumeration of leukocytes in BALB/c mice fed DON. 
At the same time, CD11b is also a marker for neutrophils which can be separated from 
monocytes due to different intercellular granularity.  
Immune cell migration is regulated by chemokines and chemokine receptors expressed in 
cell markers. Potentially reduced leukocytes by DON could be related to cell homing to other 
lymphoid organ or tissues. In previous study, peripheral blood B cell was decreased at 1.0 
and 2.0 ppm DON after 14 d in both sexes of BALB/c mice, whereas monocytes in 
peripheral blood and macrophage cells in spleen was inhibited only in female BALB/c mice 
after 28 d. In order to investigate T helper cells, T cytotoxic cells, B cells, monocytes and 
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neutrophils homing mechanisms and DON influence on homing, different chemokines 
receptors were selected for these cell types.  
CXCR5 is a chemokine receptor expressed in B cells in order to direct B cell access to 
follicles (a germinal center) by reaction with chemoattractant CXCL13 expressed by 
follicular dendritic cells in spleen (Boehmer et al. 2005).  Mature neutrophil and non-
differentiated monocyte migration to tissues require the interaction of adhesion cascade 
molecules between leukocytes and endothelical cells (Imhof and Aurrand-Lions 2004). 
Lymphocyte function-associated antigen-1 (LFA1, known as CD11a-CD18), and very late 
antigen 4 (VLA4, CD29) are important adhesion markers to regulate a variety of cellular 
response including adhesion, trafficking, proliferation and differentiation. ICAM-1 and 
VCAM1 in the surfaces of endothelial cells are the ligands for LFA1 and VLA4, respectively 
(Ley et al. 2007). Chemokines mediate control of T cell traffic in lymphoid and peripheral 
tissues. Naive T cell homing to lymph nodes undergoes multistep interactions with 
endothelial cells. After initial tethering and rolling via L-selectin (CD62L), further arrest of 
rolling cells is activated by CCR7 ligand with CCL21 or CCL19 (Förster et al. 2008, Ebert et 
al. 2005; Weninger et al. 2002). Therefore, in our study, both surface markers CCR7 and 
CD62L were selected, and CCR7
+
CD62L
+
 T cells were regarded as naive T cells or as 
memory T cells migrating between peripheral blood and lymphoid organ, whereas CCR7
-
CD62L
-
 T cells were considered to be effecter T cells with a loss of capability of migrate to 
lymph nodes, instead capable of migration to tissues. CCR9 selectively directs T cell access 
to small intestine by interaction with CCL25. CCR10 is a marker of inflammatory T cells, 
preferentially on effecter T cells in peripheral blood in order to direct T cells to large 
intestine and skin (Ebert et al. 2005, Williams 2004). 
Aging may result in the accumulation of developmental defects in bone marrow, thymus 
and secondary lymph organs (Linton and Dorshkind 2004). The influence of aging on 
immunotoxicity of DON is not well studied.  Only one study on aging interacting with DON 
was reported by Iverson et al. (1996), a two-year feeding conducted with female and male 
B6C3F1 mice fed 0, 1, 5 and 10 ppm DON.  Organ weights adjusted for body weights 
showed no effects of DON in females, however, in males, there was a trend for decreased 
liver weight (p<0.001), decreased spleen weight (p=0.04) and increased testes weight 
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(p=0.002) in DON-fed mice. There were trends toward increased lymphoid cells in females 
and decreased myeloid cells in males in bone marrow. No information on leukocyte subsets 
in old mice was reported.  
Our hypothesis was that DON exposure changed leukocyte subset numbers and migration 
potential in peripheral blood with interactions of age and sex.These leukocyte markers could 
be sensitive biomarkers to predict DON exposure for humans. DON influence on chemokine 
receptor expression, resulting in changing cell migration and possibly changing host 
resistance to infectious disease, was not reported before.  Age, sex, tissue collected, dose, 
exposure time and tissues studied all could influence assessment of DON immunotoxicity. In 
this feeding study, peripheral blood and spleen were collected to discern the relation of 
lymphocyte patterns between these tissues. Female and male BALB/c mice (2-3 month vs. 
16-17 month old) were fed DON at 0, 1.0 and 2.0 ppm for 14 and 28 d in order to investigate 
sex and age effects on DON toxicity based on the measurement of cell surface marker 
expression.  
Materials and methods      
Mice  
120 8-9 week old female and male BALB/c mice were purchased from Harlan Sprague 
Dawley, Inc and 120 16-month-old female and male BALB/c mice were obtained from 
National Institute of Aging. The old mice were given 1 mL sodium chloride solution (154 
mEq/L or 2.6 mol/L) upon arrival at our facility to reduce shipping stress. Mice were housed 
individually in plastic cages at 20°C, 12 h light/dark cycle. Low dust absorptive bedding was 
changed twice per week. Feed and water were provided ad libitum. Feed consumption and 
body weights were recorded once a week and mice observed daily for any signs of illness. 
This project was approved by the Iowa State University Institutional Animal Care and Use 
Committee. Mice were fed basal diet for a week, and then transferred to test diets for 14 d or 
28 d. 
Diets  
Purified deoxynivalenol, 3α, 7α, 15-trihydroxy-12, 3-epoxy-trichothec-9-en-8-one, was 
purchased from Sigma-Aldrich Co (Purity >98%, MO USA) and stored at 4° C. On the day 
of making diets, distilled water was added to the vial to make a stock solution of 1 mg 
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DON/ml. The control diet was AIN-93G (Reeves, 1997). All components were purchased 
from Harlan Teklad (Madison, WI). After mixing basal diet, DON in aqueous solution was 
added at 0, 1.0 and 2.0 ppm. The diets were mixed with 20% water to form a dough, and then 
cut into 10-15 g bars, which were air dried for two days until the bar weight showed no 
further change. Diets were made at the beginning of the experiment and stored in sealed 
plastic bags at -20°C.  
Experiment design    
This feeding experiment had 24 treatments. The experiment  used a randomized block 
design including four factors: sex (female and male); feeding interval (14 d and 28 d), age (8 
weeks and 16 months), doses of DON (0, 1.0 and 2.0 ppm). Mice from the two feeding 
intervals were euthanized on the same day, thus the animals fed for 28 days were started on 
their treatments two weeks before mice fed for 14 days.  Animals fed for 28 days were 
therefore 2 weeks older at euthanasia than were mice fed for 14 days. 
Collection of blood and tissue samples  
All procedures were performed aseptically at room temperature. Mice were killed with 
carbon dioxide. Blood was collected into 1cc heparinized syringe by cardiac puncture. Blood 
was transferred to 1.5 ml microfuge tubes. Spleens were removed and immediately placed 
into 15 ml centrifuge tubes containing 5 ml of RPMI medium (50 µg/ml gentamicin, 5% heat 
inactivated fetal bovine serum). Splenocyte single cell suspensions were made by gently 
grinding spleens between two frosted microscope slides; cell suspension was mixed by 
Pipetman™ (1 mL tip) several times until no obvious tissue fragments were observed. Single 
cell suspensions were settled out for about 5 min and transferred to 1.5 ml microfuge tubes 
for staining and counting.  
 Cell counts  
Concentration of spleen cells were determined by MASCOT™ multispecies hematology 
system, HEMAVET 850 (CDC Technologies Inc., Oxford, CT). Concentrations of blood 
leucocytes were determined with CountBright™ Absolute counting beads (Invitrogen) by 
FACSCanto flow cytometer (Becton-Dickinson, San Diego, CA). 
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Antibodies   
Fluorescein isothiocyanate (FITC)-CD11b, allophycocyanin-Cy7(APC-Cy7) CD19 and 
R-phycoerythrin (R-PE) CD8a (Ly-2), PE CXCR5 and their isotypes control: FITC-
conjugated rat Ig G2b, κ; APC-Cy7-conjugated rat IgG2a, κ; PE-Cy5-conjugated rat IgG2a, κ; 
and R-PE-conjugated rat IgG2a, κ were purchased from BD Biosciences Pharmingen ™ 
( San Diego, CA). APC-CCR10 and APC- IgG2B isotype control were obtained from R & D 
Systems, Inc (USA).  All the following antibodies were purchased from e-Bioscience (San 
Diego, CA): FITC-CD11a (LFA-1), PE-CD29 (VLA-4), PE-Cy7 CD11b, PE-Cy5.5 CD4, 
Alexa Fluor®700 CCR7, PE-Cy7 CD62L (L-selectin), FITC CCR9; and their background 
staining antibodies: FITC IgG2α, PE Armenian Hamster IgG, PE-Cy7 IgG2b, PE-Cy5.5 
IgG2α, Alexa Fluor®700 IgG2α, PE-Cy7 IgG2α, and FITC IgG2α. 
Flow cytometric analysis      
50 µl whole blood was transferred to 12 x 75 tubes with 100 µl 10% normal rat serum 
(Jackson ImmunoResearch, West Grove, PA), 0.1% PBS-azide, and incubated for 30 min. 4 
different assays in peripheral blood were run to 1) enumerate CD4 (T helper cells), CD8 (T 
cytotoxic cells), CD19(B cells) and CD11b (monocytes and neutrophils) in peripheral blood ; 
2) investigate CXCR5 expression in  B cells; 3) investigate LFA-1 and VLA-4 expression in 
monocytes and neutrophils; 4) investigate CCR7, L-selectin, CCR10 and CCR9 expression in 
T cells. For the first assay, 61 µL antibodies cocktail including 0.025 µg PE CD8, 0.08 µg 
APC-Cy7 CD19, 0.005 µg PE-Cy5.5 CD4 and 0.03 µg FITC-CD11b was added to each tube. 
For the second assay, 42 µL antibody cocktail including 0.08 µg APC-Cy7 CD19 and 0.4 µg 
PE-CXCR5 was added to each tube. For the third assay, 16.5 µL antibody cocktail including 
0.0625 µg FITC CD11a, 0.4 µg PE CD29, and 0.004 µg PE Cy7 CD11b was added to each 
tube. For the fourth assay, 60 µL antibody cocktail including 0.125 µg FITC CCR9, 0.025 µg 
PE CD8, 0.02 µg PE CD62L, 0.2 µg APC-CCR10, 0.005 µg PE-Cy5.5 CD4, and 0.4 µg 
Alexa Fluor®700 CCR7 were added to each tube. The determination of amount of antibody 
was based on titering. Tubes were vortexed gently and placed in the dark at room 
temperature for 40 min.  Lysing solution (2 mL, 1x, fresh daily by diluted 10x) including 
0.15 M NH4Cl, 10 nM NaHCO3 and 1 nM EDTA disodium was added to each tube in order 
to remove hemoglobin. 2 ml of PBS (1x) was used to wash cells. Finally, 200 µl BD 
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stabilizing fixative (BD Biosciences Pharmingen ™, San Diego, CA) after 3 times dilution 
and 50 µl counting beads (for assay1) were added to fix cells and enumerate cells. All cells 
were kept at 4 °C until flow cytometric analysis (within 4 days). For splenic cells, only assay 
one was run. 1x 10
6
 cells splenic cells were used to stain. 61 µL antibody cocktail including 
0.05 µg PE CD8, 0.16 µg APC-Cy7 CD19, 0.01 µg PE-Cy5.5 CD4 and 0.06 µg FITC-
CD11b was added to each tube.  
Samples were run on a FACSCanto flow cytometer (Becton-Dickinson, San Diego, CA).  
A sample of unstained cells was used to calibrate the cytometer. Four different compensation 
tubes contained blood or spleen cells that were stained with only one antibody. Isotype-
matched antibodies were used as negative controls. Forward scatter in a plane parallel to the 
laser path distinguished live from dead cells. Side scatter in a plane perpendicular laser path 
measured intracytoplastic granularity. Data were collected using FACSDiva software. 
Statistical analysis     
Absolute cell numbers and percentages of leukocytes in peripheral blood, spleen cells and 
chemokine receptors and adhesion markers were tested with a four -way factorial design of 
ANOVA with completely randomization block design with age (old vs. young), sex (female 
vs. male), dose (0, 1 and 2 ppm) and feeding intervals (14 d vs. 28 d) factorial arrangement of 
treatments. Three-way ANOVA or two-way ANOVA were used for data analysis if there 
were age or sex different in DON effect. Multiple comparison of DON effect within group 
used one-way ANOVA and Duncan‟s procedure. For comparison of two groups of data, 
student‟s t-test was used. Data were analyzed using SAS (Cary, NC) with PROC MIXED 
procedure. The values were least square means. The value p<0.05 was used to decide 
significant differences.  
Results 
Body weight and food intake 
All 120 young mice (10 mice/dose/sex/14 days or 28 days) showed no gross signs of 
illness. The initial body weights were 18.75 ± 0.13 g and 22.74 ± 0.13 g for females and 
males, respectively (mean ± SEM). After 14 days, the body weight gains were 1.01 ± 0.15 g 
and 1.27 ± 0.15 g for female and male, respectively. After 28 days, the body weight gains 
were 2.23 ± 0.15 g and 2.09 ± 0.15 g for female and male, respectively. The food intakes per 
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day were 3.29 ± 0.05 g and 3.61 ± 0.05g for female and male, respectively. There was 
significant difference in the response of body weight gain after 14 d and 28 d in young 
BALB/ c mice. The interaction of sex * dose occurred after 14 d DON (p=0.02). DON (1.0 
ppm) caused less body weight gain in young male mice but increased body weight gain in 
young female mice after 14 d.  There was no interaction of sex and dose after 28 d.  Body 
weight gain was increased at 1.0 ppm DON after 28 d in both female and male mice, 
although the body weight gain was only increased significantly in female mice (Table 4.1). 
 The initial body weights for old female mice were 26.13 ± 0.34 g and for old male mice 
were 33.34 ± 0.34 g. The body weights of mice fed test diets over 14 and 28 d were not 
significantly different from the initial weights. The final body weights for old female mice 
were 26.26 ± 0.40 g, for male old mice were 32.31 ± 0.40 g. There was no significant 
difference in food intake among doses of DON for old mice. Food intakes were 3.56 ± 0.05 g 
and 3.85 ± 0.05 g for female and male old mice, respectively. Of the first two cohorts of old 
mice, 50% died (12/24) during the first week after being shipped to our facility. After 
histopathology testing by the Department of Veterinary Pathology in Iowa State University, 
multiple organ pathologies were observed, such as spleen hemosiderosis, stomach necrosis 
with coccoid bacteria, autolyzed intestine, and liver hemorrhage. Good survival rates were 
observed for the old mice rehydrated by 1 mL sodium chloride solution immediately after 
shipping. 7 female and 6 male died after being randomly assigned to test diets. Finally, there 
were 7-8 old mice per treatment. 
Phenotyping of peripheral blood leukocytes 
Peripheral blood leukocytes labeled with PE-Cy5.5 CD4, APC-Cy7 CD19, PE CD8a and 
FITC CD11b were analyzed by flow cytometry using gates based on the two major cell type 
clusters: mononuclear cells and granulocytes. CD4, CD19, CD8 and CD11b are surface 
markers mainly expressed in T helper, B cells, T cytotoxic cells and monocytes, respectively. 
Neutrophils also express CD11b. The relative percentage of cells in a subset measured by 
flow cytometry and the absolute cell numbers were also obtained by counting beads in flow 
cytometry.  
In peripheral blood, decreased mononuclear cells including T helper, T cytotoxic, 
monocytes and B cells were observed with aging, whereas no difference in granulocytes 
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including neutrophils was noted between young and old mice (Table 4.2). There were no 
interactions among age, sex, dose and feeding intervals in T cell and B cell numbers. 
Mononuclear cells, especially T helper, T cytotoxic cells and B cells, in young and old 
BALB/c mice fed test diets over 28 d were all slightly decreased compared with 14 d. 
Concentration of monocytes were different between females and males (p= 0.0002), and age 
and sex interacted (p=0.02), with greater numbers of monocytes in 2-3 month old female 
BALB/c mice compared with old males and females and young males (Fig 4.1 A). 
Granulocytes showed a dose effect (p=0.01) and day * sex interaction (0.007). Therefore, 
three-way ANOVA was used to statistically analyze granulocytes at each time point 
separately. The results showed no effect of DON on granulocytes after 28 d. But increased 
granulocytes were observed at 1.0 and 2.0 ppm DON after 14 d, especially in old male mice 
and young female mice with a trend to increase with DON dose (Table 4.3).   
Two- way ANOVA with sexes and ages analyzed separately was used to analyze for 
percentage of circulating CD4
+
 leukocytes (T helper cells) in BALB/c mice due to age and 
sex difference and interaction of time and sex after analysis by four-way ANOVA. After 14 d 
and not after 28 d, CD4
+
% leukocytes were decreased at 2.0 ppm DON (p < 0.05), however 
when both time points were combined, 2.0 ppm DON decreased the percentage of CD4
+
 
leukocytes compared with 0 or 1.0 ppm DON in young female mice. Old female mice 
showed a greater percentage of CD4
+
 cells at 14 d than at 28 d (p=0.03, Table 4.4). 
Three-way ANOVA within each age group separately was used to analyze the percentage 
of circulating CD19
+
 leukocytes in BALB/c mice because of the overall interaction between 
age and sex (0.0014) and age and dose (0.014) after four-way ANOVA . The results showed 
no effect of DON on B cells in old mice. An increased percentage of CD19+ leukocytes was 
found in young female mice fed DON 2.0 ppm after 14 or 28 d compared with controls 
(p=0.03).  There was a significant difference in the effect of DON on B cells between young 
females and young males (p=0.01) (Table 4.5) 
Phenotyping of spleen leukocytes 
Total spleen leukocytes were significantly greater in all old mice at 14 d compared with 
old mice fed DON for 28 d (2.2 ± 0.2 x 10 
8
 vs. 1.6 ± 0.2 x 10
8
). There was no significant 
difference between old mice fed any diet over 28 days and all young mice. Enlarged spleens 
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were observed in some old mice (n=5) after 14 d compared with old mice after 28 d. 
According to cell counts, the spleen cell counts in these old mice fed for 14 d showed greater 
cell counts than old mice fed for 28 d, increased by as much as threefold. 
There were significantly greater numbers of macrophages in young females than in male 
counterparts (female vs. male, p=0.02, age * sex, p= 0.03, old vs. young, p=0.82, Fig 4.1B), 
independent of DON dose at 14 and 28 d.   
There were no significant interactions observed by four-way ANOVA for percentages of 
CD4
+
, CD8
+
 and CD19
+
 splenic cells. Percentages of CD4+ splenic cells were not different 
between young and old mice (27.1 vs. 27.9%). Percentages of CD8
+
 splenic cells were 
greater in young mice than in old ones (10.7 vs. 8.9%). Old mice had a greater percentage of 
CD19
+
 splenic cells than did young mice (42.6 vs. 39.5%). Overall, based on four-way 
ANOVA, there were significant differences in the percentage of CD11b
+
 splenocytes 
between old and young (p<0.0001), between female and male (<0.0001), and among doses of 
DON (P= 0.0062), with no difference according to feeding intervals (p=0.47). There were 
interactions of age by sex (p=0.06), age by dose (p=0.02) and age by sex by dose (p= 0.02) in 
CD11b
+
 splenocytes. Therefore, two-way ANOVA within age and sex group was used to 
analysis of CD11b
+
% splenic cells. Whereas female mice combined across feeding intervals 
showed that 1.0 ppm DON decreased CD11b
+
 splenic cells in old female mice and 2.0 ppm 
DON decreased CD11b
+
 splenic cells in young female mice compared with controls, both of 
these effects were due to differences occurring at 14 d only (Table 4.6). 
CXCR5 expression in peripheral blood leukocytes 
CXCR5 response differed between young and old mice (p=0.0001) and between females 
and males (p=0.0008) analyzed by four-way ANOVA. The expression of CXCR5 in CD19+ 
cells was 58.0%, 53.7%, 41.4% and 39.4% for old female, old male, young female and young 
male, respectively.  There was decreased CXCR5 expression in B cells in old female mice 
fed 2.0 ppm DON over 14 d compared to their controls(within age and sex)  (Table 4.7, Fig 
4.2). 
LFA-1 (CD29) and VLA-4 (CD11a) expression in peripheral blood leukocytes 
CD11b is expressed consistently in granulocytes (neutrophils) and monocytes (Imhof and 
Aurrand-Lions 2004). Therefore, we assumed all cells in mononuclear gates stained CD11b
+
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were assumed to be monocytes, and cells in the granulocyte gate stained CD11b
+
 were 
neutrophils. In the granulocyte gate, CD11b positive cells were grouped by high (CD11b
++
) 
and low (CD11b
+
) expression based on intracytoplasmic granularity (Fig 4.3). The results 
shown included all neutrophils (CD11b
++
 plus CD11b
+
) as a single cell type. 
For neutrophils, three-way ANOVA within sex was used due to interactions state the 
interactions analyzed by four-way ANOVA. Females did not differ in integrin 
(CD29+/CD11a+) expression across age, DON dose or feeding interval. Increased integrin 
expression was observed in male mice fed 1.0 ppm DON (p=0.02) compared with either 
controls or mice fed 2.0 ppm DON, across ages, but this increase was greater at 14 than at 28 
d (p=0.02) (Table 4.8). 
Young female mice fed 2.0 ppm DON for 28 d showed decreased expression of 
CD11a
+
CD29
+
 in neutrophils ( 67.0±4.0% in controls vs. 54.1± 4.0% in mice fed 2.0 ppm 
DON, p < 0.05).  
Chemokine receptors (CCR7, CCR9, CCR10) and L-selectin expression (CD62L) in 
peripheral T helper cells and T cytotoxic cells 
L-selectin and CCR7 are required for naive T cell migration to lymph nodes, whereas 
effecter T cells that can access peripheral inflammatory tissues show a loss of both markers. 
CCR7
+
CD62L
+
 T helper cells were grouped as naïve and central memory T cells and CCR7
-
CD62L
- 
cells were grouped as effecter T cells, whereas CCR7
-
CD62L
+
 and CCR7
+
CD62L
-
 T 
cells were possibly in intermediate developmental stages.  Overall, there were no interactions 
in age, sex, dose and feeding intervals by four-way ANOVA. Young mice had greater 
numbers of naïve T helper cells and effecter T helper cells than did old mice, whereas no 
difference in CCR9 and CCR10 positive T helper cells was seen between old and young mice. 
There were no differences between young and old mice in naïve T cytotoxic cells, T 
cytotoxic effecter and CCR10 positive T cytotoxic cells. Young mice had greater numbers of 
CCR9 positive T cytotoxic cells than did old mice (Table 4.10, p<0.0001).  
Overall, 1 ppm DON increased T cytotoxic effecters compared with 2.0 ppm DON but 
not compared with controls (Table 11, p=0.04). CCR9
+
 T cytotoxic cells in old males were 
increased more than twofold by 2.0 ppm DON compared with controls after 28 d (Table 
4.10). 
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Discussion 
Inhibition of body weight gain was found in young males fed 1.0 ppm DON for 14 d, but 
no decrease in body weight gain after 28 d suggested that mice adapted to DON exposure or 
became used to individual housing and other aspects of their environment (Table 4.1). 
Generally, reduced body weight gain was found in mice, rats and pigs fed DON. The LOAEL 
was set at 2.0 ppm dietary DON exposure based on growth inhibition (Pestka and Smolinski 
2005). Increased body weight gain but not food intake was found in young females and male 
mice fed 1.0 ppm DON compared with controls after 28 d (Table 4.1). This has not been 
reported previously, but suggests an improvement in feed efficiency that may deserve further 
study.  
Decreased T helper cells and T cytotoxic cells in 17- month old mice compared to 3 
month old counterparts, as well as reduced numbers of B cells and monocytes were seen in 
old mice although the scale of decrease was not as great as T cell changes between two ages 
(Table 4.2). Neutrophils were not different between these two ages of mice. Fewer T cells in 
peripheral blood could be related to accumulation of developmental defects in bone marrow, 
thymus and secondary lymph organs. Less efficiency in giving rise to T-lineage cells in aging 
bone marrow progenitors, reduction in the development potential of intrathymic T cell 
progenitors to become early T lineage progenitors with a greater rate of apoptosis, and less 
efficient emigration from their tissue of origin to secondary lymphoid organs contribute to 
decreased T cells in aging mice (Zediak et al. 2007; Min et al. 2004; Linton and Dorshkind 
2004). Decreased early B cell lineage proliferation and differentiation in bone marrow and 
reduced germinal center production or accumulation of B lineage cells in spleen reduced 
peripheral blood B cells with aging (Linton and Dorshkind 2004; Min et al. 2006; Frasca et al. 
2004; Simioni et al. 2007; Verdier et al. 2006). A comparative study in BALB/c mice done 
by Pinchuk et al. (2008) showed peripheral blood had less monocytes and dendritic cells with 
age based on relative cell number of CD11b
+
 cells and CD11b/c, respectively, the same 
marker for monocytes as used in this study.   
We observed that old mice expressed greater levels of CXCR5 than young counterparts 
(Table 4.7, Fig 4.2). CXCR5, a chemokine receptor expressed in B cells and some follicular 
T helper cells, is important to guide B cell homing to spleen for final B cell survival and 
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maturation (Reif et al. 2002).  Increased CXCR5 in old mice could compensate for less 
production of B in bone marrow and less emigration to spleen because of intrinsic errors 
happening in old mice (Table 4.3, Linton and Dorshkind 2004). 
Migration of naive T cells to lymph nodes to encounter antigen and be activated to 
effecter cells has to undergo multistep interactions with endothelial cells. Decreased numbers 
of T cell subsets (Table 4.9), especially naive T cells (CD62L
+
CCR7
+
) with aging, suggested 
reduced migration potential of T cells to lymph node, which could be related to increased 
morbidity and mortality in old people after infection.   
The immune system is very complex with multiple and varied connections with 
endocrine and nervous systems. Sex hormones could directly modulate the development or 
function of immune cells by estrogen or androgen receptors in immune cells. Young females 
showed greater numbers of monocytes in peripheral blood and macrophages in spleen than 
did males, but no difference was seen between young and old males after feeding DON (Fig 
4.1). This is consistent with our first mouse feeding study: young females had greater 
monocytes and macrophages than males. Ansar Ahmed and Talal (1990) reviewed sex 
hormone effects on phagocytic cells and summarized that female rats had more macrophages 
than males, and estrogens stimulate the number of circulating monocytes. 
Multiple surface markers were influenced by dietary DON exposure and the effect of 
DON on these markers was influenced by sex and age. In young female mice, in peripheral 
blood, several markers changed: after feeding DON for 14 d, granulocytes were increased at 
1 and 2 ppm DON, not after 28 d (Table 4.3). The results showed decreased percentages of T 
helper and CD11b
+
 (macrophages) in spleen at 2.0 ppm DON after 14 d, as well as increased 
percentage of B cells from 2.0 ppm DON after 14 and 28 d (Tables 4.4, 4.5, 4.6). The 
expression of integrins (lymphocyte function-associated antigen-1, known as CD11a, LFA1 
and very late antigen 4, known as CD29, VLA4) in neutrophils was inhibited by 2.0 ppm 
DON after 28 d (see result).  Reduced T helper cells are related to multiple immune 
inhibitions in that T helper cells are required to regulate all cell functions, especially the 
function of T cytotoxic cells, macrophages and B cells. Mature neutrophils in peripheral 
blood undergo selectin-mediated rolling, chemokine-triggered activation and integrin-
dependent arrest in order to get to the site of inflammation to mediate bactericidal activity 
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(Ley et al. 2007). Macrophages are important for innate immunity (to phagocytose pathogens) 
and cell-regulated immunity (as antigen-presenting cells). Therefore, main effect of DON in 
young females may have changed the balance of T helper and B cells in peripheral blood and 
macrophages in spleen and decreased integrin expression in neutrophils, which could be 
related to increasing infectious potential.  
After old females were fed DON, reduced CXCR5
+
 B cells was noted in peripheral blood 
at 2.0 ppm after 14 d (Table 4.7), and reduced splenic CD11b
+ 
cell % at 1.0 ppm, but no 
dose-response was seen for CD11b
+
 cell % change in spleen (Table 4.6). Decreased CXCR5
+
 
B cells after DON could transitorily interrupt B cell access to spleen for further maturation 
and survival. Surprised, peripheral blood B cells tend to deceased by 2.0 ppm DON (1.2±0.4 
x10
6 
vs. 0.7±0.4x10
6
), whereas splenic B cells tend to increased by 2.0 ppm DON (7.1±0.9 
x10
7
 vs. 8.0±1.0x10
7
) after 14 d, which suggested DON interrupted B cells migration from 
blood to spleen, and after maturation of B cells in spleen, B cell accumulation might happen 
in spleen.   
In old male mice, most significant changes were observed in increased granulocytes 
(Table 4.3) and increased expression of integrins LFA-1(CD11a) and VLA-4 (CD29) in 
neutrophils at 1.0 and 2.0 ppm DON after 14 d (Table 4.8), and increased CCR9
+
 T cytotoxic 
cells after 28 d, which could be related to inflammatory conditions in small intestine. By 
engaging endothelial cell surface ligand ICAM1 (to LFA-1) and VCAM1 (to VLA-4), 
neutrophils keep rolling slowly and are arrested near endothelial cells to finally get to sites of 
inflammation (Ley et al. 2007). It was reported that DON mediates a broad range of 
epithelial injury including atrophic growth inhibition and inflammation in the human 
gastrointestinal tract by increasing IL-8 production. Van De Walle et al. (2008) reported 0.84 
μM DON inhibited Caco-2 cell proliferation and increased IL-8 secretion for 24 h incubation. 
DON at 0.08 μM increased IL-8 secretion by activated MAPK pathway in human intestine 
407 cells for 12 h incubation (Moon et al. 2007). DON at 1.69 μM altered cell cycle progress 
related to human epithelium pathogenesis after incubating with HCT-116 cells for 48 h 
(Yang et al. 2008). Additional studies will be necessary to determine if dietary DON causes 
inflammatory injury in intestine at 1.0-2.0 ppm. For example, increased serum IL-1, IL-6, 
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TNFα and TNFβ associated with increased integrins in neutrophils could help to determine 
whether dietary 1.0-2.0 ppm DON causes gastrointestinal inflammation.  
CCR9
+
 T cytotoxic cells were increased by DON, which may stimulate T cytotoxic cell 
migration to small intestine. Young mice had more CCR9
+
 T cytotoxic cells in circulation 
compared with old mice, which was partly consistent with the finding of Olaussen et al. 
(2001) that circulating CCR9
+
 T cells decline with age from approximately 15% of all T cells 
at birth to around 1% in adults. The chemokine receptor CCR9 is expressed by thymocytes as 
well as by circulating gut-homing and resident T cells in the small intestinal mucosa. Its 
ligand CCL25 is constitutively expressed in the small intestine by the epithelial cells (Pabst 
et al. 2004; Johansson-Lindborn and Agace 2007). CCL25 mediates the localization of 
recently activated CD8
+
 lymphocytes to the small intestinal mucosa (Svensson et al. 2002). 
Increased CCR9
+
 T cytotoxic cells (CCR9
+
CD8
+
) in old males and young female mice 
suggested that DON exposure could cause intestinal mucosal inflammation. In patients, 
increased circulation of CCR9
+
 T lymphocytes was associated with small intestine 
inflammation, but not colonic inflammation (Papadakis et al. 2001). Rivera-Nieves et al. 
(2006) reported that in early stage of chronic small intestine inflammation, increased CCR9
+
 
lymphocytes, predominately within CD8
+
 T cells was observed in the distal ilea. Blockade of 
CCL25/CCR9 ameliorates early murine chronic intestine ileitis. Another explanation of 
increased circulation CCR9
+
 T lymphocytes in this study could be related to recruitment of T 
cells to small intestine to help clear intestinal infection. Integrins α4 β7 expressed in gut-
associated lymphoid tissue as well as in T cells in lamina propria of the small intestine 
(Kunkel et al. 2003), together with CCR9 on lymphocytes, mediate the migration of 
circulatory T cells to small intestine (Svensson et al. 2002). There is insufficient data to 
understand whether expression of high numbers of CCR9
+
 cells enhances cell trafficking to 
the small intestine. Additional studies, such as checking if greater numbers of CCR9
+
 T 
lymphocytes are found in Peyer‟s Patch or in local intestinal lymph nodes, or greater integrin 
α4 and β7 are expressed in T cells could help explain whether CCR9+ T lymphocytes could 
recruit to the small intestine and whether increased CCR9
+
 T lymphocytes are related to 
chronic intestine inflammation after DON exposure.  
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Increased T cytotoxic effecters at 1.0 ppm DON suggested low dose DON had some 
benefit to the immune system (Table 4.11). Increased T lymphocyte effecter could help T 
cells access inflammatory tissue even if no information exists currently as to which tissues 
effecter T cells prefer. In our lab, a previous study found male BALB/c mice fed 1.0 ppm 
DON stimulated natural killer cell cytotoxicity, plaque-forming cells and spontaneous IFN-γ 
secretion (Landgren 2005). After exposure to environmental agents, “hormesis” is the term 
used by toxicologists to explain the biphasic dose-response of a low-dose benefit and a high-
dose adverse effect. Mattson (2007) summarized cellular signaling pathways and molecular 
mechanism to mediate hormetic responses involving intracellular signal molecules kinases, 
deacetylases, and transcription factors such as Nrf-2 and NF-κB. Few investigations on DON 
influence on chemokine receptors were reported. However, the mechanisms of DON toxicity 
on cell proliferation, and dysfunction of cytokines were much studied. The results showed 
p38 MAPK signaling, protein kinases ERK1/2 and JNK, and transcription factor NF- κB 
(subunit p65) are potential molecular targets for action of DON involving the inhibition 
proliferation of lymphocytes, inhibition of function of dendritic cells and increase of 
inflammatory cytokines (Shifria and Henderson 1999; Baltriukiene et al. 2007; Bimczok et al. 
2007; Moon and Pestka 2002; Gray and Pestka 2007; Moon et al. 2007). Therefore, 1.0 ppm 
dietary DON in this study increased effecter molecules, the mechanism of which could 
involve these intracellular kinases and transcription factors. 
In this study, dominant effect of DON to young female and old female mice occurred 
after 14 d (Tables 4.4, 4.5, 4.6, 4.12). DON effect disappearing after 28 d fed suggested 
BALB/c mice were adapted to 0-2 ppm dietary DON. DON adaptation in BALB/c mice 
model was observed in several different studies (Landgren 2005, 2006, Wu et al. 2008). 
Prolonged exposure of DON may induce detoxification enzymes in small intestine, liver 
and/or alter microorganism metabolism pattern in large intestine.  DON could be degraded to 
de-epoxy DON in the gut (Worrell et al. 1989) and biotransformed to DON glucuronide by 
UDP-glucuronosyltransferase (UGT) in liver and/or intestine in rat (Meky et al. 2003). Both 
de-epoxy DON and DON glucuronide are detoxified forms of DON (Wu et al. 2007; 
Sundstol Eriksen et al. 2004). Therefore, detoxification enzyme induction and metabolism 
pattern altering in the gut deserve further study.  
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Conclusions 
After BALB/c mice were fed DON at 1.0 and 2.0 ppm, age, sex and feeding intervals all 
disrupted immune response. Decreased percentage of T helper cells after 14 d and increased 
percentage of B cells at 2.0 ppm after 14 d and 28 d in peripheral blood (PB), as well as 
decreased percentage of splenic macrophage cells at 2.0 ppm after 14 d compared with 
controls within groups, which suggested 2.0 ppm DON changed cell balance in peripheral 
blood and splenic cells in young female mice. In young male mice, no change in these cell 
markers were observed but reduced body weight gain after 14 d but not after 28 d suggested 
mice adapted to individual housing and other aspects of their environment. In old mice, the 
most important change was in migration markers in peripheral blood. Reduced CXCR5 
expression in B cells in old female mice suggested transitorily interrupt B cell access to 
spleen for further maturation and survival. Increased integrin expression in neutrophils and 
increased CCR9
+
 expression in T cytotoxic cells in old male mice suggested DON 
interrupted or adjusted the migration of leukocyte in peripheral blood. These information 
suggested intestinal inflammation response due to DON in old male mice. More studies will 
be necessary to make a decision as to whether digestive system inflammation occurred in old 
male mice after DON exposure.  For example, increased serum inflammatory cytokines IL-1, 
IL-6, TNFα and TNFβ associated with current information in neutrophils and T cytotoxic 
cells could support more evidence to small intestine inflammation in old male mice. Taken 
together, reduced PB T helper cells could be a useful biomarker to predict DON toxicity in 
young female mice. However, this effect disappeared after 28 d suggested BALB/c mice 
adapted to DON exposure in selective biomarker. DON could cause small intestine 
inflammation in old male mice at 1-2 ppm DON, which could reduce prevention capacity to 
bacteria through food since the small intestine mucosal surface is the first barrier to pathogen.    
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Table 4.1:  The food intakes and body weights of young BALB/c mice fed DON over 14 
or 28 d.     
groups 
Dose 
(ppm) 
Initial (g) Final (g) 
Body weight 
gain (g) 
Food intake (g/d) 
F14 
0 19.01 19.96 0.99 3.28 
1.0 18.79 20.15 1.36 3.32 
2.0 18.86 19.55 0.81 3.17 
M14 
0 21.91 23.88 1.97
a 
3.58 
1.0 22.31 22.98 0.74
b 
3.60 
2.0 22.44 23.44 1.10
ab 
3.62 
Probability
#
 
Female vs male 
(<0.0001) 
Female vs male 
(<0.0001) 
Sex * dose 
(0.02) 
Female vs male 
(<0.0001) 
F28 
0 18.56 20.34 1.82
b 
3.24 
1.0 18.82 21.47 2.65
a 
3.43 
2.0 18.48 20.76 2.27
ab 
3.25 
M28 
0 23.24 25.08 1.87 3.62 
1.0 23.30 25.63 2.33 3.63 
2.0 23.26 25.34 2.08 3.58 
Probability
# Female vs male 
(<0.0001) 
Female vs male 
(<0.0001) 
ns 
Female vs male 
(<0.0001) 
Different letters indicated significant difference, comparison across the column within feeding intervals 
based on one-way ANOVA analysis (p<0.05). 
#: based on two-way ANOVA analysis within day, only significant difference in factors and interactions 
were shown.  
ns: not significant difference  
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Table 4.2: Decreased mononuclear cells including T helper cells, T cytotoxic cells, 
monocytes and B cells in peripheral blood with age 
Number of cells 
 per ml blood 
Y14 Y28 O14 O28 Probability
 ¥
 
mononuclear 
6162500
a
 
 
5202833
ab 
 
4157333
bc 
 
3272741
c 
 
O vs Y (0.0004) 
CD4+ 
(T helper) 
2345190
a 
 
2027429
a 
 
1182524
b 
 
883244
b
 
 
O vs Y (<0.0001) 
CD8+ 
(T cytotoxic) 
793071
a
 
 
644548
a 
 
452629
b 
 
374820
b 
 
O vs Y (<0.0001) 
14 vs 28 (0.04) 
#
CD11b+
 
(monocytes) 
514162
a 
 
487960
a 
 
405440
ab
 
 
346885
b 
 
O vs Y (0.03) 
F vs M (0.0001)
 
Age *sex (0.0043) 
CD19+ 
(B ) 
1662238
a 
 
1379238
ab 
 
1232438
ab 
 
1090070
b 
 
O vs Y (0.05) 
€
Granuocytes 
759045
a 
 
635950
ab 
 
725405
ab 
 
628251
b 
 
Dose (0.01) 
Day *sex (0.007) 
CD11b+ 
(neutrophiles) 
510574 427688 508060 429896 
Dose (0.03) 
Day *sex (0.006) 
The values were least square means (n=42). Comparison across rows, different letters indicate significant 
difference (p<0.05). O: 16~17 month old BALB/c mice; Y: 10~12 week old BALB/c mice.  
¥ : only significant value at p=<0.05 showed in factor and factor interactions. 
#: Fig 1 showed more information on sex differences. 
€ : Table 3 showed more information on dose effect. 
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Table 4.3: Increased granulocytes in BALB/c mice fed DON after 14 d (three-way 
ANOVA with feeding intervals due to day * sex interaction shown in table 2, the values as 
number cells/ml blood). 
Groups DON doses (ppm)  Probability
 #
 
 0 1.0 2.0 
Means 
across 
doses 
 
OF14 537714 672714 571429 593952 
Sex (0.03) 
Dose (0.02) 
OM14 563286 950714 1056571 856857 
YF14 588143 733286 818143 713190 
YM14 658571 960000 796129 804900 
Means across 14 days 586929
b 
829179
a 
810568
a 
  
OF28 675714 787429 603286 688810 
ns 
OM28 564386 585201 551429 567005 
YF28 634286 593314 730143 652581 
YM28 481671 776000 600286 619319 
Means across 28 days 589014 685486 621286   
Different letters across row indicated significant difference in dose effect based on one-way ANOVA 
analysis. 
# : only significant effects  in factor and interaction were shown 
ns: not significantly different  
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Table 4.4: DON effect on circulating CD4+ leukocytes in BALB/ mice (two way 
ANOVA separately by age and sex due to age and sex difference and interaction of time and 
sex, the values as % leukocytes) 
Groups DON doses (ppm)  Probability
#
 
 0 1.0 2.0 
Mean 
across doses 
 
OF14 27.3 26.7 23.0 25.6 
14 d vs 28d   (0.03) 
OF28 20.3 22.0 20.3 20.9 
Mean across old female 23.8 24.3 21.6   
OM14 21.4 20.0 21.5 21.0 
ns 
OM28 24.0 25.1 23.8 24.3 
Mean across old male 22.7 22.5 22.7   
YF14 39.9
a
 41.1
a 
32.3
b 
37.8 
Doses (0.02) 
YF28 37.3 37.5 34.9 36.7 
Mean across young female 38.6
a
 39.3
a 
33.6
b 
  
YM14 31.8 33.4 35.0 33.4 
ns 
YM28 35.6 32.5 32.7 33.6 
Mean across young male 33.7 33.0 33.8   
Different letters across row indicated significant difference in dose effect based on one-way ANOVA 
analysis. 
# : only significant effects  in factor and interaction were shown 
ns: not significantly different  
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Table 4.5: DON effect on circulating CD19+ leukocytes in BALB/c mice (three-way 
ANOVA by age due to interaction of age *sex and age *dose, values as % leukocytes) 
Groups DON doses (ppm) 
Means across 
doses 
Probability
#
 
 0 1.0 2.0   
OF14 25.3 20.4 20.6 22.1 
OM vs OF 
(0.05) 
OF28 23.8 24.6 22.2 23.5 
OM14 21.9 16.7 15.6 18.1 
OM28 19.8 24.9 19.5 21.4 
Means across old mice 22.7 21.7 19.5   
YF14 18.4
b
 18.7
ab 
24.8
a 
20.7 
YF vs YM 
(0.01) 
Dose (0.03) 
YF28 17.6
b 
19.3
ab 
22.1
a 
19.7 
Means across young  
female mice 
18.0
b 
18.9
b 
23.6
a 
 
YM14 22.8 23.1 23.8 23.2 
YM28 21.6 23.1 22.3 22.3 
Means across young 
 male mice 
22.2
 
23.1
 
23.0
 
  
Overall, age*sex (0.0014), age * dose (0.0143).  
Different letters across row indicated significant differences in dose effect based on one-way ANOVA 
analysis. 
# : only significant effects  in factor and interaction were shown 
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Table 4.6:  DON effect on CD11b+ splenic cells (macrophages) in BALB/c mice (Two-
way ANOVA separately by age and sex, the values as % splenic cells) 
Groups DON doses (ppm)   
 0 1.0 2.0 
Mean 
across doses 
Probability
#
 
OF14 3.3
a 
2.4
b 
3.4
a 
3.0 
Dose (0.03) 
OF28 3.3 2.6 3.1 3.0 
Mean across old female 3.3
a 
2.5
b 
3.3
a 
  
OM14 2.7 2.7 2.5 2.6 
ns 
OM28 3.2 2.4 2.4 2.6 
Mean across old male 2.9 2.5 2.4   
YF14 4.2
a 
3.9
ab 
3.6
b 
3.9 
Dose (0.01) 
YF28 4.2
ab 
4.5
a 
3.9
b 
4.2 
Mean across young female 4.2
a 
4.2
a 
3.7
b 
  
YM14 3.4 3.3 3.3 3.4 
ns 
YM28 3.4 3.4 3.4 3.4 
Mean across young male 3.4 3.4 3.4   
Different letters across row indicated significant difference in dose effect based on one-way ANOVA 
analysis. 
# : only significant effects  in factor and interaction were shown  
ns: not significant difference  
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Table 4.7: Less expression of CXCR5 on B cell surface found in old female BALB/c 
mice in peripheral blood (the values as % leukocytes)  
Groups DON doses (ppm)  Probability
#
 
 0 1.0 2.0 
Mean 
across doses 
 
OF14 64.5
a 
60.5
ab 
48.5
b 
57.8 
ns 
OF28 59.3 58.4 56.5 58.1 
Mean across old female 61.9 59.5 52.5   
OM14 55.6 58.9 51.5 55.3 
ns 
OM28 53.5 48.4 54.0 52.0 
Mean across old male 54.5 53.6 52.7   
YF14 41.2 47.9 40.3 43.1 
ns 
YF28 43.9 37.8 37.3 39.6 
Mean across young female 42.5 42.9 38.8   
YM14 37.9 41.0 39.2 39.3 
ns 
YM28 35.0 30.8 37.4 39.4 
Mean across young male 36.4 35.9 38.3   
Overall, old vs. young (p=0.0001) female vs. male (p=0.0008). Therefore, two -way ANOVE analysis with 
dose and feeding intervals were used.   
Different letter indicated significant difference comparison across row based on one-way ANOVA analysis. 
# : only significant effects  in factor and interaction were shown 
ns: not significant difference  
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Table 4.8: Increased CD29
+
CD11a
+
 neutrophils in male BALB/c mice fed DON after 14 
d (three way-ANOVA within sex due to the interaction of time * sex). The data was shown 
as cell number per ml blood. 
Groups DON doses (ppm)  Probability
 #
 
 0 1.0 2.0 
Means 
across 
doses 
 
OF14 223229 218086 185357 208890 
ns 
OF28 255471 296800 261686 271319 
YF14 244886 285596 253846 261443 
YF28 263971 194829 295543 251448 
Means across 
female 
246889 248828 249108   
OM14 214243 474229 397271 361914 
14d vs 28 d 
(0.02) 
Dose (0.02) 
OM28 218871 236300 209620 221597 
YM14 287100 378014 220200 295105 
YM28 175080 334529 209771 239793 
Means across 
male 
223823
b
 355768
a 
259216
b 
 
Different letter indicated significant difference comparison across row based on one-way ANOVA analysis. 
# : only significant effects  in factor and interaction were shown  
ns: not significant difference  
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Table 4.9: Age effect on surface chemokine and L-selectin expression of T helper and T 
cytotoxic cells in BALB/c mice, independent of DON dose  and feeding interval, the values 
as cell number per ml blood). 
Parameters/ml blood old young 
Probability  
(old vs. young) 
CD4
+
CCR7
+
CD62L
+
 
(Naïve T helper cells)  
65607±6254 188151±13798 <0.0001 
CD4
+
CCR7
-
CD62L
-
 
(effecter T helper cells) 
357397±48058 520464±44624 0.0219 
CD4
+
CCR9
+
 13642±1005 13669±923 ns 
CD4
+
CCR10
+
 63634±16419 104629±15302 ns 
CD8
+
CD62L
+
CCR7
+
 1367±293 2039±270 ns 
CD8
+
CCR10
+
 6005±1884 10738±1742 ns 
The values were least square means ± standard errors. 
ns: not significant difference  
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Table 4.10: DON effect on chemokine receptor CCR9 expression in T cytotoxic cell (the 
data was shown as cell number per ml blood) 
Groups Feeding day 
DON doses (ppm) Mean across 
doses 
Probability
#
 
0 1.0 2.0 
Old female 
14 d 7212 6346 5251 6270 
OF vs OM 
(0.03) 
28d 5432 6202 4909 5514 
Old male 
14 d 10213 11514 4804 8844 
28d 5579
 
11154
 
18411
 
11715 
 
Mean across 
 old mice 
7109 8804 8344   
Young 
female 
14 d 17643 22998 23426 21356 
YF vs YM 
(0.02) 
28d 14648 17254 18557 16820 
Young 
male 
14 d 15220 18568 15755 16514 
28d 10119 12190 10823 11044 
 
Mean across 
young mice 
14407 17752 17140   
Overall, old mice vs. young mice differed (p<0.0001), age * sex (0.001). Three-way ANOVA separately by 
age was used for data analysis. 
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Table 4.11: DON effect on T cytotoxic effecters in peripheral blood in BALB/ c mice 
(The data was shown as cell number per ml blood) 
Groups 
Feeding 
day 
DON doses (ppm) Mean 
across 
doses 
Probability
#
 
0 1.0 2.0 
Old 
female 
14 d 153410 210938 116503 160283 
Doses 
(0.04) 
 
28d 199246 243788 94669 179234 
Old 
male 
14 d 233038 321906 118302 224416 
28d 101914 178729 151180 143941 
Young 
female 
14 d 229225 228586 258866 238899 
28d 251625 210563 247537 236475 
Young 
male 
14 d 222838 348975 213550 261788 
28d 111471 214242 139075 154929 
 
Mean 
across 
groups 
187846
ab 
244678
a 
167463
b 
  
Different letter indicated significant difference comparison across row based on one-way ANOVA analysis. 
# only significant p value in factors and interactions shown 
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Table 4.12: Main peripheral blood leukocyte and splenic surface marker changes in 
BALB/c mice fed DON for 14 d or 28 d 
groups 14 d 28d 
Young 
female mice 
CD19
+
 leukocytes% in PB↑ (2 ppm, by 37%) 
CD4
+
 leukocytes% in PB↓ (2 ppm, by 20%) 
CD11b
+
 splenic cells%↓ (2 ppm, by 14%) 
Granulocytes in PB↑ (1 and 2 ppm, by 25-39%) 
CD19
+
 leukocytes% in PB↑ (2 ppm, by 
26%) 
CD29
+
CD11a
+% (neutrophils) in PB ↓ (2 
ppm, by 19%) 
Young male 
mice 
Granulocytes in PB↑ (1 and 2 ppm, by 21- 46%) ns 
Old female 
mice 
CXCR5
+
% (B cells) in PB ↓ (2 ppm, by 24%) 
CD11b
+
 splenic cells%↓ (1 ppm, by 28%) 
Granulocytes in PB↑ (1 and 2 ppm, by 6-25%) 
ns 
Old male 
mice 
Granulocytes in PB↑(1 ppm and 2 ppm,  by 69-
88%) 
Number of CD29
+
CD11a
+
 neutrophils in PB↑ (1 
ppm and 2 ppm by 93-113%) 
Number of CCR9
+
T cytotoxic cells in PB 
↑ (2 ppm,  by 2.3 fold) 
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Fig 4.1: Greatest expression of CD11b+ cells occurred in young female BALB/c mice in 
peripheral blood and spleen (A) Peripheral monocytes showed difference between female 
and male mice (p=0.0002), between old and young mice (p=0.0093), the interaction of age 
and sex (0.02), no significant different in other factor interaction. (B) Splenic macrophage 
cells showed difference between young female and male mice (p=0.0006) and interaction of 
age and sex (0.03), no significant different in other factor interaction. Different letters 
indicates significantly difference (p<0.0001). The vales were mean ± SEM (n=48~60).  
Fig 4.2: Phenotypic analysis of BALB/c mice B cells subsets. Peripheral blood was 
stained with APC-Cy7 CD19 and PE CXCR5 in old female (A), old male (B), young female 
(C) and young male (D), respectively. Underlined numbers on each panel indicates the mean 
percentage of CXCR5
+
 B cells in each age and sex group. 
Fig 4.3: Phenotypic analysis of BALB/c mice neutrophils subsets (A) Peripheral blood 
was stained with PE-Cy7 CD11b; (B) Peripheral blood was stained with PE-Cy7 CD11b
++ 
CD11a
+
CD29
+
; (C) Peripheral blood was stained with PE-Cy7CD11b
+
CD11a
+
CD29
+
.  
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CHAPTER 5 GENERAL CONCLUSIONS 
General discussion 
The current work was to improve toxicological data of DON to assure that current 
guidelines provide the appropriate safety factors for the consumer. Both studies were done in 
the BALB/c mouse model. Peripheral blood and spleen leukocytes were stained 
immunochemically and detected by flow cytometry. The results showed age, sex, tissue 
collected, dose, and exposure time all influenced the final measurement of DON 
immunotoxicity.  
In the first mouse study, 6-7 week old BALB/c mice were ordered from Jackson Lab, and 
animals were acclimated for 3-7 days before they were fed test diets.  The animals were 
euthanized at 14 d and 28 d after DON was fed, and 14 d and 28 d animals were killed at two 
different times. Animals euthanized at 14 d were 2 weeks younger than animals euthanized at 
28 d. The results showed female BALB/c mice were more sensitive to DON than males in 
that percentage of mononuclear cells in peripheral blood (PB) was inhibited at 1.0 and 2.0 
ppm DON after 14 d with decreased T helper and B cells in female BALB/c mice. 
Widespread lymphoid subset inhibition could be due to decreased differentiation of lymphoid 
precursor from stem cells. Female BALB/c mice fed control diet for 28 d had greater 
percentage of PB monocytes and splenic macrophage cells than mice fed for 14 d. One and 
2.0 ppm DON after 28 d caused lesser monocytes/macrophage cells in female mice than in 
controls, which suggested that DON could delay monocyte maturation, because monocytes 
increase as females become fully mature (the age range studied). Because females and males 
were similar in B cell response, pooled data suggested that DON inhibited peripheral blood B 
cells (CD19+%) at 1.0 and 2.0 ppm DON after 14 d, compared to controls within the same 
feeding interval. 
In the second mouse study, 8-9 week old BALB/c mice were ordered from Harlan 
Sprague Dawley, Inc and 16 month old BALB/c mice were purchased from National Institute 
of Aging. All animals were acclimated for 7-11 days before fed test diets.  Animals fed DON 
for 28 days were started on treatments 2 weeks earlier than animals fed DON for 14 days, so 
all animals were killed at the same time across the treatments. Animals fed for 28 d were 2 
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weeks older at euthanasia than mice fed for 14 days. The results showed age, sex, doses, and 
feeding intervals and collected tissues all influenced DON toxicity measurement.  
 In young animals, most effects of DON occurred after 14 d, and disappeared after 28 d. 
Decreased CD4
+ 
% (T helper) in peripheral blood, and decreased percentage of CD11b
+
 cells 
in spleen were observed in 2-3 month old female mice at 2.0 ppm DON after 14 d, not after 
28 d, which suggested that DON transiently interrupted cell balance in peripheral blood and 
spleen. CD19
+
 cells % (B cells) in peripheral blood were increased in 2-3 month old female 
mice at 2.0 ppm DON after 14 d and 28 d.  In 2-3 month old male mice, 1.0 ppm DON 
inhibited body weight gain after 14 d, not after 28 d, which suggested animals adapted to 
DON exposure or became used to individual housing and other aspects of their environment. 
In old mice, DON disrupted B cells, neutrophils and T cytotoxic cell migration. In 16 month 
old female BALB/c mice, 2.0 ppm DON reduced CXCR5+ B cells in peripheral blood after 
14 d, not after 28 d, suggesting that DON transiently interrupted B cell migration potentials. 
In 16 month old male BALB/c mice, increased granulocytes and increased CD29
+
CD11a
+
 
neutrophils at 1.0 and 2.0 ppm DON after 14 d and increased CCR9
+
 T cytotoxic cells after 
28 d suggested small intestinal inflammation. 
Take together, young female mice were more sensitive to DON than young males. After 
2-3 month old female BALB/c mice were fed DON after 14 d, the leukocyte balance of T and 
B cells in peripheral blood and macrophage cell in spleen, especially in female BALB/c mice, 
was changed. The total cell numbers of lymphocyte subsets were not changed significantly 
after intake of 0-2 ppm DON. The cell balance change could be due to changed 
differentiation of lymphocyte precursors in bone marrow. No cell markers were changed in 
2-3 month old male mice. Suppressed circulating and splenic leukocytes by DON, especially 
inhibition of PB CD4
+
 % in young female mice, was observed at 14 d, but not at 28 d, 
suggesting BALB/c mice adapted to DON exposure. One and 2 ppm DON seemed to cause 
small intestine inflammation in old male mice, which could reduce pathogen prevention 
capacity because the small intestine is the first barrier. 
There are some limitations to the current studies. 1) In comparison with percentage of 
cell number, absolute cell number in peripheral blood has a larger range in this animal model. 
Therefore, some changes in percentage of cell numbers by DON may not be observed to 
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accompany significant changes in total cell numbers of particular leukocyte subsets. For 
example, the percentage of CD19
+
 leukocyte in peripheral blood increased in 2-3 month old 
young female mice fed DON at 2.0 ppm significantly, whereas  mean total cell number of 
CD19
+
 leukocytes was increased by 2.0 ppm DON, but not significantly. The percentage of 
cells is the ratio of the number of positive cells divided by total leukocytes.  It is important to 
know the absolute number of particular leukocyte subsets. Flow cytometry measures the 
percentage of cell subsets accurately. A known number of beads added to samples permits 
accurate measurement of absolute cell numbers. Both ways to report cell subsets have been 
found in immunology publications. Changes in total cell number and in percentage of subsets 
cannot in and of themselves determine if immune function has been changed. Changes of 
immune function need other experiments to decide. 2) In regard to the objectives of current 
studies in order to find sensitive biomarkers to predict DON exposure in humans, 
measurement of peripheral blood leukocytes by flow cytometry is a very practical method, 
and may help to direct more mechanistic studies regarding DON‟s action. However, more 
study is needed to determine if changed biomarkers in peripheral blood in animal models are 
related to immune functional changes. Therefore, host resistant studies are needed before 
developing leukocyte biomarkers in animal model for transfer to human epidemiological 
studies. 3) DON dose/response was consistent in percentage of T helper cells in young 
female BALB/c mice. However, the effect of DON on T helper cells was only found in 
animals fed for 14 d, not after 28 d. To predict DON toxicity, stable biomarkers are necessary. 
4) Peripheral blood B cells were inhibited in the first study, but increased in the second study 
by 2 ppm DON in female BALB/c mice, suggesting that the immune system has a very 
complicated maturation during the stage between weanling and adult.  
Recommendations for future research 
Several aspects of these findings should be studied further in animal model: 1) most of 
the toxic effects of DON in BALB/c mice fed test diets for 14 d disappeared after 28 d. Was 
the “adaptation” to DON in BALB/ c mice due to induction of DON detoxification enzyme. 
As discussed in both manuscripts, DON glucuronide and de-epoxy DON are detoxified forms 
of DON. Prolonged exposure to DON could induce UDP-glucuronosyltrasferase in small 
intestine or liver, and alter microorganism metabolism pattern to increase detoxification 
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capacity.  2) Some potential benefit was observed at 1.0 ppm DON after 14 d, such as 
increased T cytotoxic effecter cells in the second study, suggesting a hormetic effect of this 
dose of DON. The mechanism of hormesis could involve intracellular kinases and 
transcription factors including p38 MARK signaling, protein kinases ERK1/2 and JNK, and 
transcription factor NF-κβ. Any benefit of DON would need to be confirmed by host 
resistance studies. To which tissue/organ the increased T cytotoxic effecter prefers to go is 
unknown. In order to investigate if increased T cytotoxic effecters preferentially migrate to 
the digestive system, a host resistance study such as Salmonella challenge host could provide 
some information because the small intestine is the first barrier after the host is infected with 
Salmonella through food. In order to investigate if increased T cytotoxic effecter 
preferentially migrated to the respiratory system, host resistance study such as influenza virus 
challenge could determine it because the target of influenza virus is the lung. 3) The effect of 
0-2 ppm DON on the function of T helper cells in the developing immune system need 
further study. The results in both studies showed percentage of CD4
+
 (T helper cells) in 2-3 
month old female mice were inhibited in peripheral blood at 2.0 ppm DON. Reduced T 
helper cells could be related to reduced function of all other type of cells, for example, B 
cells and macrophage cells. There is not enough information currently to determine how 2.0 
ppm DON interrupts the function of T helper cells. There are two types of T helper cells in 
peripheral blood: TH1 and TH2. Cytokine IFN-γ and cytokine IL-4 and IL-6 are biomarkers 
used to measure the function of TH1 and TH2, respectively. More studies need to investigate 
the function change of T helper cells in peripheral blood in animal model fed DON at 0-2 
ppm. 4) Reduced T helper cells in peripheral blood could be related to primary T cell 
development interruption in thymus by DON at 2.0 ppm in regard to the age of mice we used. 
DON may interrupt T cell development in thymus in some step. The expression of CD44, 
CD25, CD4 and CD8 can depict different developmental stage of T cells by flow cytometry.  
Overall, 2 ppm DON altered the circulating and splenic leukocyte subset and cell 
migration marker in BALB/c mice. And 1 and 2 ppm DON increased granulocytes and 
intergrin expression in neutrophils, which may be related to inflammation condition. Age, 
sex, and feeding interval interrupt the final assessment of immunotoxicity of DON. Function 
changes by 1-2 ppm DON deserve further study.  
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